Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCG,Pro-glucagon,39980,-0.477809968085713,0.0113805548621629,-0.500115855615552,-0.455504080555873,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFGE8,Lactadherin,40332,-0.173490912853691,0.00383346515707546,-0.181004504561559,-0.165977321145823,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS15,Enteropeptidase,40305,-0.335872904193284,0.00846779721781835,-0.352469786740208,-0.31927602164636,0
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.140279149731972,0.00388357705941121,-0.147890960768418,-0.132667338695526,7.43512383494725e-273
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYY,Peptide YY,37562,-0.308973709609498,0.00872155029344279,-0.326067948184646,-0.29187947103435,1.29570044332936e-262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRP,Agouti-related protein,40516,-0.16995829902216,0.00497080377451474,-0.179701074420209,-0.160215523624111,2.18709122531189e-247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.163958111173989,0.00488006529920012,-0.173523039160421,-0.154393183187556,3.83186994163948e-239
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPY,Pro-neuropeptide Y,40489,-0.193044190541179,0.00624709783849109,-0.205288502304621,-0.180799878777736,1.02167971426006e-203
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0835809040699718,0.00275203001746107,-0.0889748829041956,-0.0781869252357481,5.97847377317983e-197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN1,CCN family member 1,40280,-0.219116525458706,0.00731503407467052,-0.23345399224506,-0.204779058672352,8.35644956191877e-192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF9,Protein turtle homolog A,37990,-0.221683795084027,0.00740523317668696,-0.236198052110333,-0.20716953805772,1.01962243263081e-190
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.186894179565386,0.00630442913827443,-0.199250860676404,-0.174537498454369,6.20550415341218e-188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9,Complement component C9,37987,0.133507373779965,0.00454826427214569,0.124592775806559,0.14242197175337,1.15179049075559e-183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.140894231678326,0.00510490319613399,-0.150899841942749,-0.130888621413904,3.76684667761405e-163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS8,Prostasin,40293,-0.103482388470795,0.00380934446351628,-0.110948703619287,-0.0960160733223028,7.11111653812389e-159
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.129398979651377,0.00484759282991698,-0.138900261598014,-0.11989769770474,6.29387854500413e-153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP1,Neuropilin-1,40424,0.069723844057612,0.00266648088808024,0.0644975415169747,0.0749501465982493,1.29571534643863e-147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.32448714052905,0.0124811291116676,-0.348950153587919,-0.300024127470182,5.44374522360947e-146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.0664803022610285,0.00259216582888931,0.0613996572364055,0.0715609472856515,3.43177828124773e-142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES1,Liver carboxylesterase 1,40352,-0.17761025466971,0.00720704090075321,-0.191736054835186,-0.163484454504234,1.24374983461051e-131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0746412702200294,0.00303366493751039,-0.0805872534975498,-0.0686952869425091,3.33287282048862e-131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG2,Secretogranin-2,40392,-0.0746906476436097,0.00305588631724436,-0.0806801848254086,-0.0687011104618107,1.48315036370014e-129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.0732787749703863,0.00300057183064593,0.0673976541823203,0.0791598957584523,2.36015534633675e-129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.15337857404943,0.00639634783434417,-0.165915415804744,-0.140841732294115,7.60698199567798e-125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.120904504920668,0.00506451427374436,-0.130830952897207,-0.110978056944129,8.77867709371356e-124
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0822580759063795,0.00351218313682106,-0.0891419548545488,-0.0753741969582102,2.61935797836759e-119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF3,Trefoil factor 3,40309,-0.118698743869058,0.00508283579526935,-0.128661102027786,-0.10873638571033,1.28374262061633e-118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KITLG,Kit ligand,40359,0.0804814352922112,0.00345568597322129,0.0737082907846975,0.0872545797997249,5.28804324045438e-118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH,Parathyroid hormone,37572,-0.173394347080045,0.00744488338402137,-0.187986318512727,-0.158802375647363,1.3263596051226e-117
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0759346925201778,0.00329370117650231,-0.0823903468261223,-0.0694790382142333,1.00163937664786e-115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.249119263503728,0.011141034507202,0.227282835869612,0.270955691137844,4.39788064836257e-109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0422113402977574,0.00189180043396859,0.0385034114471789,0.0459192691483358,1.29731751757246e-108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOF,Apolipoprotein F,37987,0.0502797473760598,0.00228669961715805,0.04579781612643,0.0547616786256896,2.59537753605271e-105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC13,Mucin-13,39961,-0.104347866533015,0.00477320073307975,-0.113703339969851,-0.0949923930961787,2.2780576831394e-104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3B,Protein FAM3B,40305,-0.0748677229771365,0.00343481342794158,-0.081599957295902,-0.0681354886583711,8.29026551689931e-104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0869637019473017,0.00399220670270985,-0.094788427084613,-0.0791389768099904,1.06634157531337e-103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.240449024606008,0.0111395767896026,-0.262282595113629,-0.218615454098387,7.00582443124535e-102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.15269886016893,0.00709571224796198,-0.166606456174935,-0.138791264162924,2.99281598889006e-101
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR3,Anterior gradient protein 3,39963,-0.120883211732838,0.00565242736476594,-0.131961969367779,-0.109804454097897,4.98767624722781e-100
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPY,Pancreatic prohormone,40337,-0.204757078514573,0.00959546226111779,-0.223564184546364,-0.185949972482783,1.23160690734844e-99
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0729008649745115,0.00358479735692266,0.065874662154943,0.0799270677940799,8.7030367732978e-91
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLTP,Phospholipid transfer protein,40461,0.065609720061901,0.00326037098227255,0.0592193929366468,0.0720000471871552,5.78595845287146e-89
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBP,Protein AMBP,40470,-0.0379322182586956,0.00190727482501522,-0.0416704769157255,-0.0341939596016658,5.76159740470935e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.101015885661247,0.00508446963950848,0.0910503251678107,0.110981446154684,9.06602172695268e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.128973362789223,0.00648578029984335,-0.141685492176916,-0.11626123340153,9.52878831216749e-87
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.0581644883121524,0.00299721292699311,0.0522899509752459,0.0640390256490589,6.23531351961828e-83
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F7,Coagulation factor VII,40376,-0.0554196114908356,0.00285971611856335,-0.0610246550832197,-0.0498145678984514,1.03082422007949e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0386307344399988,0.00199935648936918,-0.0425494731591623,-0.0347119957208352,3.03847738861169e-82
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.0898031998951713,0.00466363829355783,-0.0989439309505446,-0.0806624688397979,1.1137521607474e-81
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0585654851333211,0.00304388488179076,-0.064531499501631,-0.0525994707650112,2.32695287160061e-81
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0546281756143689,0.00285018152671479,-0.0602145314067299,-0.0490418198220079,5.75148700431934e-81
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.135816923877742,0.00714400011736412,-0.149819164107776,-0.121814683647708,1.50242919697419e-79
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0620648862839556,0.00329558751310665,-0.0685242378096446,-0.0556055347582666,2.87062430886185e-78
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0617160166778784,0.00330226856238105,0.0552435702956116,0.0681884630601453,3.98887697093554e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADIPOQ,Adiponectin,38013,0.118127990562967,0.00631466091191274,0.105751255175618,0.130504725950316,4.05108856188314e-77
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSE,Cathepsin E,37671,-0.0915680698359055,0.00491691815700058,-0.101205229423627,-0.0819309102481844,1.97965394620554e-76
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY1,Aminoacylase-1,40359,-0.104410003975179,0.00567807749808309,-0.115539035871422,-0.0932809720789363,9.6945507411903e-75
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.259733631378692,0.0141361822319103,-0.287440548553236,-0.232026714204147,1.29266752787135e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL27,C-C motif chemokine 27,40359,-0.10416383694808,0.0056783278051049,-0.115293359446085,-0.0930343144500743,2.15023114181427e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HJV,Hemojuvelin,37959,-0.0802532091516588,0.00437710955194279,-0.0888323438734667,-0.0716740744298509,3.46268024835823e-74
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.107385690117288,0.00588813276195688,0.0958449499038527,0.118926430330724,1.47149470365114e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0680868909936132,0.00373520193868658,-0.0754078867934389,-0.0607658951937875,1.68546536585847e-73
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA14,Carbonic anhydrase 14,40489,0.0597952481096664,0.0032995998645071,0.0533280323752324,0.0662624638441003,1.1343810662472e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUSB,Beta-glucuronidase,40419,-0.10088101540455,0.00557486950474272,-0.111807759633846,-0.0899542711752548,1.82455256794697e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHR,Growth hormone receptor,37671,-0.0497605577913033,0.00275038804672708,-0.0551513183628884,-0.0443697972197182,2.72846715150016e-72
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.0523568088086043,0.00291106258274155,-0.0580624914707778,-0.0466511261464309,1.30259982477724e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL16,C-C motif chemokine 16,40536,-0.0906331000445561,0.00505282362194282,-0.100536634343564,-0.0807295657455481,2.99043690915591e-71
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.036800971677159,0.00208387868036195,0.0327165694636496,0.0408853738906684,3.86207689378745e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.0779296398504335,0.00441322883004586,-0.0865795683573233,-0.0692797113435436,3.99200612613091e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPM,Carboxypeptidase M,40415,-0.057631238817321,0.00326660774558974,-0.0640337899986769,-0.0512286876359651,5.24390899206257e-69
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.057162744657058,0.00325836620429411,0.0507763468966415,0.0635491424174744,2.92229194041923e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLA,Alpha-galactosidase A,37642,-0.0604412984037423,0.00345377621763473,-0.0672106997903064,-0.0536718970171783,8.33576997148779e-68
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MVK,Mevalonate kinase,40044,-0.127204969674319,0.00731215279460196,-0.141536789151739,-0.112873150196899,3.78203402407754e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0699475473413625,0.00402197093610208,-0.0778306103761226,-0.0620644843066025,4.00536659147527e-67
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.0621660139480789,0.0035930217387495,-0.0692083365560279,-0.0551236913401299,2.44502310628457e-66
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.0962075984928051,0.00559324321643674,-0.107170355197021,-0.085244841788589,1.06533606397672e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.129537535972896,0.00755898878774862,-0.144353153996883,-0.114721917948909,3.04601307723657e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG2,Desmoglein-2,40332,0.0441180765779781,0.00257778614582288,0.0390656157321653,0.049170537423791,4.4177961039083e-65
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.165258026468496,0.00969016834908586,-0.184250756432704,-0.146265296504288,1.27598470456736e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLUL1,Clusterin-like protein 1,40338,0.0737998006956306,0.00435311138162524,0.0652677023876451,0.082331899003616,6.62778709208161e-64
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0669846472714371,0.00396887919450801,-0.0747636504926728,-0.0592056440502014,2.35466265442081e-63
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0870189022528047,0.00518299058777788,-0.0971775638048494,-0.0768602407007601,1.305461983672e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREG1,Protein CREG1,40145,-0.0573974349345707,0.00344221430154821,-0.0641441749656052,-0.0506506949035362,6.8373056148981e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA2,Carboxypeptidase A2,40398,-0.102196614369311,0.00612988044702242,-0.114211180045475,-0.090182048693147,7.01050738528068e-62
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.16591552196817,0.0100235674996084,-0.185561714267403,-0.146269329668938,4.98947449163709e-61
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPL,Lipoprotein lipase,40359,0.0721514114439218,0.00438803991500399,0.0635508532105139,0.0807519696773296,2.96904431506705e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0666348532165766,0.0040609547979423,-0.0745943246205435,-0.0586753818126097,5.26948159099635e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOMO1,Nodal modulator 1,40332,-0.0371583833155908,0.00226654369668112,-0.0416008089610858,-0.0327159576700958,6.52229227695551e-60
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS4,Galectin-4,40357,-0.0826341120115243,0.00506715128636854,-0.0925657285328066,-0.072702495490242,2.62966537914051e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0403088107219925,0.00247332328275838,-0.0451565243561989,-0.035461097087786,3.83330048897942e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FETUB,Fetuin-B,40372,-0.0527495614701086,0.00324049960972216,-0.0591009407051641,-0.0463981822350532,4.2280052695675e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FURIN,Furin,40411,-0.0523802823254455,0.00322201621452497,-0.0586954341059145,-0.0460651305449766,5.93027918258633e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0530972596694395,0.00326785147433608,-0.0595022485591382,-0.0466922707797407,6.81505542658716e-59
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSZ,Cathepsin Z,40345,-0.0482240439957075,0.00298054431410532,-0.0540659108513539,-0.0423821771400611,2.05679931310519e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSD,Cathepsin D,39243,-0.061795130368506,0.00382074453200803,-0.0692837896512417,-0.0543064710857703,2.45083082106603e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOM,Apolipoprotein M,40372,0.0412851625566003,0.00256639848349162,0.0362550215289567,0.0463153035842438,9.00746155391405e-58
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.084666699606168,0.0052755948160846,-0.0950068654456938,-0.0743265337666422,1.65430085738033e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOT,Angiomotin,37671,-0.0637056453513668,0.00399232277096172,-0.0715305979824518,-0.0558806927202818,8.62280764444385e-57
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0529648944314686,0.0033285955286777,-0.0594889416676769,-0.0464408471952603,1.42243744767893e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AREG,Amphiregulin,40305,-0.0752908012332749,0.00474527082591787,-0.0845915320520739,-0.0659900704144759,2.92965184927316e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.121667972879768,0.00768279134009441,-0.136726243906353,-0.106609701853183,4.78910340023006e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMD,Osteomodulin,40422,0.0672685696965355,0.00424931548286307,0.0589399113501238,0.0755972280429471,5.11545405644789e-56
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.095163689478395,0.00608248207955739,0.0832420246024625,0.107085354354327,9.04794474459982e-55
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS1,Protein MTSS 1,37901,-0.16474992264945,0.01054480454086,-0.185417739549536,-0.144082105749365,1.51099694015443e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0675152014281541,0.00432981207060937,-0.0760016330865484,-0.0590287697697597,2.03479636248736e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0842996753093397,0.00541490254938648,-0.0949128843061372,-0.0736864663125422,3.01875517339568e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0503689312415616,0.00324455559096819,-0.0567282601998592,-0.0440096022832639,5.92427313398979e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.0683708631338715,0.00440674649041229,-0.0770080862550796,-0.0597336400126634,6.890076773536e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0847125477859318,0.00546370251238988,-0.095421404710216,-0.0740036908616476,9.37503396783394e-54
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0409162429265984,0.00264395092736862,-0.0460983867442408,-0.0357340991089559,1.2516908376596e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPB1,Beta-ureidopropionase,37990,-0.134178505906806,0.00869963949725988,-0.151229799321435,-0.117127212492176,3.22609610258294e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADM,Pro-adrenomedullin,40489,-0.0397379737452624,0.00258080512639315,-0.0447963517929929,-0.0346795956975318,4.08037231898413e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3C,Protein FAM3C,40330,-0.0437496180177164,0.00284378313551564,-0.0493234329633271,-0.0381758030721058,5.03295275861842e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UMOD,Uromodulin,40502,0.0797787075761011,0.00518951313620103,0.0696072618291471,0.0899501533230551,5.91633247633361e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0498380012756591,0.00324340595794731,-0.0561950769532358,-0.0434809255980823,6.59721344144036e-53
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.043600661237641,0.0028484136727563,0.0380177704390386,0.0491835520362433,1.62423133539711e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSF,Cathepsin F,40411,-0.0585295586264384,0.00383653724562611,-0.0660491716278656,-0.0510099456250112,3.51438665977206e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN1,Contactin-1,40536,0.0402454340012666,0.00264727692340146,0.0350567712313998,0.0454340967711335,7.7928708650464e-52
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.127507503524477,0.00840605649532429,-0.143983374255313,-0.111031632793641,1.31579527591219e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0826230658763991,0.00545798076573676,-0.0933207081772431,-0.071925423575555,2.4551139566372e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0849723851948637,0.00562000928307479,-0.0959876033896903,-0.0739571670000371,2.71843802932995e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0641771975116097,0.00426486118648702,-0.0725363254371243,-0.0558180695860952,7.90405643494258e-51
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0438438412045036,0.00291972894653221,0.0381211724693005,0.0495665099397067,1.49622326341295e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0371581547277027,0.00248046397491742,0.0322964453368646,0.0420198641185409,2.16127167325482e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.061749482062479,0.0041247553506148,-0.0698340025496841,-0.053664961575274,2.4994635665415e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.0781415812405924,0.00524311190363077,-0.0884180805717087,-0.0678650819094761,6.90794178319297e-50
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0338777318785375,0.00228051212151553,-0.0383475356367079,-0.029407928120367,1.38313077142754e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MME,Neprilysin,40305,-0.115583921607874,0.00779298718908398,-0.130858176498479,-0.100309666717269,1.95754482408559e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.0898942648725953,0.00606640941152308,-0.101784427319181,-0.07800410242601,2.36559807377396e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN2,Nectin-2,40330,-0.0409528880071768,0.00277155325636728,-0.0463851323896566,-0.0355206436246969,4.42200493952532e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0382289751601738,0.00259054096794625,-0.0433064354573484,-0.0331515148629991,6.70967408938487e-49
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.052915269233594,0.00361059183982526,-0.0599920292396515,-0.0458385092275365,2.56546066018438e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBC,Inhibin beta C chain,40332,-0.0597224992623059,0.00408443060679194,-0.0677279832516181,-0.0517170152729937,4.17777667356877e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0613337378824363,0.00419885434905233,-0.0695634924065788,-0.0531039833582937,5.24019036506069e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.0727948716724648,0.00499329715303741,-0.0825817340924181,-0.0630080092525115,7.7900907872857e-48
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRP2,Neuropilin-2,40332,0.0405496681981997,0.00278983822833743,0.0350815852706583,0.046017751125741,1.47359282550786e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGF,Hepatocyte growth factor,40516,-0.0474960103717871,0.0032801369010236,-0.0539250786977934,-0.0410669420457809,3.22003475298357e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0601949111733641,0.00416276756181927,-0.0683539355945298,-0.0520358867521983,4.29805436667952e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0567901614782408,0.00392998700753763,-0.0644929360130146,-0.0490873869434671,4.93020968423356e-47
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.116060854188419,0.00806338416653723,-0.131865087154832,-0.100256621222006,1.13091662143056e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0390703479934287,0.00273923481296624,-0.0444392482268425,-0.0337014477600148,7.07614637608413e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0378482068280985,0.00265755602964649,0.0326393970099914,0.0430570166462056,9.62375199591496e-46
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0330758687156013,0.00232329572587161,0.0285222090928929,0.0376295283383096,1.02909648058281e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0448670912415222,0.00316177408676793,-0.0510641684515874,-0.0386700140314571,1.97647069247242e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0273185064516246,0.00192770531978236,0.0235402040248511,0.031096808878398,2.59267210429311e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F9,Coagulation factor IX,40372,-0.0244316357107862,0.00172655848051086,-0.0278156903325875,-0.0210475810889849,3.48478550664621e-45
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0389582556617874,0.00278008254079443,0.0335092938818303,0.0444072174417445,2.35515937106259e-44
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0509328925644623,0.00368398624200461,-0.0581535055987913,-0.0437122795301332,3.53094813728646e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTR,Transthyretin,37871,-0.0336852099203999,0.00244109915649274,-0.0384697642671257,-0.0289006555736741,5.0675799533345e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0354380716974569,0.00257313330249485,-0.0404814129703468,-0.0303947304245669,7.30339144846716e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0357059191251072,0.0025944175475273,0.0306208607319537,0.0407909775182608,7.53788778638615e-43
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.049111902725024,0.00357892339681223,-0.056126592582776,-0.0420972128672721,1.2942146694497e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0417964853938459,0.00304648225806712,0.0358253801680344,0.0477675906196575,1.3536266663042e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0493098672952414,0.00360100139214287,-0.0563678300238414,-0.0422519045666414,1.94451425052058e-42
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0368828869632032,0.00273470629074321,-0.0422429112930599,-0.0315228626333466,3.13818829499734e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0237951820925476,0.00176871691627226,-0.0272618672484412,-0.020328496936654,5.00973896296265e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.0791644299283535,0.00590437145762844,-0.0907369979853053,-0.0675918618714018,9.17826264172567e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.155823218600603,0.0116168602050868,-0.178592264602573,-0.133054172598633,9.33500864729471e-41
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0313066460170685,0.00233873281053776,0.0267227297084145,0.0358905623257225,1.20695557084793e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASET2,Ribonuclease T2,40465,-0.0338588864625899,0.00253315890017902,-0.0388238779069408,-0.028893895018239,1.56979252491276e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0488051416299393,0.00365888794384113,-0.0559765619998679,-0.0416337212600107,2.25752675068743e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0393291512554716,0.00295143738467461,-0.0451139685294339,-0.0335443339815094,2.71294141843653e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.113078865030502,0.00854378873330142,-0.129824690947773,-0.0963330391132315,9.05811293951315e-40
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGA,Fibrinogen alpha chain,37698,0.0389668775224701,0.0029534583011309,0.0331780992522536,0.0447556557926867,1.69375307372576e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0256522361187348,0.00195228039459033,-0.0294787056921318,-0.0218257665453377,3.12884033675745e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.070122823233351,0.00533700840779996,-0.0805833597126389,-0.059662286754063,3.18110085150701e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0444287098396631,0.00339009124995597,-0.0510732886895768,-0.0377841309897494,4.88106184838286e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0442505074168239,0.00337806760718074,-0.0508715199268982,-0.0376294949067497,5.31745306954178e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES2,Cocaine esterase,40305,-0.0671549698220731,0.00513704865920104,-0.0772235851941071,-0.057086354450039,7.49275234208891e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP1,Interstitial collagenase,39757,-0.116748717473087,0.00894091859740728,-0.134272917924005,-0.0992245170221689,9.24157910081825e-39
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0793973548232561,0.00608213895975807,0.0674763624621303,0.091318347184382,1.04540987274388e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0565196985965697,0.00433871663114876,0.0480158139995181,0.0650235831936213,1.35267083417675e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL11,Eotaxin,40516,-0.0469999517413279,0.00360982078684145,-0.0540752004835371,-0.0399247029991186,1.47547085532787e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVR,Poliovirus receptor,40471,-0.0458827797124247,0.00352424681700882,-0.052790303473762,-0.0389752559510874,1.49369081073285e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAST,Gastrin,37942,-0.161883390944375,0.0124386583048648,-0.18626316122191,-0.13750362066684,1.7245046385446e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0714747290438522,0.0055183412391403,-0.0822906778725671,-0.0606587802151372,3.85902702855617e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB1,Carboxypeptidase B,40536,-0.0699352683462773,0.0054078375473038,-0.0805346299389927,-0.0593359067535618,4.58490151201697e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.036437170519147,0.0028242755733223,0.0309015903954353,0.0419727506428587,6.84946350674129e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELN,Elastin,37990,-0.0433340231059312,0.00335794382704658,-0.0499155930069425,-0.0367524532049199,7.05989095670095e-38
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0685196585831027,0.00532330274017616,-0.0789533319538479,-0.0580859852123574,1.08127064758878e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0466588561659784,0.00363319025786559,-0.053779909071395,-0.0395378032605619,1.45282935068648e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLB1,Beta-galactosidase,40228,-0.0501758150793721,0.00391978392397825,-0.0578585915703694,-0.0424930385883747,2.49333553611241e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS2,Trypsin-2,40403,-0.0617268731161757,0.00482837100875076,-0.0711904802933272,-0.0522632659390242,3.06053953759214e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0200851307543686,0.00157239866216373,0.0170032293765277,0.0231670321322096,3.49231587222919e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APLP1,Amyloid-like protein 1,40359,0.0638303786496905,0.00499716099117822,0.0540359431069812,0.0736248141923998,3.51882010032173e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.112071413217819,0.00881090366143637,-0.129340784394234,-0.0948020420414036,7.01587694496958e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0441333506388487,0.00347038936832742,-0.0509353138007704,-0.0373313874769269,7.2067798219666e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0825234376465715,0.00649720731681097,-0.095257963987521,-0.069788911305622,9.56386953109788e-37
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0485131331359112,0.0038288172158556,-0.0560176148789882,-0.0410086513928342,1.29506018491657e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCAN,Neurocan core protein,40471,0.0453181191511865,0.00357737882508736,0.0383064566540153,0.0523297816483578,1.33319002122161e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0329591017189688,0.0026021544925946,-0.0380593245244542,-0.0278588789134834,1.36697755402017e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGF,Placenta growth factor,40516,-0.0318153664376431,0.00251950799443035,-0.0367536021067266,-0.0268771307685597,2.21435663587113e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKB,Creatine kinase B-type,37998,0.0728130280449201,0.00578472897062654,0.0614749592624921,0.0841510968273481,3.95975163645802e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0519527798722324,0.00413135108786721,-0.0600502280044521,-0.0438553317400127,4.29156203362028e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0308888048468933,0.00245814229317736,-0.035706763741521,-0.0260708459522657,4.83128196873722e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CES3,Carboxylesterase 3,40305,-0.0824495557690173,0.00658786842086653,-0.0953617778739157,-0.0695373336641189,9.080827958374e-36
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0915661677487714,0.00736316888149351,-0.105997978756499,-0.0771343567410441,2.43806827878919e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.0925645045753899,0.00745426581220828,-0.107174865567318,-0.0779541435834617,3.0421003710887e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.0861696211308619,0.00693883527082555,-0.09976973826168,-0.0725695040000438,3.2272399020599e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.0872502957250021,0.00704764492689935,-0.101063679781725,-0.0734369116682794,4.87788529210566e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0253761723640504,0.00205349273324087,-0.0294010181212025,-0.0213513266068983,6.40449231614412e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0613269009904644,0.00496266120556533,-0.0710537169533725,-0.0516000850275563,6.42393099525183e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0456538531823474,0.00369789236518935,-0.0529017222181185,-0.0384059841465762,7.90161472595285e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFM,Afamin,38013,-0.0220279543188055,0.00178437962444524,-0.0255253383827182,-0.0185305702548929,7.98434110302977e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0488992223423108,0.00396497328807927,0.0411278746976754,0.0566705699869461,8.68687268595779e-35
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0822882372971294,0.00670544196249497,-0.0954309035436196,-0.0691455710506393,1.97731403006043e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15,Interleukin-15,40341,-0.0385468136792147,0.00314628457104006,-0.0447135314384532,-0.0323800959199761,2.35563137991365e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0596515405144213,0.00488400891438291,-0.0692241979866118,-0.0500788830422308,3.98509255599852e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0617932141783848,0.00509213830164752,-0.0717738052496139,-0.0518126231071556,9.71469679167973e-34
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0784506317776256,0.00648714959999271,-0.0911654449936113,-0.0657358185616399,1.71104230423736e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0566670612220521,0.00469565931464263,-0.0658705534787517,-0.0474635689653526,2.20058812471689e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.0875723135272115,0.00725719660189825,-0.101796418866932,-0.0733482081874909,2.22644181928089e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.0959016696500185,0.00795181263210234,-0.111487222408939,-0.0803161168910979,2.53967179351673e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0634364482907297,0.00528240517544375,-0.0737899624345995,-0.05308293414686,4.44166100534103e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0363215277912724,0.0030362593789532,0.0303704594085241,0.0422725961740206,7.69001130892958e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUCB2,Nucleobindin-2,40447,-0.0426084266676227,0.0035647807265752,-0.0495953968917101,-0.0356214564435353,8.6782758943302e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0341673660789089,0.00286049638665333,-0.0397739389967494,-0.0285607931610684,9.56560084367917e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0341963574759323,0.00286188151005139,-0.039805645235633,-0.0285870697162315,9.634315509617e-33
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.0825906408115369,0.00695417682355505,-0.0962208273857048,-0.068960454237369,2.14822793531802e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0373946799234248,0.00315507656262178,-0.0435786299861635,-0.0312107298606861,3.03758022355519e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH9,Myosin-9,37998,-0.126808535959638,0.0107303192070246,-0.147839961605407,-0.10577711031387,4.54022409949863e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0305017508734256,0.00258386163307854,0.0254373820725917,0.0355661196742595,5.02033924099223e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA4,Ephrin-A4,40203,-0.0333704848370409,0.00283343710120168,-0.0389240215553961,-0.0278169481186856,6.94626892076323e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0506940667011058,0.0043124591087491,-0.059146486554254,-0.0422416468479576,8.99938819778758e-32
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0291354436434031,0.00248469079585246,-0.0340054376032739,-0.0242654496835323,1.26587920996551e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POSTN,Periostin,37998,0.0424020376476548,0.00362313047215976,0.0353007019222216,0.0495033733730879,1.74084130577249e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.0942784856877259,0.00806307233350258,-0.110082107461391,-0.0784748639140608,1.9889950422646e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAN,Brevican core protein,40228,0.0375001232517701,0.00322669093300965,0.0311758090230711,0.043824437480469,4.27240139196186e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0348133172810909,0.00299661441671847,0.0289399530243227,0.0406866815378591,4.4844675177296e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0611141856413707,0.00526089791785346,-0.0714255455603635,-0.0508028257223779,4.53010639425673e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0610237323885684,0.00525679073681437,-0.0713270422327245,-0.0507204225444122,4.97487867660758e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2AP,CD2-associated protein,40359,-0.0712691194208492,0.00614227957728165,-0.0833079873923213,-0.0592302514493772,5.30142600841562e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0661475713127813,0.00570126609332469,-0.0773220528556977,-0.0549730897698649,5.35481814164591e-31
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0660373499332441,0.00572215360704538,-0.077252771003053,-0.0548219288634351,1.0883851982758e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXN,Paxillin,39961,-0.0573823295732057,0.00497301374031475,-0.0671294365042227,-0.0476352226421888,1.12272989536471e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0720005521374317,0.00624065886218634,-0.0842322435073169,-0.0597688607675465,1.18972840857353e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH2,Neutral ceramidase,40228,-0.0582303000483521,0.00505220575881324,-0.068132623335626,-0.0483279767610781,1.29818468093762e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASN,Vasorin,40116,0.0304543762030064,0.00264490981504047,0.0252703529655271,0.0356383994404857,1.482869609656e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.065748418316923,0.00571248552656092,-0.0769448899489824,-0.0545519466848636,1.55766486427261e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0585067490636356,0.0050897057390385,-0.0684825723121511,-0.0485309258151202,1.84212536638987e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.027182365836159,0.0023651151501428,0.0225467401418791,0.0318179915304389,1.88722979527847e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCLY,Selenocysteine lyase,40434,-0.0526206988222176,0.0045807775029188,-0.0615990227279385,-0.0436423749164968,2.01215417681781e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.143689192830622,0.0125283446858209,-0.168244748414831,-0.119133637246413,2.47570942219177e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUMB,Protein numb homolog,37598,-0.0915271175163145,0.00797818991207483,-0.107164369743981,-0.0758898652886479,2.53772671109539e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.032820639908401,0.00288015524511002,0.0271755356279854,0.0384657441888167,5.7865991587073e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0450889860319727,0.00395722484788665,0.0373328253301149,0.0528451467338305,5.85239443449611e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0401482279381715,0.00353053905538841,-0.0470680844867328,-0.0332283713896102,7.89586557084284e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.0160639784155781,0.00141289427831285,0.0132947056300849,0.0188332512010713,8.10059392082975e-30
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.028012537457597,0.00247431805298397,-0.0328622008414456,-0.0231628740737484,1.33468525310872e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0672315473937504,0.00594767223635477,-0.0788889849770057,-0.055574109810495,1.6281495493598e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFASC,Neurofascin,40516,-0.0295117294973464,0.00261588447736836,-0.0346388630729884,-0.0243845959217045,2.08374697821988e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FYB1,FYN-binding protein 1,40311,-0.0990352530152362,0.00878703540060075,-0.116257842400414,-0.0818126636300587,2.37005158230754e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.101400506934775,0.00899471519042752,-0.119030148708013,-0.083770865161537,2.40591378133311e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0619656745381624,0.00549903406235388,-0.072743781300376,-0.0511875677759488,2.41936917162339e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0506632396904709,0.00450045438973153,-0.0594841302943447,-0.0418423490865971,2.74865364508684e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0619172005764634,0.00551291811695014,-0.0727225200856857,-0.0511118810672412,3.85872573682997e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN2,CCN family member 2,40358,-0.062081481117903,0.00553970700630857,-0.0729393068502678,-0.0512236553855382,4.85998413660896e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OCLN,Occludin,37959,-0.0467440482090014,0.00417377863073072,-0.0549246543252336,-0.0385634420927692,5.5046222268362e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0726052028021189,0.00648814903245901,-0.0853219749057385,-0.0598884306984992,5.8108616608551e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EREG,Proepiregulin,40192,-0.0863488444121241,0.0077216423618388,-0.101483263441328,-0.0712144253829201,6.3696425044748e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.0888662554377741,0.00794791658997717,-0.104444171954129,-0.0732883389214189,6.47236162566334e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL16,Pro-interleukin-16,40516,-0.0433286233194537,0.00387565208364812,-0.050924901403404,-0.0357323452355034,6.55426049287811e-29
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCA,Calcitonin,40192,-0.0585842305126497,0.005295352019513,-0.0689631204708952,-0.0482053405544042,2.40339080283246e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0649101397262584,0.00587766701137869,-0.0764303670685607,-0.0533899123839562,2.97958155787586e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM1,Isthmin-1,40341,-0.0412835581434155,0.00374265215078241,-0.048619156358949,-0.033947959927882,3.44444668003909e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXLNA,Alpha-taxilin,40228,-0.094438387010469,0.00857014193387881,-0.111235865200871,-0.0776409088200666,3.89942197023736e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAN,Aggrecan core protein,40224,0.0300066990802573,0.00273126378914981,0.0246534220535237,0.035359976106991,5.61310674631245e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.071736747086768,0.00653070642833677,-0.0845369316863081,-0.0589365624872279,5.72107195835885e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.064985235646632,0.00593360990188371,-0.0766151110543241,-0.0533553602389399,8.15213709585598e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F10,Coagulation factor X,37987,-0.0272521612765006,0.00248821718359373,-0.0321290669563443,-0.0223752555966569,8.45715516938556e-28
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.10168063834716,0.00934015389597316,-0.119987339983267,-0.0833739367110521,1.67446732257979e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.077325707902038,0.00711426380145723,-0.0912696649528942,-0.0633817508511819,2.02345921898237e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD63,CD63 antigen,40203,-0.0544963310758925,0.00501531822169628,-0.0643263547904172,-0.0446663073613678,2.0943199349351e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.11327693658472,0.0104324787358376,-0.133724594906962,-0.0928292782624786,2.28875301307405e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0499222660624167,0.00460089570639592,-0.0589400216469527,-0.0409045104778807,2.47171996207149e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BECN1,Beclin-1,37628,-0.0633012649881149,0.00584179982749728,-0.0747511926500096,-0.0518513373262202,3.0304137257856e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0562429568059074,0.00519526748191007,-0.0664256810704511,-0.0460602325413637,3.23295878274573e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0359356948562994,0.00332032705843851,-0.0424435358908389,-0.0294278538217599,3.33663174826558e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA4,Kallistatin,37781,-0.0248680304256915,0.00229871245186606,-0.029373506831349,-0.0203625540200341,3.65820418099863e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHK,Ketohexokinase,37628,-0.0667202435385833,0.0061738594505744,-0.0788210080617091,-0.0546194790154574,4.14802068350182e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSO,Cathepsin O,40516,-0.0312103516021838,0.00288957040295452,-0.0368739095919747,-0.0255467936123929,4.21724655693939e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0697448234662217,0.00646693779446347,-0.0824200215433701,-0.0570696253890733,5.06124828636385e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0446539289977455,0.00414942451695074,0.036521056944522,0.0527868010509689,6.47950357554731e-27
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.0882151475147159,0.0082557919879255,-0.10439649981105,-0.0720337952183819,1.52377917199955e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCA2A,Guanylin,40276,-0.0343741282884242,0.00322568423035962,-0.040696469379929,-0.0280517871969193,2.00112968933238e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0506840591411298,0.00476186129083157,-0.0600173072711597,-0.0413508110110999,2.29873767457503e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0392349003712282,0.00369582818818945,-0.0464787236200795,-0.0319910771223769,3.08680442132617e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.0839018437062023,0.0079068065852964,-0.0993991846133832,-0.0684045027990213,3.24541033415374e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPN,Asporin,37990,0.0277458389954485,0.00261447964885867,0.0226214588836855,0.0328702191072114,3.30857241742286e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0463593858447355,0.00437007467827065,-0.054924732214146,-0.037794039475325,3.33537823401942e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.0555249857318319,0.00523670588285326,-0.0657889292622243,-0.0452610422014395,3.54192394386345e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0464832338017262,0.00438742311263377,-0.0550825831024883,-0.037883884500964,3.86346214121444e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO3,Beta-enolase,37628,-0.0576299381156149,0.00544040104933984,-0.068293124172321,-0.0469667520589088,4.09150800099779e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0220386623774497,0.00208136689519978,-0.0261181414920412,-0.0179591832628581,4.10472747991972e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0313326835528579,0.00296246953988701,-0.0371391238510364,-0.0255262432546793,4.66743224121636e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0535699013780779,0.00507001691866228,0.0436326682174998,0.063507134538656,5.22418383424823e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0329954981577098,0.00312749607728445,-0.0391253904691873,-0.0268656058462322,6.16692389630096e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOD,Apolipoprotein D,37345,0.0450270024819784,0.00426633617596752,0.036664983577082,0.0533890213868747,6.20858571244885e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0470430761652996,0.00446016147292499,-0.0557849926522326,-0.0383011596783666,6.58759218045435e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EZR,Ezrin,40471,-0.0239450642890169,0.00227218499163524,-0.028398546872622,-0.0194915817054118,6.98870231230151e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0661196589689972,0.00627647329670604,-0.0784215466305411,-0.0538177713074534,7.28773927050762e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0962575193716138,0.00913848457308885,-0.114168949134868,-0.0783460896083596,7.39000137465452e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0363746950805448,0.00345626295660558,-0.0431489704754918,-0.0296004196855979,8.15585608234482e-26
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSB,Cathepsin B,40353,0.0545237162137905,0.00519450539371277,0.0443424856421135,0.0647049467854675,1.0886079573448e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0634700105212105,0.00604765536476927,-0.0753234150361583,-0.0516166060062627,1.11037426074805e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN4,Contactin-4,40332,0.0245732914950706,0.00234177281164732,0.0199834167842419,0.0291631662058994,1.12336397920809e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMN,Protein amnionless,40044,-0.04789217462253,0.00457431405641164,-0.0568578301730969,-0.0389265190719632,1.44522131146564e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.0775026191116886,0.00740401104275755,-0.0920144807554934,-0.0629907574678838,1.47348832929702e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0326143010730125,0.00311495030374977,-0.0387196036683621,-0.026508998477663,1.4906718176695e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0334915809666718,0.00321337092868731,-0.039789787986899,-0.0271933739464447,2.35748759488097e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0724827307612439,0.00696742136599456,-0.0861388766385932,-0.0588265848838946,2.89319344981548e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPO,Erythropoietin,40341,-0.0780907036404568,0.00752257795280673,-0.092834956427958,-0.0633464508529556,3.64772372018094e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C8B,Complement component C8 beta chain,38013,0.030426785012288,0.00293190924980898,0.0246802428826624,0.0361733271419136,3.88570268314234e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM3D,Protein FAM3D,37901,-0.0815703965654563,0.00788845559771743,-0.0970317695369825,-0.0661090235939301,5.73300209811858e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0733564400943224,0.00709538805442667,-0.0872634006809986,-0.0594494795076461,5.87743030644804e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0310568197252898,0.00300966197472863,-0.036955757195758,-0.0251578822548217,6.93000594166236e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.030098952415237,0.00292242699963176,-0.0358269093345153,-0.0243709954959588,8.48335751616108e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0433662990451734,0.00421631910802886,-0.0516302844969099,-0.0351023135934368,9.81314681031635e-25
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PF4,Platelet factor 4,37934,-0.0957846039377198,0.00933089711994116,-0.114073162292804,-0.0774960455826351,1.24429729191739e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0261477460855977,0.00255247207571228,-0.0311505913539938,-0.0211449008172017,1.49870846659526e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.0421718344864438,0.00412065758609956,-0.0502483233551989,-0.0340953456176886,1.65928138172044e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN5,Contactin-5,40367,0.0364374155729235,0.00356184415820812,0.0294562010228356,0.0434186301230114,1.73397100503956e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC1,Stanniocalcin-1,40471,-0.0406637268413674,0.00397606417094761,-0.0484568126164247,-0.0328706410663101,1.78247009392023e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.102696671008143,0.0100591121835184,-0.12241253088784,-0.0829808111284472,2.2105584306537e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL5,C-C motif chemokine 5,40403,-0.098296683554301,0.0096527705647628,-0.117216113861236,-0.0793772532473659,2.79468034737397e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0680313039617993,0.00669131653583672,-0.0811462843720393,-0.0549163235515593,3.30856685675592e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.035621952596364,0.00351010703332207,-0.0425017623816753,-0.0287421428110528,3.98414596039253e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0545065637375996,0.00537121781391731,-0.0650341506528775,-0.0439789768223216,4.00767568844059e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.10318178629221,0.0101726819093342,-0.123120242834505,-0.0832433297499148,4.21440260187703e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.105364101364377,0.0103967587451029,-0.125741748504779,-0.0849864542239758,4.74457830818821e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0835092107815722,0.00824507231040602,-0.099669552509968,-0.0673488690531764,4.88705093936345e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0402871174783293,0.00397814024311196,-0.0480842723548287,-0.0324899626018299,4.94492815085423e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.093621428607346,0.00924702239381624,-0.111745592499226,-0.0754972647154662,5.08111295809124e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0419388783916253,0.00414400066733059,-0.0500611196995933,-0.0338166370836574,5.49261828455456e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0560388700592,0.00553904563512404,-0.0668953995040431,-0.0451823406143569,5.49332950366972e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.0886063020721965,0.00876791845723937,-0.105791422248386,-0.0714211818960073,6.15005244488659e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0825474618733953,0.00816996198261911,-0.0985605873593287,-0.0665343363874618,6.28343493286849e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.0247971092914419,0.0024545018708824,0.0199862856245124,0.0296079329583714,6.52974547081798e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPBP,Platelet basic protein,37934,-0.0811865588519741,0.00804741244312872,-0.0969594872405064,-0.0654136304634418,7.54519162848966e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0620101070891502,0.00614987453761656,-0.0740638611828786,-0.0499563529954217,7.96042027948621e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOA,Elongin-A,40305,-0.0494415181188945,0.00490674528427266,-0.0590587388760689,-0.0398242973617201,8.29993868663713e-24
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0675352676895406,0.00672120033712352,-0.0807088203503027,-0.0543617150287785,1.1064207644429e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0334462597030085,0.00334029030115124,-0.0399932286932649,-0.0268992907127521,1.56751807920797e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYNU,Kynureninase,40516,-0.0427945202115543,0.00428473591591523,-0.0511926026067481,-0.0343964378163604,2.01995762498609e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPH,Hephaestin,37990,-0.0239905366023949,0.00240235195909451,-0.0286991464422202,-0.0192819267625697,2.10913120633341e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0265678127305039,0.00266422642465491,-0.0317896965228275,-0.0213459289381802,2.36677650704218e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COCH,Cochlin,37990,-0.0444395729034719,0.00446638736206165,-0.0531936921331128,-0.0356854536738311,3.03716838201933e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST3,Cystatin-C,40372,-0.0268924681999958,0.00270658324444025,-0.0321973713590987,-0.0215875650408929,3.39259586826349e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.019980365071863,0.00201324118079926,0.0160344123574965,0.0239263177862296,3.81594267024178e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0757109909841958,0.00762896695094465,-0.0906637662080473,-0.0607582157603443,3.92559783057696e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP5,Retinol-binding protein 5,40305,-0.0527454574351594,0.00532016079241418,-0.0631729725882912,-0.0423179422820276,4.213515862522e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0647091648350645,0.0065333822727895,-0.0775145940897319,-0.0519037355803971,4.64816715732764e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0846934902537664,0.00855393044621084,-0.10145919392834,-0.0679277865791932,4.80650794011395e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0399655024104239,0.00403705123451374,0.032052881990777,0.0478781228300709,4.87109334986808e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0399565210252991,0.00403891684272816,-0.0478727980370463,-0.0320402440135519,5.20549214119712e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.112772723072601,0.0114111796003928,-0.135138635089371,-0.0904068110558307,5.95385861557154e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.069712114554995,0.0070546590779446,0.0558849827622236,0.0835392463477664,5.97691951898702e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.0281665427337369,0.0028525059659988,-0.0337574544270945,-0.0225756310403792,6.27558732299243e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0293715532439269,0.00297594294285524,-0.0352044014119231,-0.0235387050759306,6.57977274783484e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0501008487546413,0.00507860741532942,0.0401467782205956,0.060054919288687,6.86417695889401e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0217668809512219,0.00220766314199353,-0.0260939007095293,-0.0174398611929146,7.23995242224077e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN4,CCN family member 4,40489,-0.038829891226806,0.00393898930861473,-0.0465503102716909,-0.0311094721819212,7.36375831537223e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0683091434949182,0.00693514849805236,-0.0819020345511009,-0.0547162524387356,8.24184520608029e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0868868951489198,0.00882646688599018,-0.104186770245461,-0.069587020052379,8.46291982056469e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0292292614599916,0.00297345079647687,-0.0350572250210862,-0.0234012978988969,9.97734793443073e-23
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.107134084999753,0.010913010321589,-0.128523585230068,-0.0857445847694385,1.10300034506886e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0632606125408888,0.00644903697396109,-0.0759007250098525,-0.0506205000719251,1.19090413842266e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAD,Chondroadherin,37671,0.05077503354257,0.00517955785155313,0.0406231001535259,0.0609269669316141,1.30549477363947e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0742039721912281,0.00757156518715,-0.0890442399580421,-0.0593637044244141,1.34085387423651e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0347370307642566,0.00354729533982571,-0.041689729630315,-0.0277843318981982,1.44846425158196e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0376181309018763,0.00384809442206927,-0.0451603959691321,-0.0300758658346206,1.698906996879e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.101330162373095,0.0103736749771316,-0.121662565328273,-0.080997759417917,1.83530598787624e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0399545536163982,0.00409182435226513,0.0319345778859586,0.0479745293468379,1.84842586490223e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.130373211702252,0.0133616050490422,-0.156561957598374,-0.104184465806129,2.03717142156072e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0793772212683686,0.00813814050651692,-0.0953279766611418,-0.0634264658755954,2.06085257793226e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAYN,Layilin,40192,-0.0322790925355594,0.00331262821462227,-0.0387718438362191,-0.0257863412348998,2.25804968820411e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK14,Kallikrein-14,40489,0.0430044669996801,0.00442525915000847,0.0343309590656635,0.0516779749336967,2.91209899430389e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO2,Roundabout homolog 2,40471,0.0217551426643389,0.00223897758848363,0.017366746590911,0.0261435387377668,2.95269772903588e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0351651285763951,0.00362891453619074,0.0280524560854612,0.042277801067329,3.81982075810353e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSN,Gelsolin,37928,0.017725484626047,0.00183020358068161,0.0141382856079111,0.021312683644183,4.12313993222061e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0669409650651222,0.0069141926658807,-0.0804927826902483,-0.053389147439996,4.14525712276261e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0413055836938876,0.00427525679881103,0.032926080368218,0.0496850870195573,5.04654340645948e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0481344379008072,0.00498539963420204,-0.0579058211838432,-0.0383630546177712,5.37349168987489e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO1,Forkhead box protein O1,40341,-0.0783774154075163,0.00812207009542254,-0.0942966727945445,-0.0624581580204882,5.65137000388609e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAXX,Protein PAXX,37671,-0.0420834831616928,0.00436033307838823,-0.0506297359953337,-0.0335372303280519,5.72712904276259e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0540621271839378,0.00560600176392161,-0.0650498906412241,-0.0430743637266514,6.00426798466397e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100P,Protein S100-P,40042,-0.0497033107910086,0.00516272833229929,-0.0598222583223152,-0.039584363259702,7.05223224916874e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.0171897317022842,0.00178613653721959,0.0136889040893338,0.0206905593152346,7.441428517939e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0252173634439113,0.00262344659289892,-0.0303593187659932,-0.0200754081218295,8.32893043257962e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSM,Oncostatin-M,40268,-0.0668892873226504,0.00696825102422017,-0.0805470593301219,-0.0532315153151789,9.24026025003403e-22
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SBSN,Suprabasin,37977,0.0308291737680952,0.00322008014104922,0.0245178166916387,0.0371405308445517,1.2040197254958e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXIN1,Axin-1,40341,-0.0862993830843823,0.00902224859153458,-0.10398299032379,-0.0686157758449745,1.28081915622624e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0449115129497335,0.00470011374436105,-0.0541237358886811,-0.0356992900107858,1.40475856425943e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0532395554701713,0.00557546920475871,-0.0641674751114984,-0.0423116358288443,1.50141100756446e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0287420636469534,0.0030126669154104,-0.0346468908011578,-0.022837236492749,1.62204091828085e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.112129539347175,0.0117585346413478,-0.135176267244217,-0.0890828114501337,1.69501684288076e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0319064522344467,0.0033472453091152,-0.0384670530403125,-0.0253458514285809,1.76002734418873e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSG,Basigin,40502,-0.0185059364857559,0.00194209672724334,-0.0223124460711528,-0.014699426900359,1.81258883088983e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0405174120703575,0.00425179258590697,-0.0488509255387351,-0.0321838986019798,1.85397428423336e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0560789445313196,0.00588751519594685,-0.0676184743153754,-0.0445394147472637,1.88204310412501e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTSS2,Protein MTSS 2,37900,-0.0895924367137974,0.00941544171901065,-0.108046702483058,-0.0711381709445365,2.11217108673748e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0598911501315436,0.00630002189679927,-0.0722391930492701,-0.047543107213817,2.24514782169752e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_E,,40341,-0.026222323463686,0.00276999920719547,-0.0316515219097891,-0.0207931250175828,3.28974836360193e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MENT,Protein MENT,37671,0.0197152852790023,0.00208752167872061,0.0156237427887099,0.0238068277692947,4.16796258890916e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGRN,Agrin,40422,-0.0301359572658351,0.00319476231062364,-0.0363976913946575,-0.0238742231370128,4.52469165786438e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0354397443206102,0.00375827050218169,-0.0428059545048863,-0.0280735341363341,4.66494339247161e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0480959797756283,0.0051064864088969,-0.0581046931370662,-0.0380872664141903,5.17916672899203e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0271640363144618,0.00289154603482539,-0.0328314665427195,-0.021496606086204,6.6750712159864e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.0824063253008081,0.0087740945762,-0.0996035506701601,-0.0652090999314562,6.81440323334354e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCG,Gamma-synuclein,40228,-0.0605054575848984,0.00644534193605103,-0.0731383277795584,-0.0478725873902384,6.96679912715829e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0241038854029436,0.00257387237664906,-0.0291486752611758,-0.0190590955447114,8.64265788512617e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.02537144570897,0.00271089003060094,-0.0306847901689479,-0.0200581012489922,9.10832667049263e-21
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0294560531721957,0.00316615298120379,0.0232503933290362,0.0356617130153551,1.56580185288757e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA2,Apolipoprotein A-II,37987,0.0424859945813404,0.00457097012112083,0.0335268931439436,0.0514450960187373,1.69810707112104e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.021257088647955,0.0022881924806678,0.0167722313858461,0.0257419459100639,1.74069644913712e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPOCK1,Testican-1,40228,0.0224881987522938,0.00242481394127082,0.017735563427403,0.0272408340771847,2.01683318446624e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0305065705175455,0.00329749754974224,0.0240434753200507,0.0369696657150403,2.48860976354878e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0342459419738655,0.00370136963682178,-0.0415006264620362,-0.0269912574856948,2.53396933911195e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARC,SPARC,40411,-0.0629998734138433,0.0068141349555015,-0.0763555779266263,-0.0496441689010604,2.6320477779915e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0293900425816419,0.00317926420008411,-0.0356214004138068,-0.0231586847494771,2.66311933735171e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA9,Serpin A9,40228,-0.064192816179546,0.00695063242119661,-0.0778160557250914,-0.0505695766340007,2.89055305780038e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAL,Galanin peptides,40422,0.0555588418228572,0.0060173900117578,0.0437647573998119,0.0673529262459024,2.95398151954317e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0245805945967929,0.00266446635874099,0.0193582405336605,0.0298029486599252,3.17501186711491e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0390700207537563,0.00423688822676595,-0.0473743216782175,-0.030765719829295,3.36959338145933e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0468720515304499,0.00509728434544725,-0.0568627288475265,-0.0368813742133732,4.19075407787814e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0750382825977677,0.00817023551588902,0.0590246209866252,0.0910519442089102,4.63931263943655e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.0743370166306469,0.00809641875662208,-0.0902059973936261,-0.0584680358676676,4.87901479884183e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0590041424934073,0.00643474792635046,-0.0716162484290542,-0.0463920365577604,5.31480119580813e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELP,P-selectin,40403,-0.0509305572725737,0.00555840766733406,-0.0618250363005485,-0.040036078244599,5.66023244069814e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF2,Trefoil factor 2,40396,-0.0502314083115977,0.0054952735042416,-0.0610021443799112,-0.0394606722432841,6.92923537933634e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0265403054463253,0.00290948913367334,-0.032242904148325,-0.0208377067443255,8.43365944333816e-20
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0575171726217319,0.00632577539743502,-0.0699156924007045,-0.0451186528427592,1.07896459889669e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0300603062941904,0.00330866653180214,0.0235753198918582,0.0365452926965226,1.15314498066966e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0534281356866249,0.00588435546696409,-0.0649614724018745,-0.0418947989713753,1.21438823789843e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0518786873844144,0.00571637088353822,-0.0630827743161494,-0.0406746004526795,1.2862971858752e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.035778279255327,0.00394779032774433,-0.0435159482977059,-0.0280406102129481,1.41427556197316e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0424581343001274,0.00468978948556192,-0.0516501216918287,-0.033266146908426,1.54456502408034e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0718077786730849,0.00794132091800525,-0.0873727676723752,-0.0562427896737946,1.70724482268748e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POF1B,Protein POF1B,37598,-0.0402078373773287,0.00445853603571369,-0.0489465680073275,-0.0314691067473298,2.17445771557187e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE6,Ribonuclease K6,37917,-0.0255111894576524,0.00283533665629706,-0.0310684493039946,-0.0199539296113101,2.61239362381477e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD209,CD209 antigen,40382,0.0336516262449435,0.00374177527240134,0.0263177467110368,0.0409855057788501,2.65969621654972e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC3B,Tetranectin,37681,0.0182269218422474,0.00202658171561602,0.01425482167964,0.0221990220048548,2.70641233163258e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0720630977157181,0.00802853253767218,-0.0877990214895556,-0.0563271739418806,3.17889828786857e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0717096313862894,0.00799494373976685,-0.0873797211162324,-0.0560395416563463,3.37887822815656e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNXB,Tenascin-X,40332,0.0219921896936732,0.00245672830487161,0.0171770022161248,0.0268073771712215,3.87705430289276e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NBN,Nibrin,40044,-0.0438051915376193,0.00489733375135595,-0.053403965690277,-0.0342064173849617,4.14174389440579e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0235920159901852,0.00264134691618148,-0.0287690559459009,-0.0184149760344695,4.63983993362669e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD27,CD27 antigen,40411,-0.0349760540880755,0.00392083662664896,-0.0426608938763075,-0.0272912142998435,5.13422595152708e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0224149250667931,0.00251522224049371,-0.0273447606581608,-0.0174850894754254,5.55741323034708e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0546875667433505,0.00614411444142784,-0.066730031048549,-0.0426451024381519,6.24351865058948e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPTC,Opticin,40305,0.0386369418002346,0.00434345532994936,0.0301237693535339,0.0471501142469354,6.43657949773066e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0630998370855099,0.00709756228067786,-0.0770110591556385,-0.0491886150153813,6.85309468247462e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0541225954821976,0.00609037996728848,-0.066059740218083,-0.0421854507463122,7.11610322005963e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0263204109923258,0.00296230814952302,-0.032126534965391,-0.0205142870192607,7.18218857218061e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSA,Arylsulfatase A,40332,-0.0380995296963747,0.00429387344460203,-0.0465155216477947,-0.0296835377449547,7.86691130920219e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0322056552793704,0.00363111449520697,-0.039322639689976,-0.0250886708687647,8.13293787342043e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINH1,Serpin H1,37714,-0.109590530123346,0.0123584822218535,-0.133813155278178,-0.0853679049685128,8.41599994114867e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18,Interleukin-18,40292,-0.0404634953807893,0.0045691133667479,-0.0494189575796152,-0.0315080331819634,9.16901646346797e-19
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0259591643035175,0.00293547072169063,0.0202056416890038,0.0317126869180311,1.02524171666728e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTYMK,Thymidylate kinase,37990,-0.0586863081905889,0.00663501566258496,-0.0716909388892555,-0.0456816774919224,1.02785951600995e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0410705749390559,0.00464672937619514,0.0319629853617135,0.0501781645163984,1.08772855232262e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0430931109130915,0.00487595400245117,-0.0526499807578958,-0.0335362410682872,1.09751162449016e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0641117453501016,0.00726373381787368,-0.078348663633134,-0.0498748270670692,1.19184473879532e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.0940831559384866,0.0106640792559845,0.073181560596757,0.114984751280216,1.26506755929861e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0572436055521895,0.00650409553982592,-0.0699916328102483,-0.0444955782941307,1.52196393482945e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.04175871091646,0.00475761113531341,-0.0510836287416743,-0.0324337930912457,1.84306077042669e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0279989712168753,0.00319143240585922,-0.0342541787323593,-0.0217437637013912,1.9103751444171e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0513083626351185,0.00585185310207466,-0.0627779947151848,-0.0398387305550521,2.00659776020694e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0408832773709973,0.00466413978446114,-0.0500249913485411,-0.0317415633934534,2.08649869931251e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0453078411666842,0.0051806687181175,0.0351537304791739,0.0554619518541944,2.47829972765103e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0376250075782519,0.00430665656772707,-0.046066054450997,-0.0291839607055069,2.69326771490633e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0398926881372331,0.00457116900838852,-0.0488521793936746,-0.0309331968807917,2.91939546824239e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA11,Integrin alpha-11,40341,0.0285472984942424,0.00327580700311022,0.0221267167681464,0.0349678802203385,3.2021262783134e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.0172641099736273,0.00198603923169395,0.0133714730795072,0.0211567468677475,3.87703678125366e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0507381232825583,0.0058414089261614,0.039288961787282,0.0621872847778346,4.1167068945526e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.0796896152169613,0.00918106850395278,-0.0976845094847087,-0.0616947209492138,4.41524018752167e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUS,RNA-binding protein FUS,39960,-0.0329217954394196,0.0037937858627202,-0.0403576157303512,-0.025485975148488,4.42975366108689e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0634712928798744,0.00731379418936474,-0.0778063294910293,-0.0491362562687195,4.47321356590547e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0310680014199745,0.00359413129977017,-0.038112498767524,-0.0240235040724249,5.93747441609565e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLN,Promotilin,40341,-0.0736555208761028,0.00852512329333471,-0.0903647625310388,-0.0569462792211667,6.15876842680503e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0704896247533361,0.00818005704383383,-0.0865225365592504,-0.0544567129474218,7.49482026970263e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0240080545348898,0.00278707774529367,0.0185453821541142,0.0294707269156654,7.83337551049546e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0655694340490722,0.00761958050537263,-0.0805038118396026,-0.0506350562585419,8.43634380595303e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNR,Tenascin-R,40228,0.0351982111650917,0.00409303665287236,0.0271758593254619,0.0432205630047215,8.74654471965594e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0453848897760449,0.00528368618485079,-0.0557409146983524,-0.0350288648537373,9.54951560105648e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPP1,Osteopontin,40497,0.0394080064543538,0.00458837200183023,0.0304147973307666,0.0484012155779411,9.59612971082104e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD302,CD302 antigen,40305,-0.0248881793106391,0.00289849567722724,-0.0305692308380045,-0.0192071277832737,9.78112006501445e-18
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0191392408157169,0.00223028566418796,-0.0235106007175253,-0.0147678809139085,1.02147486472332e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARSB,Arylsulfatase B,40305,-0.0453207926822752,0.00528727163337196,-0.0556838450836842,-0.0349577402808661,1.11276422826398e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0671722504995035,0.00784802784204932,-0.0825543850699202,-0.0517901159290868,1.23999125630386e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGN,Biglycan,39956,0.100031463158191,0.0116937208259307,0.0771117703393669,0.122951155977015,1.29560907932411e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0331302242236456,0.00388295657583104,-0.0407408191122745,-0.0255196293350168,1.56680691845213e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0316003834248335,0.00370631911014109,-0.03886476888071,-0.0243359979689569,1.64830136044515e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0913760521945895,0.0107150625260441,-0.112377574745636,-0.0703745296435431,1.65163690709962e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0299442664140213,0.0035173319680825,-0.036838237071463,-0.0230502957565796,1.8707374068218e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGT,Angiotensinogen,37987,-0.0198124872141504,0.00232980245150016,-0.0243789000190907,-0.0152460744092101,2.02323548007589e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZN,Kazrin,37901,-0.0842931835587591,0.00994937396196988,-0.10379395652422,-0.0647924105932981,2.65592880843549e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0595548949338323,0.00703401203757392,-0.0733415585274772,-0.0457682313401874,2.74255670085251e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN3,Contactin-3,40332,-0.0284578592853458,0.00336820600364515,-0.0350595430524903,-0.0218561755182013,3.19075828063793e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0222535070281173,0.0026353833036111,-0.0274188583031951,-0.0170881557530396,3.32517067770903e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPE,Carboxypeptidase E,40360,0.0310488364177158,0.00368488433980972,0.0238264631116887,0.0382712097237428,3.8793415251473e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.051966027082412,0.00616858278010703,-0.0640564493314218,-0.0398756048334022,3.94343935910634e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0294077380933866,0.00349171859679453,-0.0362515065431039,-0.0225639696436693,4.00920310948362e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0210642256677469,0.00250325445471191,0.0161578469365115,0.0259706043989822,4.26528108591682e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0702737976462287,0.00836774679515229,-0.0866745813647272,-0.0538730139277302,4.91313585601016e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MBL2,Mannose-binding protein C,37810,0.0860293752144887,0.0102653163293627,0.0659093552089377,0.10614939522004,5.78899400377188e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0442732142457285,0.00528946947768589,-0.0546405744219928,-0.0339058540694641,6.24452406409606e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0428169478801625,0.0051192201631358,-0.0528506193999086,-0.0327832763604163,6.56306892499744e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.039079827063618,0.00467600010378112,-0.048244787267029,-0.029914866860207,7.03948683665877e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH1,Cadherin-1,39806,-0.0322435765541043,0.00386935457846565,-0.0398275115278969,-0.0246596415803116,8.53823436854541e-17
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0605591316978084,0.00728739739140725,-0.0748424305849666,-0.0462758328106502,1.03287466126822e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0461083701292169,0.00556735148399006,-0.0570203790378374,-0.0351963612205964,1.31024430067738e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD226,CD226 antigen,37598,-0.0332610661596261,0.00401948071988318,-0.0411392483705972,-0.0253828839486551,1.4079567723914e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDK,Midkine,40352,-0.0403626703337076,0.0048795322023906,-0.0499265534503932,-0.0307987872170221,1.42266386639502e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0660120398482244,0.00799621170373271,-0.0816846147875405,-0.0503394649089083,1.63178820946167e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0655466947614891,0.0079448111602585,-0.0811185246355957,-0.0499748648873824,1.70339375077497e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0530469943106882,0.00643543394111002,-0.0656604448352638,-0.0404335437861126,1.81012609918546e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0250512403760458,0.00304214787163436,-0.0310138502044492,-0.0190886305476425,1.93786728082423e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0426381115025217,0.00518044923095364,-0.0527917919951909,-0.0324844310098526,2.00983543046975e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH5,Cadherin-5,40536,0.024076962051751,0.00292661022897172,0.0183408060029665,0.0298131181005356,2.06669396688126e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0475207654161834,0.00577745096215021,-0.0588445693019978,-0.036196961530369,2.09828444332112e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMA,Granzyme A,40516,-0.027817913901895,0.00338703746717542,-0.0344565073375588,-0.0211793204662311,2.31896202963547e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0246834939335308,0.00300561105340749,-0.0305744915982094,-0.0187924962688521,2.33044366639715e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0544693011419718,0.00663287992766703,-0.0674697458001992,-0.0414688564837444,2.34415284097987e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0416803673868606,0.00508125437205019,-0.051639625956079,-0.0317211088176423,2.53159801686195e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PZP,Pregnancy zone protein,38013,-0.0512777451474147,0.00626554811347685,-0.0635582194498294,-0.0389972708450001,2.98699854346688e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0587641854553709,0.007183385329139,-0.0728436207004833,-0.0446847502102584,3.08246411131289e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNA4,Plexin-A4,40341,-0.0648020078270673,0.00793115079475077,-0.0803470633847788,-0.0492569522693557,3.29858046264147e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0254271393331794,0.00311262332116727,-0.0315278810426673,-0.0193263976236916,3.34103913804825e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0296904682855422,0.00364679514255935,0.0225427498061258,0.0368381867649585,4.19402509914282e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSHB,Follitropin subunit beta,37628,0.0545648726730904,0.00671474002238058,0.0414039822292245,0.0677257631169564,4.82493479082952e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0447233146599612,0.00550906739355689,-0.0555210867513327,-0.0339255425685897,5.14353202700745e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN1,Perilipin-1,39961,-0.0276927403853896,0.00341479283885961,-0.0343857343495544,-0.0209997464212247,5.45398151417762e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0206789625005156,0.00256111055550335,0.0156591858117291,0.0256987391893022,7.36262659611451e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0801588367770437,0.00996011325721099,-0.0996806587611772,-0.0606370147929101,9.00775340116116e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0531829072364171,0.00660940933399882,-0.0661373495310548,-0.0402284649417794,9.22408158134489e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0228272313083185,0.00283992032890208,-0.0283934751529665,-0.0172609874636704,9.77556783728802e-16
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0274275395659889,0.00341375545131451,-0.0341185002505653,-0.0207365788814125,1.01999280915732e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1,Integrin beta-1,40333,0.0169370372517653,0.00211460115051004,0.0127924189967657,0.021081655506765,1.23043713182786e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0538617465934134,0.00673000685415428,-0.0670525600275558,-0.040670933159271,1.31322487662973e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0293302551876326,0.00366549019186165,-0.0365146159636814,-0.0221458944115837,1.31562678417801e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0471158660856629,0.00589156014002317,-0.0586633239601083,-0.0355684082112174,1.36230978544383e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP20,Centrosomal protein 20,39980,-0.0565900235333036,0.00707866119482326,-0.0704641994751572,-0.04271584759145,1.39255956375989e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0678405012883827,0.00849461447737039,-0.0844899456640287,-0.0511910569127368,1.5025860959383e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.065528663328603,0.00821277409217647,-0.0816257005492688,-0.0494316261079371,1.57711541509671e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0388874256443202,0.00488524343782426,-0.0484625027824557,-0.0293123485061847,1.85487766910679e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0630518216685423,0.00792886974904592,-0.0785924063766723,-0.0475112369604123,1.97701314044074e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.0870444955812269,0.0109493294217057,-0.10850518124777,-0.0655838099146836,2.01705737540544e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFF1,Trefoil factor 1,40261,-0.0596099371146825,0.0075000076901361,-0.0743099521873493,-0.0449099220420157,2.02286676508442e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0585685341045504,0.00738793804587486,-0.0730488926744651,-0.0440881755346357,2.40847350525134e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0585916390379207,0.00740194209313283,-0.073099445540461,-0.0440838325353803,2.61958588674341e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCR,Breakpoint cluster region protein,40341,-0.069189917107046,0.00874768152075551,-0.0863353728877268,-0.0520444613263653,2.75298242137026e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCTN3,Tectonic-3,37990,-0.0221413348873125,0.00279904851263959,-0.0276274699720861,-0.0166551998025389,2.76576519202427e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.016071607505069,0.00203273450813358,0.0120874478691271,0.0200557671410108,2.85345340605081e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.0794005317531483,0.0100637614197348,-0.0991255041358285,-0.0596755593704681,3.22306679848536e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEP,Leptin,40359,-0.0484848080079097,0.00615088371134531,-0.0605405400821465,-0.0364290759336729,3.41367919106883e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0359933460584881,0.00457583772250407,-0.044961987994596,-0.0270247041223801,3.89656964444302e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0217216198156633,0.00276270996541569,0.0163067082834485,0.027136531347878,4.00816665311495e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0423511201012574,0.00538667338571035,-0.0529089999372497,-0.0317932402652651,4.01233398534796e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0845896384757873,0.0107626622591393,-0.1056844565037,-0.0634948204478742,4.10349188186998e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0243421954866215,0.00309849656946871,0.0182691422104628,0.0304152487627801,4.26839791201399e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP43,Centrosomal protein 43,39934,-0.0521641037502974,0.00664111998127276,-0.065180698913592,-0.0391475085870028,4.26856201481542e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTNB,Dystrobrevin beta,37878,-0.0314229514679503,0.00400309824097791,-0.039269024020267,-0.0235768789156336,4.48656118871134e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0596187396536244,0.00759733422178453,-0.0745095147283221,-0.0447279645789267,4.52617028496274e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0710300984851596,0.00906101639689776,-0.0887896906230792,-0.05327050634724,4.8253211935684e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0233370048312807,0.00297814807765054,-0.0291741750634758,-0.0174998345990857,4.95258510385343e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0398696066883618,0.00509040894638565,-0.0498468082232777,-0.0298924051534459,5.09160683291583e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLA2,Src-like-adapter 2,37959,-0.0774636050828411,0.00988902857895885,-0.0968461010976005,-0.0580811090680818,5.10618059608736e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0297605809147597,0.00379924329474851,-0.0372070977724668,-0.0223140640570526,5.10759084037147e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.0290430146629654,0.00371587776488025,-0.0363261350821307,-0.0217598942438001,5.79708892180439e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0342466918246041,0.00438136554383959,-0.0428341682905297,-0.0256592153586785,5.84352511270181e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GET3,ATPase GET3,37990,-0.0420952980651369,0.00539023426123724,-0.0526601572171618,-0.0315304389131119,6.15985091974733e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0558588865414836,0.00715573851473194,-0.0698841340303582,-0.041833639052609,6.32658954853946e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0338343182623842,0.00433994976142229,-0.0423406197947719,-0.0253280167299965,6.78632025221675e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOC,Brother of CDO,40042,0.0177426009995133,0.00227697304275237,0.0132797338357187,0.022205468163308,6.99940447446242e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0539309013017656,0.00692060282739946,-0.0674952828434685,-0.0403665197600626,7.04555377160066e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0515615493256525,0.00662360447984713,-0.0645438141061529,-0.0385792845451521,7.4253594307863e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0146556798820486,0.00188403750355958,-0.0183483933890254,-0.0109629663750718,7.76539412434306e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XCL1,Lymphotactin,40489,-0.0421967706959474,0.00543178078059675,-0.052843061025917,-0.0315504803659778,8.42078149993835e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0459585208572036,0.0059168374997368,-0.0575555223566877,-0.0343615193577194,8.4974502805514e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0331190686112752,0.00426359099891218,-0.0414757069691431,-0.0247624302534073,8.55714656374623e-15
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN1,Pantetheinase,37987,-0.0538773385858252,0.00695886906031943,-0.0675167219440513,-0.0402379552275991,1.04579517752583e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G1B,Phospholipase A2,40514,0.0312216840682225,0.00404073896803951,0.0233018356908651,0.03914153244558,1.16841385474338e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0535351994335041,0.00693244396432316,-0.0671227896035775,-0.0399476092634307,1.22193411228246e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0298106974296909,0.00387155516535258,-0.037398945553782,-0.0222224493055998,1.44167691048088e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0196017527542519,0.00254675665678428,0.0146101097069547,0.024593395801549,1.47763919766052e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0214724435216205,0.00278999011419806,-0.0269408241454487,-0.0160040628977923,1.48335454952294e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FEN1,Flap endonuclease 1,39980,-0.0458401632655404,0.0059656179966053,-0.0575327745388868,-0.034147551992194,1.63307544697228e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0484086973670364,0.00630135430893946,0.0360580429215151,0.0607593518125578,1.67047070506981e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0395703025327939,0.00515333455679183,-0.0496708382641059,-0.0294697668014819,1.7217442454167e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0250991268745276,0.00327041120211649,0.0186891209183792,0.0315091328306759,1.75521264994548e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0200611638940803,0.0026220903620995,-0.0252004610037953,-0.0149218667843653,2.13240545738073e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAG1,Dystroglycan,40422,-0.0347919592649782,0.00456047504998603,-0.0437304903629508,-0.0258534281670056,2.49844038918722e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRC,Chymotrypsin-C,40360,0.0461339257710604,0.00605493576687556,0.0342662516679843,0.0580015998741365,2.69533283021574e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0284309131237664,0.00373313379900699,-0.0357478553698201,-0.0211139708777127,2.7945666097695e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD248,Endosialin,37998,0.0291979533717033,0.0038444288864166,0.0216628727543268,0.0367330339890799,3.28237884477766e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPPK1,Epiplakin,37628,-0.0535948032802884,0.0070681434826715,-0.0674483645063245,-0.0397412420542522,3.6137655467605e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F12,Coagulation factor XII,38013,-0.0303779156607946,0.00401390204267642,-0.0382451636644404,-0.0225106676571488,4.02873671021447e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN1,Ficolin-1,37967,-0.0410510915213916,0.00542548547078433,-0.0516850430441289,-0.0304171399986543,4.08653310779889e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.0653884150105585,0.00864484023864761,0.0484445281428092,0.0823323018783078,4.12637420887094e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAV,Integrin alpha-V,40489,0.0119338608812004,0.00157835329210282,0.00884028842867884,0.0150274333337219,4.21721685263675e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0309487245439315,0.00409962862361564,-0.0389839966462181,-0.0229134524416448,4.61706961868779e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0280954161066732,0.00372309239023413,-0.0353926771915321,-0.0207981550218143,4.72288336484743e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0316003143089912,0.00419189360183244,-0.0398164257685828,-0.0233842028493996,5.06769167762477e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0191808821349499,0.0025453423550911,-0.0241697531509284,-0.0141920111189713,5.17359898721684e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0552226374772918,0.00733026967045714,-0.0695899660313878,-0.0408553089231958,5.20551447349224e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0254049423896121,0.00337704553008564,-0.03202395162858,-0.0187859331506443,5.6534130669595e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN2,Calsyntenin-2,40516,0.0282621592418185,0.00376062587622524,0.020891332524417,0.03563298595922,5.97763878431523e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0392575674115988,0.00523049408428275,-0.049509335816793,-0.0290057990064046,6.44479745595625e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R9B,Neurabin-2,40516,-0.067758897826614,0.00902991025291613,-0.0854575219223296,-0.0500602737308984,6.52209722404285e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.017450967963994,0.00232746356552963,0.0128891393755559,0.0220127965524321,6.82951778054305e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0304066892511945,0.00406240892770975,-0.0383690107495056,-0.0224443677528833,7.5339195818796e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0185651882898508,0.00248573423989734,0.013693149179652,0.0234372274000496,8.59435456087253e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0402259105178836,0.00539311525660793,-0.0507964164208351,-0.029655404614932,9.28354026690252e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNST,Consortin,40359,-0.0773764691758397,0.0103841832765483,-0.0977294683978745,-0.057023469953805,9.71130693010416e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0744224795439072,0.00999150539402295,-0.0940058301161921,-0.0548391289716222,9.91709896332145e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0146783196876923,0.00197030873791671,-0.0185401248140091,-0.0108165145613756,9.92106282994881e-14
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0347148940214269,0.00466795130421175,-0.0438640785776819,-0.0255657094651718,1.08379012376373e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0439492157472344,0.00591251211803944,-0.0555377394985917,-0.0323606919958771,1.12490629762199e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0201175708515251,0.00270850630746821,-0.0254262432141628,-0.0148088984888874,1.16233708870859e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.060285921821352,0.0081174641921263,-0.0761961516379196,-0.0443756920047845,1.18044897004597e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS2,Thrombospondin-2,40332,-0.0256384571435747,0.00345477079163485,-0.032409807895179,-0.0188671063919704,1.21959723157709e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0557314553977065,0.00751761063943983,-0.0704659722510085,-0.0409969385444044,1.30370423731629e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0688924148724145,0.00929421986878974,-0.0871090858152424,-0.0506757439295866,1.30405056149914e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0218901225051791,0.00295474223246658,0.0160988277295446,0.0276814172808136,1.34162271765552e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0200832854119708,0.00271254025145075,-0.0253998643048143,-0.0147667065191274,1.40082731620726e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FST,Follistatin,40396,-0.0370326894913237,0.00501187902113985,-0.0468559723727578,-0.0272094066098896,1.55282015960294e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.038673406155661,0.00523591499854579,-0.0489357995528108,-0.0284110127585113,1.60172621419774e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0517876275020337,0.00702394167501218,-0.0655545531850575,-0.0380207018190098,1.76492607447065e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TF,Serotransferrin,38013,-0.01545395452295,0.00209703523407186,-0.0195641435817308,-0.0113437654641691,1.81267080465323e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0209944859743563,0.00285319287899663,-0.0265867440171897,-0.0154022279315229,1.97339990547551e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0730503029389869,0.00993636490309636,-0.0925255781490558,-0.0535750277289181,2.05078620617479e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0301625210919673,0.00410643132700228,-0.0382111264928918,-0.0221139156910428,2.15429440296705e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.0553615183184586,0.00755470493619962,-0.0701687399934098,-0.0405542966435073,2.4471242721936e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0239256022684297,0.00326736007384154,0.0175215765237003,0.0303296280131591,2.54956635012048e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0249667480058135,0.00341486271250256,-0.0316598789223185,-0.0182736170893084,2.79719367679217e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0434597295181666,0.00594770793946858,-0.055117237079525,-0.0318022219568081,2.89035255950949e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELE,E-selectin,40536,-0.0351521240773227,0.00481394936934089,-0.0445874648412308,-0.0257167833134146,2.96484554723981e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.03294302636092,0.00451519665519424,0.0240932409167393,0.0417928118051007,3.10723732341096e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID2,Nidogen-2,40332,-0.0518586331343667,0.00711611235825968,-0.0658062133565557,-0.0379110529121778,3.30622214928022e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0489719772203629,0.0067352108583739,-0.0621729905027758,-0.0357709639379501,3.76439410634243e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0803803413477244,0.0110606756687206,-0.102059265658417,-0.058701417037032,3.84058586383686e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBIN,Erbin,40305,-0.071683837845688,0.00986455784757024,-0.0910183712269257,-0.0523493044644503,3.85228997521556e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0350944564962358,0.00484169279289875,-0.0445841743703174,-0.0256047386221543,4.41654973946855e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGN,Secretagogin,40044,-0.0306420949529114,0.00422889388318562,-0.0389307269639552,-0.0223534629418675,4.49730970588728e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0377622776497537,0.00521268684791807,-0.0479791438716732,-0.0275454114278343,4.58887132395044e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.0244605903067546,0.00337731321171447,-0.0310801242017149,-0.0178410564117942,4.60679711749545e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0474488447694083,0.00656236051289809,-0.0603110713746886,-0.034586618164128,5.08048038222267e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.043835943728902,0.00606291429301741,-0.0557192557432162,-0.0319526317145879,5.08296854079993e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.0678370801600626,0.00939555191201202,-0.0862523619076062,-0.0494217984125191,5.43468093213032e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0160075104237289,0.00221940665509768,-0.0203575474677204,-0.0116574733797375,5.78419006014979e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.0193554228122088,0.00268516706463911,0.0140924953655161,0.0246183502589015,5.9201106045146e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0262125734253401,0.00364556410633625,-0.0333578790737591,-0.019067267776921,6.7601958405083e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0655244662314124,0.00912375021167039,-0.0834070166462864,-0.0476419158165385,7.18993429716967e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.0173065822793863,0.00241355611395291,0.0125760122960385,0.022037152262734,7.86541693548157e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.020139001515836,0.00280863968009683,0.0146340677428462,0.0256439352888258,7.8698126524111e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.020696498248548,0.00289334946285685,-0.0263674631957475,-0.0150255333013486,8.91959592791767e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.02720970171743,0.00380757511488311,0.0197468544922591,0.0346725489426009,9.30905345656331e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0305837833447607,0.00428178558156372,-0.0389760830846256,-0.0221914836048958,9.55340180754149e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0177520549951993,0.00248541878949863,0.012880634167782,0.0226234758226166,9.56318470070092e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0712904585114106,0.00998298672032374,-0.0908571124832451,-0.0517238045395761,9.7275955990066e-13
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0531407267170254,0.00745267516371884,0.0385334833961365,0.0677479700379143,1.04365750948146e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.0944719650641264,0.0132624210722874,-0.12046631036581,-0.0684776197624431,1.09918396297984e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGA4,Pepsin A-4,37987,-0.0466364852586157,0.00654766574954704,-0.0594699101277279,-0.0338030603895035,1.11249153613183e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0181613991109797,0.00255408864775197,-0.0231674128605736,-0.0131553853613859,1.203628103731e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0393085419786903,0.00553145953264873,-0.0501502026626818,-0.0284668812946988,1.24305228085715e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0462008009647674,0.00650696897285205,-0.0589544601515574,-0.0334471417779774,1.29821630673383e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0382035981163056,0.00538307374905762,-0.0487544226644585,-0.0276527735681527,1.32836919224718e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB8,Serpin B8,40516,-0.0372274298431701,0.00525186230735944,-0.0475210799655946,-0.0269337797207456,1.41290007604472e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK2,Docking protein 2,40359,-0.0823772903081764,0.0116224686468749,-0.105157328856051,-0.0595972517603016,1.42022884177365e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0204118557563717,0.0028853430791206,-0.0260671281914481,-0.0147565833212953,1.56466038832171e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00588492567376356,0.000833179454916098,0.00425189394212801,0.00751795740539912,1.69365678938469e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.035775698123156,0.0050665269637302,-0.0457060909720672,-0.0258453052742448,1.73307919605867e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0495729388110305,0.0070275227914622,-0.0633468834822964,-0.0357989941397646,1.81011855063217e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN5,CCN family member 5,40332,-0.0266764511902671,0.00378656295132396,-0.034098114574862,-0.0192547878056721,1.93035897899761e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0373994340897412,0.00531212275743584,-0.0478111946943155,-0.026987673485167,1.99731074068418e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0556705082576917,0.00790990935803952,-0.0711739305994492,-0.0401670859159343,2.0456399185895e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM3,Dynamin-3,37959,-0.0370399665103251,0.00526349292059691,-0.0473564126346951,-0.0267235203859552,2.05679390285943e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0374697911008154,0.00532953161418393,-0.0479156730646159,-0.0270239091370149,2.14231938112766e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0576149708990549,0.00819549505090028,-0.0736781411988195,-0.0415518005992904,2.15028130406617e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMNL1,Formin-like protein 1,39961,-0.0405221670727092,0.00577591685426416,-0.051842964107067,-0.0292013700383515,2.38246849065162e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0261430907243488,0.00372818185986916,0.0188358542790052,0.0334503271696923,2.43894661804471e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTD,Biotinidase,38013,-0.0139195914059969,0.00198500246167347,-0.0178101962308769,-0.0100289865811169,2.45391985136226e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.0844008386612554,0.0120440121073691,-0.108007102391699,-0.060794574930812,2.51949866986313e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.0180123105916342,0.00257105970328794,0.0129730335731898,0.0230515876100785,2.55554721683585e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0392775791413502,0.00561069614629073,-0.0502745435880801,-0.0282806146946204,2.65206142766216e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0265035644495269,0.00379236883202044,-0.0339366073602869,-0.0190705215387668,2.90563721362233e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPSE,Heparanase,37848,-0.0622101532048158,0.00890340490375303,-0.0796608268161718,-0.0447594795934599,2.93612932138756e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0228989810886776,0.00328329104868,-0.0293342315440904,-0.0164637306332648,3.19192088991501e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0328395290229795,0.00471173854614807,-0.0420745365734297,-0.0236045214725292,3.3028748592821e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0329235596735546,0.0047270236672505,-0.0421885260613655,-0.0236585932857436,3.41204399191117e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRAP,BRCA1-associated protein,37778,-0.0730978172065607,0.0105020538093178,-0.0936818426728235,-0.0525137917402979,3.55345161269178e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0397338340956037,0.00571048053301969,-0.0509263759403223,-0.0285412922508851,3.587417421064e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0381671649591339,0.0054906924589712,-0.0489289221787175,-0.0274054077395504,3.76138567441395e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0337596292231773,0.00485866789858282,-0.0432826183043996,-0.024236640141955,3.83976496689486e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREH,Trehalase,37998,-0.0495694167990743,0.00714177436188117,-0.0635672945483614,-0.0355715390497873,4.07708088865698e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0245000220433008,0.00353030304259895,0.0175806280798069,0.0314194160067948,4.10235847399926e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.0696742480875542,0.0100410025807463,-0.089354613145817,-0.0499938830292915,4.10280348202802e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0240849263815071,0.00347575418818188,0.0172724481726706,0.0308974045903436,4.38843966910596e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0401079679066315,0.0057887948159669,-0.0514540057459266,-0.0287619300673364,4.41811576315445e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0395578766522666,0.00570978461695384,-0.0507490545014962,-0.0283666988030371,4.43068790657964e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0411274165583357,0.00593937481891665,-0.0527685912034123,-0.0294862419132591,4.54285375994962e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0401728480585899,0.00580601122161178,-0.0515526300529489,-0.0287930660642308,4.74685720626402e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0413664854411054,0.00597923110814748,-0.0530857784130745,-0.0296471924691363,4.77500754897144e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A14,Protein S100-A14,37959,-0.0356736762895716,0.00516869379565302,-0.0458043161290515,-0.0255430364500917,5.36102839844209e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0364456235639038,0.00528671242712895,-0.0468075799210765,-0.026083667206731,5.67270418110768e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0508741880305346,0.00738002591785948,-0.0653390388295392,-0.03640933723153,5.68539913662076e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YJU2,Splicing factor YJU2,37900,-0.0211706168479041,0.00307162202160921,-0.0271909960102582,-0.0151502376855501,5.73338895109394e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0433916078835338,0.00630054258241386,-0.055740671345065,-0.0310425444220027,5.95165790054176e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELL,L-selectin,38013,0.0153233232751387,0.00222919022505708,0.0109541104340268,0.0196925361162505,6.51819719163088e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0356649565836476,0.00520620237616059,-0.0458691132409223,-0.0254607999263728,7.62816018091395e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0437172539574594,0.00639012228800835,-0.0562418936419558,-0.0311926142729631,8.18756285689173e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0194405518889826,0.00284755487908856,-0.0250217594519962,-0.0138593443259691,9.03318878182e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGRN,Neugrin,37942,-0.014422831173255,0.00211433173347679,-0.0185669213708695,-0.0102787409756405,9.39606019545876e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM2,Paralemmin-2,37942,-0.0241679825817727,0.00354619415255766,-0.0311185231207857,-0.0172174420427597,9.81380032173065e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0190854886491282,0.00280110275748229,-0.0245756500537935,-0.013595327244463,9.86419757472611e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0101940330618598,0.00149655882849018,0.00726077775801905,0.0131272883657006,9.99058067502839e-12
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0495200178253163,0.00727286428554922,-0.0637748318249928,-0.0352652038256398,1.02522061460125e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0535882205553548,0.00787639590988221,-0.0690259565387239,-0.0381504845719857,1.06319329566288e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0215194688567153,0.00316736267296267,0.0153114380177085,0.0277274996957222,1.13520850861634e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0211973818144371,0.00312207654194027,-0.02731665183664,-0.0150781117922341,1.16506215129062e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0355814667093946,0.00525241301342679,-0.0458761962157111,-0.0252867372030781,1.29400711086631e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0441767058973055,0.00653660206034495,-0.0569884459355816,-0.0313649658590294,1.44362692398013e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A4,Protein S100-A4,40411,-0.0375230681125479,0.00556287178036801,-0.0484262968020692,-0.0266198394230266,1.57990891067246e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.0693466408026195,0.0102914841906287,-0.0895179498162517,-0.0491753317889873,1.66806379047474e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS9,Galectin-9,40350,-0.0208815449930679,0.00310013768710195,-0.0269578148597877,-0.0148052751263481,1.68756958297247e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0188514313725605,0.00279921520726133,-0.0243378931787927,-0.0133649695663283,1.71107033101032e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0447654248572773,0.00664992472265724,-0.0577992773136855,-0.0317315724008691,1.73376859781179e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0531491997293683,0.00789725819414466,-0.0686278257898918,-0.0376705736688448,1.75318240927343e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0586019544594558,0.0087281562122748,-0.0757091406355144,-0.0414947682833972,1.95607609530786e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCN2,Ficolin-2,40291,-0.026598061873944,0.00396225337448945,-0.0343640784879433,-0.0188320452599446,1.97324326949617e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B2M,Beta-2-microglobulin,38013,-0.020467984354955,0.00305198647206455,-0.0264498778402015,-0.0144860908697085,2.07320685932646e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0663534280778651,0.00990253100050696,-0.0857623888388587,-0.0469444673168714,2.14470706699885e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA,Adenosine deaminase,40516,-0.0219407012503812,0.00327558602812531,-0.0283608498655068,-0.0155205526352556,2.17927719869828e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNCA,Alpha-synuclein,37671,-0.0734881093333378,0.0109740572879318,-0.0949972616176841,-0.0519789570489915,2.22052213348465e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.0288181206782156,0.00430926395129274,-0.0372642780227494,-0.0203719633336818,2.36223667878831e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0376426232959101,0.0056472675727689,-0.0487112677385372,-0.0265739788532831,2.73980298253743e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0171523239313976,0.00257842164548562,-0.0222060303565494,-0.0120986175062458,2.98103285940946e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINC1,Antithrombin-III,37981,0.00940461343853583,0.00141551413859479,0.00663020572689004,0.0121790211501816,3.17056199177585e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD40LG,CD40 ligand,40516,-0.0488578725227104,0.00737076048579211,-0.063304563074863,-0.0344111819705579,3.49659527876042e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOXO3,Forkhead box protein O3,39980,-0.061855004665488,0.00933497260731485,-0.0801515509758252,-0.0435584583551509,3.55873393105184e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA6,Carbonic anhydrase 6,40295,0.0407578151452158,0.00615338802065323,0.0286971746247354,0.0528184556656961,3.61747060078812e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.0121029652848051,0.00182755378712016,-0.0156849707075606,-0.00852095986204957,3.6453772715858e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTDH,Protein LYRIC,37598,-0.0581573724389546,0.0087817133508717,-0.0753695306066631,-0.0409452142712461,3.66772918566727e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0313761851541905,0.00474473885271954,-0.0406758733055208,-0.0220764970028602,3.91638039869486e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0505031927540576,0.00765067141983851,-0.0654985087369411,-0.0355078767711741,4.20808037968998e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOC,Myocilin,40332,0.0292136919077945,0.00442612051735469,0.0205384956937794,0.0378888881218097,4.23342066337446e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0262419092313878,0.00397613705211403,-0.0340351378535313,-0.0184486806092443,4.27323430015018e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0174663557963626,0.00264689876366995,0.0122784342195695,0.0226542773731557,4.27445753962408e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.0315423980932598,0.00478107670061756,-0.0409133084264703,-0.0221714877600494,4.34145127405494e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM13A,Protein FAM13A,37901,-0.0425809046823269,0.00646357585195579,-0.0552495133521602,-0.0299122960124935,4.62923555611406e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0500674078006131,0.00760484080420018,-0.0649728957768454,-0.0351619198243807,4.76084296469524e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0337507102540378,0.00513502372831562,-0.0438153567615364,-0.0236860637465392,5.09673067243875e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0452550233957003,0.00688874776982296,-0.0587569690245533,-0.0317530777668473,5.23648688098519e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0110520693603662,0.00168402345105248,-0.014352755324429,-0.00775138339630331,5.46908756441999e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0273039023713766,0.00416032766297833,-0.0354581445908141,-0.0191496601519391,5.47484237499135e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0440245574118775,0.00670959907260426,-0.0571753715941818,-0.0308737432295731,5.49275917026542e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLGN,Calmegin,37572,-0.0281068308866236,0.00428354865773128,-0.0365025862557769,-0.0197110755174703,5.52414306602191e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.0205789213013723,0.00313705279779832,0.0144302978176876,0.026727544785057,5.57793143243311e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0257036275877421,0.00392021023727642,0.0180200155226804,0.0333872396528039,5.67099682773626e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.0216997512441465,0.00331087743454643,0.0152104314724355,0.0281890710158575,5.77097911104245e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0630039948346866,0.00962340866244928,-0.0818658758130872,-0.044142113856286,6.05031570837878e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0550521807473795,0.00841548231031801,-0.0715465260756028,-0.0385578354191563,6.26443768121133e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,0.0188069733067784,0.00287719865718772,0.0131676639386905,0.0244462826748664,6.48550164140406e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.042093264755615,0.00644353084213963,-0.0547225852062086,-0.0294639443050213,6.6630209146216e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0340985400277952,0.0052270203669939,-0.0443434999471032,-0.0238535801084871,7.07313451699258e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.040327686572534,0.0061817514544085,-0.0524439194231747,-0.0282114537218934,7.11046627538613e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0211639934382595,0.00324500498136335,-0.0275242032017316,-0.0148037836747873,7.19038543760802e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS27,Serine protease 27,40314,-0.0254116570265961,0.00389970981983086,-0.0330550882734646,-0.0177682257797276,7.42372235732023e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0282707688610003,0.00433978222564195,-0.0367767420232585,-0.019764795698742,7.52101181465086e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0292076642647713,0.00449693712394473,-0.0380216610277029,-0.0203936675018396,8.59460292592317e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0461389472150421,0.00712315991619099,-0.0601003406507764,-0.0321775537793077,9.66748121579088e-11
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0639247577143164,0.00987816207780949,-0.083285955386823,-0.0445635600418098,1.00587729292643e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0491876858768152,0.00760945318232972,-0.0641022141141814,-0.0342731576394489,1.05534848203607e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0593622673836262,0.00918482992476238,-0.0773645340361605,-0.041360000731092,1.05569143630199e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0263654824639975,0.00408086976047032,-0.0343639871945193,-0.0183669777334757,1.07177254399341e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0126877136100649,0.00197193763643182,0.00882271584265858,0.0165527113774713,1.28473120738564e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0266603851458845,0.00414743593101205,-0.0347893595706681,-0.0185314107211009,1.32925074195098e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.035002928617587,0.00544672898463079,-0.0456785174274634,-0.0243273398077107,1.35132784102181e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0379165840277992,0.00590131514106263,-0.049483161704282,-0.0263500063513165,1.35532258037212e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADD1,Alpha-adducin,37671,-0.0433615516347051,0.00676845569246085,-0.0566277247919283,-0.0300953784774818,1.54027262378699e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0468572688739407,0.00732766325116613,-0.0612194888462263,-0.0324950489016551,1.66319681280487e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.081221741949885,0.0127192105685721,-0.106151394664286,-0.0562920892354837,1.75266931098805e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0599048540718855,0.0093833807489759,-0.0782962803398783,-0.0415134278038928,1.78151765832105e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFI,Complement factor I,38013,-0.0123034596462025,0.00193091637343634,-0.0160880557381377,-0.00851886355426728,1.92829753570641e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENR,Density-regulated protein,37598,-0.0352436587517964,0.00553254186285873,-0.0460874408029995,-0.0243998767005933,1.95012245212967e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0500958109878776,0.00787173581942439,-0.0655244131939494,-0.0346672087818058,2.02884700368186e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0229100326255517,0.00360183120123947,-0.029969621779981,-0.0158504434711223,2.07358807982708e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,-0.0538927489687079,0.0084789078327524,-0.0705114083209026,-0.0372740896165132,2.12562268394906e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANPEP,Aminopeptidase N,40370,0.0173726131357916,0.00273358156624554,0.0120147932659504,0.0227304330056329,2.13737090978819e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0550710971476289,0.00866825983857686,-0.0720608864312395,-0.0380813078640183,2.17660043407136e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBKS,Ribokinase,39991,-0.0305112464638598,0.00480459956179099,-0.0399282616049701,-0.0210942313227494,2.20686997984664e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PENK,Proenkephalin-A,37671,-0.0188854831408311,0.00297496124091997,-0.0247164071730343,-0.013054559108628,2.25049552614321e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0545266835971655,0.00859365629300205,-0.0713702499314495,-0.0376831172628815,2.2971540472067e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0108410094664027,0.00170927093657484,0.00749083843071597,0.0141911805020893,2.32215286046031e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0296946896303996,0.00468379344446173,-0.0388749247815446,-0.0205144544792546,2.36193691036255e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0195203332081826,0.00308022469709302,-0.025557573614485,-0.0134830928018803,2.41428569214612e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0237807034775377,0.00376185313128237,-0.0311539356148512,-0.0164074713402243,2.67377213266081e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0297422717595982,0.00471142507924851,-0.0389766649149253,-0.0205078786042712,2.82862670107177e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA2,Annexin A2,37441,-0.0434587534123,0.00688458473484315,-0.0569525394925926,-0.0299649673320074,2.83545465654162e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.03773573591486,0.00598484006679591,-0.04946602244578,-0.02600544938394,2.96752784074077e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHISA5,Protein shisa-5,37998,-0.0150352762203596,0.00238842660450911,-0.0197165923651974,-0.0103539600755217,3.16767232209861e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0367517921708635,0.00585169777639908,-0.0482211198126057,-0.0252824645291213,3.46182601635173e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF6,SLAM family member 6,39980,-0.0229685191921261,0.00366085133174283,-0.030143787802342,-0.0157932505819101,3.61000451448047e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0604592080255949,0.00963545440018813,-0.0793446986499637,-0.0415737174012262,3.61070817845684e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0179107643291691,0.0028552535084504,-0.0235070612057319,-0.0123144674526063,3.63580640824765e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFC1,Cryptic protein,39980,-0.0278952239689287,0.00444794318673468,-0.0366131926149287,-0.0191772553229288,3.67075348716626e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0539079903656159,0.00862530889253513,-0.0708135957949848,-0.0370023849362471,4.23193603540001e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0170666114204502,0.00273113216485344,0.0117135923773375,0.0224196304635629,4.23802133999722e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0262875109738704,0.00420780888845849,-0.0345348163952491,-0.0180402055524918,4.28402420676859e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.046078201141791,0.00737527539759714,-0.0605337409210814,-0.0316226613625006,4.29505499560234e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0311948714364374,0.00499605578376972,-0.040987140772626,-0.0214026021002487,4.39573337685103e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGH,Gamma-glutamyl hydrolase,40077,0.0205598628123819,0.00330600569172222,0.0140800916566063,0.0270396339681574,5.13243281067713e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0551712174577426,0.00887199804977182,-0.0725603336352954,-0.0377821012801899,5.16872175652857e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0145280680128534,0.00233656259768952,-0.0191077307043249,-0.00994840532138196,5.17180379339837e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0209540327129279,0.00337225078602272,-0.0275636442535325,-0.0143444211723234,5.32904523067152e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSTB,Cystatin-B,40097,-0.0250175560115161,0.00402664479618405,-0.0329097798120369,-0.0171253322109954,5.32968803389914e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH2,Cadherin-2,40359,-0.0210886457676195,0.00339734319388174,-0.0277474384276277,-0.0144298531076112,5.52063689333501e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0294415369060234,0.00474340537025576,-0.0387386114317247,-0.0201444623803221,5.56728354467333e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100G,Protein S100-G,37959,0.0265483721328819,0.00427794414234033,0.0181636016138949,0.034933142651869,5.59844382586753e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0319780764437655,0.0051563635439044,-0.0420845489898181,-0.0218716038977129,5.72367945979238e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0610563539664933,0.00984758467996328,-0.0803576199392214,-0.0417550879937653,5.80648333749368e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0171736260344381,0.00277116392496162,0.0117421447415134,0.0226051073273629,5.9161144439987e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0244782443653736,0.00395420435862768,0.0167280038224633,0.0322284849082838,6.14869210747917e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0293442013892907,0.00474788554081567,-0.0386500570492894,-0.020038345729292,6.54975559313018e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0428443577151789,0.00693361010989556,-0.0564342335305742,-0.0292544818997836,6.59864142758811e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0376221058877881,0.00610146353898446,-0.0495809744241976,-0.0256632373513786,7.17364819225329e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.0643710541622604,0.0104475384274361,-0.0848482294800352,-0.0438938788444856,7.41802452559014e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPHN1,Oligophrenin-1,37942,-0.0631511144288589,0.0102541951150499,-0.0832493368543566,-0.0430528920033612,7.54919213698324e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0455499833421812,0.00740440366217971,-0.0600626145200535,-0.031037352164309,7.8476521225604e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0193252486844642,0.00314144869672038,0.0131680092388923,0.0254824881300362,7.88161753405069e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4C,Semaphorin-4C,40305,0.0167997043881765,0.0027334459157596,0.0114421503932877,0.0221572583830653,8.137244315354e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.034573584243173,0.00562834359375699,0.0235420307994093,0.0456051376869367,8.30220557858912e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0474739858604639,0.00773326952683007,-0.0626311941330508,-0.032316777587877,8.54693480419486e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0457417862364878,0.00745223578011312,-0.0603481683655095,-0.0311354041074661,8.59676189832984e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0400126254574123,0.00652172827404006,-0.0527952128745308,-0.0272300380402938,8.74572490110805e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6AP2,Renin receptor,39980,-0.0246167487962326,0.00401574034603008,-0.0324875998744516,-0.0167458977180136,8.99673779462192e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EGFLAM,Pikachurin,37901,-0.018128446704547,0.00295783719235482,-0.0239258076015625,-0.0123310858075316,9.09308230980222e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0592345852213781,0.00966759539219388,-0.0781830721900781,-0.0402860982526781,9.15900750725883e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLB,Beta-klotho,39961,0.0434776318553025,0.00709786020020075,0.029565825862909,0.057389437847696,9.26068929286692e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0194331383393389,0.00317437861766505,-0.0256549204299624,-0.0132113562487154,9.46321079104039e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0391921429571229,0.00640153637676565,-0.0517391542555835,-0.0266451316586622,9.48660914628236e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0439927621324596,0.00719453578670468,-0.0580940522744007,-0.0298914719905184,9.93801568705492e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0186883899108939,0.00305650912024978,-0.0246791477865834,-0.0126976320352043,9.96628275810253e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA9,Carbonic anhydrase 9,40489,-0.0265464440839162,0.0043424462870626,-0.0350576388065589,-0.0180352493612735,9.98848135643568e-10
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0571607841016461,0.0093537446325526,-0.0754941235814492,-0.0388274446218431,1.01317129136031e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0376652001601135,0.00617232598700008,-0.0497629590946337,-0.0255674412255934,1.06996452351777e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0261671143951334,0.00428798945655097,-0.0345715737299733,-0.0177626550602935,1.0740409304394e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.016925459468652,0.00277491870677893,-0.0223643001339387,-0.0114866188033653,1.09407961344206e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.028250227895497,0.0046344321097816,-0.0373337148306689,-0.0191667409603251,1.1190856032239e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.0340426451481949,0.00558954697372147,0.0230871330797008,0.044998157216689,1.1518970623221e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0466490933405738,0.00765958829188429,-0.061661886392667,-0.0316363002884806,1.15860341656899e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0344600750321792,0.00565912931135849,-0.0455519684824418,-0.0233681815819166,1.16502020520957e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.025165624854977,0.00413913779785338,-0.0332783349387696,-0.0170529147711844,1.23476313044225e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0374960905908971,0.00617027430490632,-0.0495898282285135,-0.0254023529532807,1.25844842048764e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI3,Elafin,40074,-0.0313402911643848,0.00515794922452989,-0.0414498716444634,-0.0212307106843062,1.25987258388244e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0276097665184662,0.00454716684165638,-0.0365222135281127,-0.0186973195088196,1.29826189851322e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0301065923621933,0.00495988346584856,-0.0398279639552564,-0.0203852207691301,1.30869108540263e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPP,Lipoma-preferred partner,37562,-0.0390610582827952,0.00644278184817551,-0.0516889107052192,-0.0264332058603712,1.37478625132505e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0347496426783983,0.00573240911389985,-0.0459851645416421,-0.0235141208151546,1.37583035104399e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAMBP,STAM-binding protein,40192,-0.0378092009057845,0.00623873656247946,-0.0500371245682443,-0.0255812772433248,1.388847289006e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH1,Somatotropin,40330,0.102264175168345,0.0168753971855348,0.0691883966846968,0.135339953651993,1.39234677757345e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0564219968176969,0.00931813095126907,-0.0746855334821843,-0.0381584601532095,1.43532594458387e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0338607991980782,0.00559232918785217,-0.0448217644062684,-0.0228998339898879,1.43716134910583e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLG,Plasminogen,37705,-0.0130438838978514,0.00215911913602906,-0.0172757574044684,-0.00881201039123443,1.56974705534891e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0383597085218248,0.00635337743461263,-0.0508123282936656,-0.0259070887499841,1.60437830139684e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0391507032830998,0.00648611139215079,-0.0518634816117153,-0.0264379249544842,1.62127873129843e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0406589084812201,0.00674859172084011,-0.0538861482540667,-0.0274316687083735,1.73083373370982e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.0606224026880966,0.0100666123294112,-0.0803529628537426,-0.0408918425224506,1.75913974874685e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0350273172295869,0.00581802592168542,-0.0464306480360903,-0.0236239864230834,1.77694560793166e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0335091760560009,0.0055700747975246,-0.0444265226591491,-0.0225918294528526,1.82873812738913e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0203298943466355,0.00337925425037166,-0.0269532326773639,-0.013706556015907,1.83506127953344e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0242690627167588,0.00403632298103904,-0.0321802557595953,-0.0163578696739222,1.87308011292908e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0190083179140733,0.00316561521309748,0.0128037120964022,0.0252129237317443,1.95966066281383e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.045920040739035,0.0076626880188699,-0.06093890925602,-0.03090117222205,2.10902485899481e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0751870207780442,0.0125598385873867,-0.0998043044093221,-0.0505697371467663,2.20266730116342e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0531429662305032,0.00888109054472543,-0.0705499036981651,-0.0357360287628414,2.22718902598615e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0385953688794901,0.00645107898196566,-0.0512394836841428,-0.0259512540748374,2.24035265579321e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0478118810867751,0.00799185314179136,-0.0634759132446861,-0.032147848928864,2.25212860745748e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0353099899679251,0.00591222362530575,0.0237220316623259,0.0468979482735244,2.38769827782034e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSS,Cathepsin S,37057,-0.0141293354568585,0.00237820766013801,-0.018790622470729,-0.00946804844298797,2.90463277199587e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0436582337979289,0.00735375685722138,-0.0580715972380828,-0.029244870357775,2.97840451662486e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.022665369896764,0.00381958532710049,0.015178982655647,0.030151757137881,3.01804164518917e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0252890770992375,0.00426223656457645,-0.0336430607658073,-0.0169350934326676,3.03110857938068e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0137159979616046,0.00231385104069709,0.00918084992183831,0.0182511460013709,3.13400441740783e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0146818588410161,0.00247689075521588,0.00982715296079301,0.0195365647212393,3.13843852951587e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0106444774707336,0.00179973063184709,-0.0141719495091539,-0.00711700543231333,3.4093439516661e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0219496992975117,0.0037137967413427,0.01467065768448,0.0292287409105434,3.48580887812912e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.0530776535924163,0.00898222473832236,-0.0706828140795281,-0.0354724931053045,3.50821164121417e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORT1,Sortilin,40330,-0.0206463853698031,0.00349993348629795,-0.0275062550029471,-0.0137865157366591,3.72964839803703e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0476513246111904,0.00808730558334303,-0.0635024435545427,-0.031800205667838,3.89012435209948e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.03317846821397,0.00565639104669916,-0.0442649946655004,-0.0220919417624396,4.56298469877639e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0204086004351563,0.00348144241744399,-0.0272322275733465,-0.0135849732969661,4.67985181725947e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LARP1,La-related protein 1,37900,-0.0357112882235298,0.00609459738887196,-0.0476566991057188,-0.0237658773413408,4.75132084057462e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0482812634601019,0.00824399107618827,-0.0644394859694309,-0.0321230409507728,4.82158475842039e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0381726971050989,0.00653644749620081,-0.0509841341976525,-0.0253612600125453,5.32223587080828e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOC1,Apolipoprotein C-I,37981,0.020324584772196,0.0034838847929728,0.0134961705779694,0.0271529989664227,5.53896162135498e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP2,Retinol-binding protein 2,40305,0.0427392486005514,0.00734411254336589,0.0283447880155543,0.0571337091855486,6.0153985129619e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALY,RNA-binding protein Raly,37900,-0.0269766138844993,0.00463841365156369,-0.0360679046415642,-0.0178853231274345,6.1674197855342e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0517822086996241,0.00891341330126133,-0.0692524987700963,-0.0343119186291519,6.40828714486431e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.022293473475468,0.00383884390237062,-0.0298176075241144,-0.0147693394268216,6.4932428993069e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0214387351333389,0.00369481177495979,-0.0286805662122601,-0.0141969040544177,6.68874374003598e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASC3,Protein CASC3,37572,-0.022904563511243,0.00394758777402912,-0.03064183554834,-0.0151672914741459,6.6974681256359e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP1,Dipeptidase 1,40192,0.0284280206055231,0.00490826073163323,0.018807829571522,0.0380482116395243,7.09340118793611e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2,Brorin,40167,-0.021728238312528,0.0037542443870643,-0.029086557311174,-0.0143699193138819,7.27397269285871e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0328406358040492,0.00567456148516935,-0.0439627763149812,-0.0217184952931173,7.28461195959417e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0117457726235763,0.00203057774504502,0.00776584024328802,0.0157257050038645,7.41114232919284e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0439523057617193,0.00763069172640165,-0.0589084615454666,-0.0289961499779721,8.57312389976893e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0197230450902484,0.00342924627750239,-0.0264443677941531,-0.0130017223863437,9.04688508363439e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0195469300536985,0.00339953926624157,-0.026210027015532,-0.012883833091865,9.12946583569877e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0343113129547263,0.00596805323699865,-0.0460086972992437,-0.022613928610209,9.16256556950468e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.0117709003780052,0.00204874867628832,-0.0157864477835303,-0.00775535297248014,9.37201777950472e-09
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0511184663618894,0.00893014796877536,-0.0686215563806891,-0.0336153763430897,1.05806047676673e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0347460930767436,0.00607256783676548,-0.046648326036804,-0.0228438601166833,1.07296515712974e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0179204006392739,0.00313193212635774,0.0117818136716128,0.0240589876069351,1.07665108532465e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.058430308861549,0.0102166783863928,-0.0784549984988788,-0.0384056192242192,1.09394249443064e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0352859495556803,0.00617214823490886,-0.0473833600961017,-0.0231885390152589,1.10439657295558e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPG,Macrophage-capping protein,40185,-0.0320052774198345,0.00560330510852453,-0.0429877554325425,-0.0210227994071264,1.13769839352705e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.036882742998248,0.00646333967818117,-0.0495508887674831,-0.0242145972290129,1.17777516164099e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE4,Ribonuclease 4,37575,-0.0150266066446521,0.00263406933670627,-0.0201893825445964,-0.00986383074470784,1.19056851067653e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0210646830616698,0.00369460368433797,0.0138232598403674,0.0283061062829723,1.20884948184335e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0309680942566958,0.00543203673052538,-0.0416148862485256,-0.0203213022648661,1.21660849904296e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.031434428829756,0.00551584556810458,-0.042245486143241,-0.020623371516271,1.2268128879128e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0299432132530721,0.00526357765909021,-0.0402598254648889,-0.0196266010412553,1.30264842409597e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.043761156356543,0.00769290656791576,-0.0588392532296578,-0.0286830594834281,1.30892058630676e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0222248134528077,0.00391181067461519,0.0145576645305619,0.0298919623750535,1.3630658195918e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTBDN,Retbindin,40305,-0.0160309814338649,0.00282195893313399,-0.0215620209428076,-0.0104999419249223,1.36420894704564e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0199188798625509,0.00350672043259496,0.0130457078146648,0.026792051910437,1.36889587812056e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0209669506879893,0.00369578402736707,-0.0282106873816288,-0.0137232139943499,1.42577848855481e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAB2,Disabled homolog 2,40489,-0.0602542680537144,0.0106210488855692,-0.08107152386943,-0.0394370122379989,1.42657547854339e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0335639623806294,0.00593320441146991,-0.0451930430271104,-0.0219348817341484,1.56785264383708e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0352817120135234,0.00624180337914621,-0.0475156466366499,-0.0230477773903968,1.61356525016142e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0222102016353048,0.00393273005123258,-0.0299183525357206,-0.0145020507348889,1.65612065991803e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.0129253865487039,0.00229026917816348,-0.0174143141379043,-0.00843645895950344,1.69332468288549e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0193915870467422,0.00344579104584358,0.0126378365968888,0.0261453374965956,1.85799384366071e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0185989220336718,0.0033085620287034,-0.0250837036099305,-0.0121141404574131,1.9250397147545e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPACT,Protein IMPACT,37942,-0.0306956209481892,0.00546071013764719,-0.0413986128179777,-0.0199926290784007,1.93419898882589e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0364587165894386,0.00648947723566604,-0.049178091971344,-0.0237393412075331,1.96967035093551e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0348100384258422,0.00619719392874857,-0.0469565385261894,-0.022663538325495,1.98054285188812e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0360120009532443,0.00641792375645831,-0.0485911315159026,-0.023432870390586,2.04301371676303e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0246975305121743,0.00440458313617766,0.0160645475652661,0.0333305134590825,2.08995380512939e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0186230518443418,0.0033234606130221,-0.0251370346458651,-0.0121090690428184,2.13540913743513e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0168546773957874,0.00300786726984782,-0.0227500972446891,-0.0109592575468857,2.14239792680113e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0204433070688531,0.0036495475461038,-0.0275964202592165,-0.0132901938784896,2.16012716293276e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.028179898532585,0.0050336106872135,-0.0380457754795235,-0.0183140215856466,2.1998756533696e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN3,Ataxin-3,37942,-0.0334848754316334,0.00598327594831241,-0.0452120962903258,-0.0217576545729411,2.23097232456183e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0139480064749059,0.00249441927535339,0.00905894469521326,0.0188370682545986,2.29228852156034e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.012640841040888,0.00226098060066593,-0.0170723630181933,-0.00820931906358282,2.30429307374332e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0240456250342451,0.00430738638434111,-0.0324881023475537,-0.0156031477209365,2.41185069812639e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0231705590944411,0.00415636427980776,-0.0313170330828643,-0.0150240851060179,2.52823817183507e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0610043752088434,0.0109461040859682,-0.0824587392173411,-0.0395500112003458,2.54950450609173e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLK1,Protein delta homolog 1,40536,-0.0284477007609747,0.0051095498318796,-0.0384624184314587,-0.0184329830904907,2.6246977184957e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6L,Seizure 6-like protein,40411,0.014752676653362,0.00264985483919297,0.00955896116854379,0.0199463921381803,2.62806811498645e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.041863524929564,0.00752245562229409,-0.0566075379492604,-0.0271195119098675,2.66205021431328e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRKL,Crk-like protein,40374,-0.0571070227596502,0.0102712488753375,-0.0772386705553116,-0.0369753749639888,2.74281319584678e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0319493954164249,0.00574675182600745,-0.0432130289953995,-0.0206857618374503,2.75603571986206e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAEP,Glycodelin,40228,-0.070568896245423,0.0126994085375425,-0.0954597369790063,-0.0456780555118396,2.79108762118896e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OPLAH,5-oxoprolinase,37628,-0.0363835492082205,0.00654827008192508,-0.0492181585687937,-0.0235489398476473,2.81045996299962e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0264306030320834,0.00476929002498754,-0.035778411481059,-0.0170827945831079,3.05070766862415e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RETN,Resistin,40283,-0.0221543014528174,0.00399855908271216,-0.0299914772549333,-0.0143171256507016,3.06293547263668e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD109,CD109 antigen,40332,0.0178786020121418,0.00322746741914314,0.0115527658706213,0.0242044381536624,3.08129103836128e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.012888224533659,0.00232714963721783,-0.017449437822606,-0.00832701124471209,3.11288744096997e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0398964761765388,0.0072059755855301,-0.0540201883241778,-0.0257727640288998,3.13411321615637e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENG,Endoglin,40536,0.00909934662472046,0.00164469669995623,0.00587574109280625,0.0123229521566347,3.20555253596274e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0325193942458676,0.00588109452182885,-0.0440463395086521,-0.020992448983083,3.27143567142993e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUOM,Fucose mutarotase,37671,-0.0332699085179514,0.00601706371702376,-0.045063353403318,-0.0214764636325849,3.27684477095057e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0377148976874445,0.00683919700969049,-0.0511197238264378,-0.0243100715484511,3.5616225582295e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0481427481674055,0.00873515764178327,-0.0652636571453007,-0.0310218391895103,3.62570026031811e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0304219436061023,0.00552645475592167,-0.0412537949277088,-0.0195900922844958,3.7654839745073e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USO1,General vesicular transport factor p115,40305,-0.0480098403215552,0.00873450800858164,-0.0651294760183752,-0.0308902046247351,3.93224649385337e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.022288162529733,0.00405474985628794,-0.0302354722480574,-0.0143408528114086,3.93881526976647e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOK1,Docking protein 1,37942,-0.0718770551229564,0.0130831618256167,-0.0975200523011651,-0.0462340579447477,4.00369557303373e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0201031259201497,0.00366637787081194,-0.0272892265469411,-0.0129170252933583,4.24426860419199e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0355454410394333,0.00649464568746741,-0.0482749465868694,-0.0228159354919972,4.50515518699943e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM17,Splicing factor 45,37959,-0.0401045168229695,0.00732864429689453,-0.0544686596448828,-0.0257403740010563,4.52157825948514e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK11,Kallikrein-11,40260,-0.0156903481227966,0.00286801409819966,-0.0213116557552679,-0.0100690404903253,4.54801942859555e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0368049932123758,0.00672737885740317,-0.049990655772886,-0.0236193306518656,4.55696485096529e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0191549289117621,0.00350539175478512,-0.0260254967511409,-0.0122843610723833,4.7141913895515e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0417352541250099,0.00764174200389438,-0.0567130684526429,-0.0267574397973769,4.79253024763991e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.0347179605707943,0.00637363516871809,-0.0472102855014817,-0.0222256356401068,5.19526484428152e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA6,Integrin alpha-6,40341,-0.027830318433234,0.00511664969686526,-0.0378589518390899,-0.017801685027378,5.43210711536845e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX15,Sorting nexin-15,37671,-0.0284389725522873,0.00522807587948352,-0.038686001276075,-0.0181919438284996,5.43312100479685e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0180300010221852,0.00331494801016378,-0.0245272991221062,-0.0115327029222642,5.43876760731951e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0272080684761046,0.00500820628790995,-0.0370241528004081,-0.0173919841518011,5.63194127469493e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0173712221828396,0.00320967721347783,0.011080254844423,0.0236621895212561,6.31706806833998e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0244125086034423,0.0045142787887404,-0.0332604950293735,-0.0155645221775111,6.47318411644219e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0346432315399298,0.00641432449882111,-0.0472153075576191,-0.0220711555222404,6.72780821835823e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNG,Interferon gamma,40044,-0.0591396312612215,0.0109554430216613,-0.0806122995836776,-0.0376669629387653,6.82987245062391e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0185337147301708,0.00343560389231731,-0.0252674983591128,-0.0117999311012289,6.98685415622617e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0319064380106223,0.00592018606854913,-0.0435100027049786,-0.020302873316266,7.16843182045794e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADA2,Adenosine deaminase 2,40258,0.0218217357038146,0.00405093168685246,0.0138819095975838,0.0297615618100454,7.27317438355632e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0134105944957848,0.00248959375448323,-0.0182901982545719,-0.00853099073699762,7.29795244200953e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SELENOP,Selenoprotein P,38013,0.0117087254391045,0.00217578855424982,0.00744417987277481,0.0159732710054341,7.51497674683798e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0552845584995476,0.0102764395939438,-0.0754263801036774,-0.0351427368954178,7.58350312285055e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH3,Neurexophilin-3,37598,0.0156846199048303,0.00291740360081897,0.0099665088472251,0.0214027309624355,7.73635547411337e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F11,Coagulation factor XI,37810,0.015681811531841,0.00291785020079557,0.00996282513828165,0.0214007979254003,7.81113214857669e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL8,Interleukin-8,40209,-0.0351273246134697,0.00653735426499776,-0.0479405389728653,-0.0223141102540741,7.83967707656145e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0273038579465268,0.00508491903837211,-0.0372702992617361,-0.0173374166313175,8.00587653233136e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP8,Neutrophil collagenase,40442,-0.0378605685972506,0.00705328618549764,-0.0516850095208259,-0.0240361276736752,8.08184939586024e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0133646382029583,0.00249463060950575,-0.0182541141975895,-0.008475162208327,8.5616508301961e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0430317411731838,0.00803425311598318,-0.0587788772805108,-0.0272846050658568,8.62520391293545e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0227923940467582,0.00425652452036451,-0.0311351821066726,-0.0144496059868438,8.68790692804473e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA12,Serpin A12,39903,-0.0590298322102469,0.0110279520873878,-0.080644618301527,-0.0374150461189669,8.78663242395793e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0347850798674796,0.00651503270971253,-0.0475545439785161,-0.022015615756443,9.46714209154033e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0394490019274358,0.00739219956566384,-0.053937713076137,-0.0249602907787347,9.60157900124622e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QDPR,Dihydropteridine reductase,40290,-0.02250162729969,0.00421980537260144,-0.0307724458299888,-0.0142308087693912,9.82614667393536e-08
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0395626717137381,0.00742905642804017,-0.0541236223126969,-0.0250017211147794,1.02377486033872e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD69,Early activation antigen CD69,40288,-0.0450573326757243,0.00847349605340166,-0.0616653849403916,-0.028449280411057,1.06664432218174e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX8,Syntaxin-8,40341,-0.0249829835971013,0.0047017771656436,-0.0341984668417627,-0.0157675003524398,1.08978931491199e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPR,Nucleoprotein TPR,37562,-0.023966653352273,0.00451123798250587,-0.0328086797979845,-0.0151246269065615,1.09806896314845e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL32,Interleukin-32,40341,0.0218433717748082,0.00411203421247799,0.0137837847183514,0.0299029588312651,1.0985398196134e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDA,Cytidine deaminase,37970,-0.0233949826584756,0.00440508804407823,-0.0320289552248689,-0.0147610100920822,1.10813505606834e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0239603890257189,0.00451347896722069,-0.0328068078014714,-0.0151139702499664,1.12196959898353e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0259934410924964,0.00490162410229361,-0.0356006243329919,-0.0163862578520009,1.15408226841475e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0429147432337169,0.00810384468745769,-0.058798278821134,-0.0270312076462998,1.20525237257791e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0312522700382962,0.00592632003148046,-0.0428678572999979,-0.0196366827765945,1.35933358409739e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD2,Polycystin-2,37562,-0.0301653212899204,0.00572093638493528,-0.0413783566043935,-0.0189522859754472,1.36496898279425e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0410607785482023,0.00780740193625708,-0.0563632863432662,-0.0257582707531384,1.46948316004453e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0170151715971842,0.0032366704922753,-0.0233590457620437,-0.0106712974323246,1.48698534725285e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0458425703113472,0.00872974382806753,-0.0629528682143595,-0.0287322724083348,1.53324997461656e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS8,Galectin-8,40471,-0.0304913464254749,0.00581559787258427,-0.0418899182557401,-0.0190927745952098,1.59968890216751e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,-0.00901396622676879,0.00172044480388951,-0.0123860380423922,-0.00564189441114534,1.63581036592521e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0200454430953536,0.00383165736864435,-0.0275554915378965,-0.0125353946528106,1.70634778738978e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TWF2,Twinfilin-2,37998,-0.0415898562031635,0.0079526329943995,-0.0571770168721865,-0.0260026955341405,1.72316858077645e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0161464102206911,0.00308849611501252,-0.0221998626061157,-0.0100929578352666,1.73578892401075e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAM,Integrin alpha-M,40332,0.0159770565877481,0.00305957324701682,0.00998029302359511,0.0219738201519011,1.79245405955046e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0462123535821784,0.00886474828855847,-0.0635872602277529,-0.0288374469366038,1.88134960471019e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164,Sialomucin core protein 24,40332,-0.0133509221422046,0.00256150315747566,-0.0183714683308569,-0.00833037595355231,1.89009203415403e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX2,Heme oxygenase 2,39961,-0.0228808626476406,0.00439947977171735,-0.0315038430002067,-0.0142578822950746,2.00944510226589e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0228333278837855,0.00439496622522417,-0.0314474616852249,-0.0142191940823462,2.06848602345733e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0148679202534044,0.00286446717538528,0.00925356458964931,0.0204822759171596,2.12330847067326e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.0126390453519611,0.00243578946279544,-0.0174131926990401,-0.007864898004882,2.14141693299925e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0169207992310915,0.00326221127029949,-0.0233147333208785,-0.0105268651413045,2.16413179623063e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0213831199094419,0.00412609837989821,-0.0294702727340424,-0.0132959670848414,2.21704178279309e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.0198150737656514,0.00382965176435598,-0.0273211912237891,-0.0123089563075137,2.31799631658773e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0263944690780186,0.00510213334135729,-0.0363946504270789,-0.0163942877289583,2.333994653625e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0520319019019698,0.0100620433155133,-0.0717535068003759,-0.0323102970035637,2.35536427597247e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0200046490107531,0.00387245144993947,-0.0275946538526345,-0.0124146441688717,2.42801614756371e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0210762935382633,0.0040808038504294,0.0130779179914217,0.029074669085105,2.44284029537293e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0186146608939929,0.00360523934450433,-0.0256809300092214,-0.0115483917787644,2.45660756412548e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.019860205639926,0.00384853498096252,-0.0274033342026125,-0.0123170770772394,2.49830471846472e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.013676303211124,0.00265411669835327,-0.0188783719398965,-0.00847423448235164,2.59619586617994e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0424247511558997,0.00824598857679598,-0.0585868887664198,-0.0262626135453796,2.71511154621459e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSNAX,Translin-associated protein X,37562,-0.0195041635585599,0.00379133623767274,-0.0269351825843985,-0.0120731445327213,2.72246056376319e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD46,Membrane cofactor protein,40250,-0.0142169157278669,0.00276947958465359,-0.019645095713788,-0.0087887357419459,2.87893120409613e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN2,Centrin-2,39961,-0.033082930141445,0.00647983967693742,-0.0457834159082424,-0.0203824443746477,3.33796710903527e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0282717505095266,0.00554479562037044,-0.0391395499254527,-0.0174039510936006,3.45746172762072e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0137125548944317,0.00268975215190013,-0.018984469112156,-0.00844064067670746,3.47909034088538e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0390060787037793,0.00765689742387749,-0.0540135976545792,-0.0239985597529795,3.5499368836163e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0579047362033676,0.0113670278887521,-0.0801841108653217,-0.0356253615414134,3.55133129003702e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0162654339938754,0.00319377566753377,-0.0225252343022416,-0.0100056336855092,3.57485106174273e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0547316296749773,0.0107513633232315,-0.0758043017885111,-0.0336589575614435,3.60878530343709e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBNL,Drebrin-like protein,40422,-0.0452317569817242,0.00890240423732558,-0.0626804692868823,-0.027783044676566,3.79993452689871e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0397947229843034,0.00783812697777305,-0.0551574518607386,-0.0244319941078682,3.87663116825792e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA10,Annexin A10,39961,-0.0404915403462807,0.00797555744175785,-0.056123632932126,-0.0248594477604353,3.87975326330263e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0129194703308671,0.00254990529534308,-0.0179172847097395,-0.00792165595199462,4.09401573096644e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0350406829781895,0.00691693498156111,-0.0485978755420493,-0.0214834904143298,4.10954601666429e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0223619607286813,0.00441653295797525,-0.0310183653263128,-0.0137055561310498,4.16806567687641e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0175355194943468,0.00346405665241865,-0.0243250705330874,-0.0107459684556063,4.19312061157349e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0237543128311288,0.00469269207062334,0.014556636372707,0.0329519892895505,4.20518659145524e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED8,Protein TMED8,37901,-0.0497013860241509,0.00985995154891629,-0.0690268910600268,-0.0303758809882749,4.69779966844925e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0435499748491598,0.00864350684773009,-0.0604912482707108,-0.0266087014276088,4.75338897092413e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL19,Interleukin-19,39924,-0.0330632645557179,0.00656410973210512,-0.0459289196306439,-0.0201976094807918,4.78268649052838e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.018144141185778,0.00360813103368295,0.0110722043597594,0.0252160780117965,4.99468177154737e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0244864536430586,0.00486938596739689,-0.0340304501391565,-0.0149424571469607,5.00298562875092e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0221281054719251,0.00440189688485796,-0.0307558233662467,-0.0135003875776035,5.04738417552411e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7,Complement component C7,37678,0.0152851240500299,0.00304099818652082,0.00932476760444908,0.0212454804956107,5.06436522962968e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0341162883396685,0.00678854219453627,-0.0474218310409595,-0.0208107456383774,5.08503603348137e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR1,Complement receptor type 1,37959,0.0175334216190861,0.0034903222908692,0.0106923899289825,0.0243744533091897,5.14025467061001e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0236621925029088,0.00471500989786924,-0.0329036119027325,-0.0144207731030851,5.26466248599537e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0207935548677773,0.00414455714404893,-0.0289168868701132,-0.0126702228654414,5.31492272262336e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0531518029061444,0.0105993013832561,-0.0739264336173263,-0.0323771721949625,5.37001513457639e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0169399969497233,0.00337968155827137,-0.0235641728039352,-0.0103158210955114,5.4465653356076e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0136578535944093,0.00272801984870052,0.00831093469095624,0.0190047724978623,5.60167959806686e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTF2,Transcription termination factor 2,37572,-0.0234741905048765,0.0046898368527359,-0.0326662707362388,-0.0142821102735141,5.6488990714623e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.0158441315249748,0.00316589192011773,-0.0220492796884055,-0.00963898336154401,5.65635466263729e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0315953886521311,0.00631855120294701,-0.0439797490099072,-0.0192110282943549,5.78304726104161e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD7,T-cell antigen CD7,37567,-0.0206252899155255,0.00412922413518237,-0.028718569220483,-0.0125320106105681,5.96067228571025e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBLN2,Fibulin-2,37998,0.0147650446965429,0.0029648487227195,0.0089539412000127,0.0205761481930731,6.4356230029049e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0314151491257149,0.00631420006568293,-0.0437909812544534,-0.0190393169969763,6.58231406298155e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0340143976335534,0.00685175076312134,-0.0474438291292712,-0.0205849661378356,6.96506418943475e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0172032387073093,0.00346918967814532,-0.0240028504764742,-0.0104036269381445,7.16399814297356e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.032532375711971,0.0065610879429773,-0.0453921080802065,-0.0196726433437355,7.19460855216264e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB3,Plexin-B3,40310,-0.0223130170821561,0.00450103664722478,-0.0311350489107167,-0.0134909852535956,7.22153638685751e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.0229570705533614,0.00463219925971181,0.0138779600043263,0.0320361811023965,7.2710977942662e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPT,Dermatopontin,40536,0.0126573235884797,0.00255458081181846,0.00765034519731548,0.0176643019796438,7.31570879382461e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0205920121029141,0.00416502233111988,-0.0287554558719091,-0.0124285683339191,7.7305321875734e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.016931618198119,0.00343250436022697,-0.0236593267441639,-0.0102039096520742,8.19097442993328e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0510048819124021,0.010346375194599,-0.0712837772938161,-0.0307259865309881,8.33191320941122e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLG4,Disks large homolog 4,37942,-0.0331697609470481,0.00673029717339472,-0.0463611434069018,-0.0199783784871945,8.38798530455596e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.012707850524724,0.00258059531600195,0.00764988370536018,0.0177658173440878,8.56475882175746e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRL,Appetite-regulating hormone,40359,-0.0374283698455386,0.00760503055451201,-0.0523342297323821,-0.022522509958695,8.67307277486511e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR,GMP reductase 1,40516,-0.0241555598402519,0.00491713290306208,-0.0337931403302536,-0.0145179793502502,9.07937653487628e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0467480206784264,0.0095173013951456,-0.0654019314129118,-0.028094109943941,9.1116657742197e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0415216857513759,0.0084682188660089,-0.0581193947287534,-0.0249239767739985,9.52029993168781e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0368313382726613,0.00751314778684224,-0.0515571079348721,-0.0221055686104505,9.57017699210905e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0336751684976356,0.00687132580808428,-0.0471429670814808,-0.0202073699137904,9.65666645635705e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0196317621509286,0.00400680318954503,0.0117784278994203,0.0274850964024369,9.69694316917086e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.011443973056003,0.00233720583623001,0.00686304961699216,0.0160248964950138,9.85464320452596e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CETN3,Centrin-3,37901,-0.0360925721764571,0.00737261102627772,-0.0505428897879615,-0.0216422545649528,9.91973326150229e-07
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.0139192898709905,0.00284661839226411,0.00833991782215282,0.0194986619198281,1.01932038246706e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0354770165427631,0.00725893124097124,-0.0497045217750668,-0.0212495113104595,1.03372199221259e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0422285593125883,0.00864159297537915,-0.0591660815443315,-0.0252910370808452,1.03561196189116e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0376634920517393,0.00771075444412114,-0.0527765707622168,-0.0225504133412619,1.04679389094677e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0286910566181807,0.00589539635085775,-0.0402460334658619,-0.0171360797704995,1.14803707535309e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0396515158156678,0.00814963325677799,-0.0556247969989526,-0.0236782346323829,1.15533510900437e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0295320129386103,0.00607539522469101,0.0176242382982159,0.0414397875790047,1.17959860800338e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.0182167589714692,0.00375373059624562,-0.0255740709401106,-0.0108594470028277,1.22776484379492e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0287907606722079,0.00593543905050534,-0.0404242212111983,-0.0171573001332174,1.2447156005877e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0312445631976242,0.00644205838887467,-0.0438709976398185,-0.0186181287554298,1.24823016236685e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0413004540546118,0.00851923428038566,-0.0579981532441677,-0.0246027548650559,1.26197799169807e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TALDO1,Transaldolase,37966,-0.0207612542918506,0.00428327032766742,-0.0291564641340788,-0.0123660444496225,1.26699416755526e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0197017332378017,0.00406583238996459,-0.0276707647221323,-0.0117327017534711,1.27368548292757e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.02170644511604,0.00448039849982807,-0.030488026175703,-0.0129248640563769,1.27976564865408e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK13,Kallikrein-13,40032,-0.0202270671283047,0.00419023358523754,-0.0284399249553703,-0.0120142093012391,1.39784027877817e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASAH1,Acid ceramidase,37882,-0.0213962432953282,0.00443280565720554,-0.0300845423834511,-0.0127079442072054,1.40274931982584e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0209138273911464,0.00434631127991861,-0.0294325974997869,-0.012395057282506,1.51199188750761e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.023738666461467,0.0049345930945096,-0.0334104689267058,-0.0140668639962282,1.51810590019852e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0175604938312611,0.00365804077828795,-0.0247302537567055,-0.0103907339058167,1.59681004301994e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0188585638447027,0.0039289541675633,-0.0265593140131268,-0.0111578136762787,1.60444650448829e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0309784386668364,0.00646962302872834,-0.043658899803144,-0.0182979775305289,1.70025122759284e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO3,R-spondin-3,40489,-0.0131973376495083,0.00275809370779522,-0.018603201316787,-0.00779147398222971,1.72553884754407e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0225999357614106,0.00472329417912874,-0.0318575923525029,-0.0133422791703183,1.72696579062611e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0137240789189943,0.00287110755450563,-0.0193514497258253,-0.00809670811216325,1.77081646491226e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0436166888231837,0.0091577779062675,-0.061565933519468,-0.0256674441268994,1.92620363978449e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0144377852192425,0.00303598654815589,0.00848725158485691,0.020388318853628,1.99874982363537e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCG3,Secretogranin-3,40379,0.015320964984194,0.00322332613992468,0.00900324574994164,0.0216386842184464,2.02018093713937e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0173842248544809,0.00365827769966825,-0.0245544491458306,-0.0102140005631311,2.0315372653238e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0163891092128482,0.00345107881796392,-0.0231532236960575,-0.00962499472963894,2.06547387446765e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGA,Chromogranin-A,37998,-0.0411940928855954,0.00867844029552408,-0.0582038358648227,-0.0241843499063682,2.0886038193722e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HYAL1,Hyaluronidase-1,40214,-0.010548379358148,0.00222427857318897,-0.0149079653615984,-0.00618879335469766,2.13068628522238e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0312775567434762,0.0065962614322685,-0.0442062291507225,-0.0183488843362299,2.14151312323758e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0162728716094554,0.00343298691454205,-0.0230015259619578,-0.00954421725695297,2.15805715885198e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMPR2,GMP reductase 2,37671,-0.0310034948942307,0.00654283260603813,-0.0438274468020654,-0.0181795429863959,2.17501605753149e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0408061282241051,0.00862025889958254,-0.0577018356672869,-0.0239104207809234,2.22362826470233e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0141481192467393,0.00299039556127258,-0.0200092945468336,-0.0082869439466451,2.25129913817594e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.020467496038108,0.00432892544163251,0.0119828021725083,0.0289521899037077,2.28592359843797e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APCS,Serum amyloid P-component,37882,-0.0163204106602661,0.00345214458462414,-0.0230866140461295,-0.00955420727440281,2.29479893262957e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0527225393502586,0.0111775256371802,-0.0746304895991318,-0.0308145891013855,2.41584298532011e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GLB2,Endophilin-B2,37942,-0.030302474223234,0.00642975895378092,-0.0429048017726447,-0.0177001466738234,2.46719449549538e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0117609196242801,0.00249633648763967,0.00686810010850632,0.0166537391400538,2.48690827514897e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0131316823985938,0.00278795489450903,-0.0185960739918315,-0.00766729080535614,2.49994893746897e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0253870692739456,0.0053926002578202,-0.0359565657792731,-0.014817572768618,2.53004889185694e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0323570197529434,0.00687659392043881,-0.0458351438370035,-0.0188788956688833,2.55514789812684e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAM,Basal cell adhesion molecule,40332,0.0107578439406178,0.00228837341907004,0.00627263203924051,0.0152430558419951,2.6095346579466e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.018514035760115,0.00394325555924389,-0.0262428166562331,-0.010785254863997,2.69087650792173e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.0663847304581618,0.014158599930578,-0.0941355863220947,-0.0386338745942289,2.77714159369256e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH7,Protocadherin-7,37901,-0.0157145561759861,0.00335207510449563,-0.0222846233807975,-0.00914448897117464,2.78585689214295e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0348589485996641,0.00744481732861047,-0.0494507905637406,-0.0202671066355876,2.8600228301161e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPEP2,Dipeptidase 2,40305,0.0129603265896797,0.00276934830460938,0.00753240391264532,0.0183882492667141,2.8936135462869e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0132848187164583,0.00284152095598559,0.00771543764272657,0.0188541997901901,2.95980807272477e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST5,Cystatin-D,40070,-0.024877639072304,0.00532594686131589,-0.0353164949204832,-0.0144387832241249,3.02195905478834e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BOLA1,BolA-like protein 1,37541,-0.0246358906283119,0.00527758044484458,-0.0349799483002073,-0.0142918329564165,3.07123715576096e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.0145287118448384,0.00311308891898237,-0.0206303661260438,-0.00842705756363294,3.0816938169461e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.0224877414221051,0.00482321623755658,0.0130342375964942,0.031941245247716,3.15089687348838e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0222306992142891,0.00476917878771014,-0.031578289638201,-0.0128831087903772,3.17328500551312e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP7,Caspase-7,37942,-0.0374736196859759,0.00803960170188325,-0.0532312390216671,-0.0217160003502847,3.17490853044642e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEXN,Nexilin,37987,-0.0306069729020116,0.00657606260646801,-0.0434960556106889,-0.0177178901933343,3.28166875327515e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COLEC12,Collectin-12,40357,-0.0114804124859455,0.00247064287292273,-0.0163228725168741,-0.00663795245501699,3.39941482139001e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0210984140132724,0.0045441411539677,0.0121918973514957,0.0300049306750491,3.46147033716869e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0391056535079104,0.00842231597570227,-0.0556133928202869,-0.022597914195534,3.46468031713079e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD93,Complement component C1q receptor,39725,0.0141870308768233,0.00305766565501389,0.00819400619299608,0.0201800555606505,3.51602077459292e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH9,Protocadherin-9,37901,-0.0150481767372578,0.00324959812694717,-0.0214173890660742,-0.00867896440844131,3.67701133942437e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0129026069979283,0.00278723015920324,-0.0183655781099667,-0.00743963588588998,3.70539720109488e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0433589102210709,0.0093867915449085,-0.0617570216490915,-0.0249607987930502,3.88981076757705e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB2,Integrin beta-2,40221,0.0127912833794152,0.00276947695067795,0.00736310855608638,0.0182194582027439,3.89271203078761e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0212271465695864,0.00460081911749966,0.0122095410992871,0.0302447520398857,3.98508410527589e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0300752929337445,0.00652621690667934,-0.042866678070836,-0.017283907796653,4.0896577812797e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH3,Cadherin-3,40471,-0.0157292395240102,0.00341630935744138,-0.0224252058645953,-0.00903327318342514,4.17314394802501e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0250776163815004,0.00544677213306026,-0.0357532897622985,-0.0144019430007022,4.18086706146577e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGLL,Monoglyceride lipase,40396,-0.0383157399880833,0.00832577300791331,-0.0546342550835934,-0.0219972248925733,4.21549517164812e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0218764525523167,0.00475561412789316,-0.0311974562429873,-0.0125554488616461,4.2606140552479e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0185653478678061,0.00403673916433453,-0.0264773566299018,-0.0106533391057105,4.28280767516196e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BIN2,Bridging integrator 2,40332,-0.0402200139647811,0.00875517381342049,-0.0573801546390853,-0.023059873290477,4.38473130928856e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0270337274648263,0.00588892165966632,-0.0385760139177723,-0.0154914410118803,4.45344184769566e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0164117812941521,0.00357578905667626,-0.0234203278452376,-0.00940323474306667,4.47333588300296e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0273733033386891,0.00596761324368437,0.0156767813810677,0.0390698252963105,4.53903945634404e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXNB2,Plexin-B2,40472,-0.0103070155544946,0.00224738433111677,-0.0147118888434835,-0.00590214226550577,4.54744181923888e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.0138304229671127,0.00301630609733559,-0.0197423829178904,-0.00791846301633494,4.57003562372346e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0329751664812645,0.00719306978786928,-0.0470735832654883,-0.0188767496970408,4.59603026772544e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0134211044502307,0.00293146151646511,-0.0191667690225023,-0.0076754398779591,4.73073715040809e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17C,Interleukin-17C,40044,-0.0309921567561673,0.00676985288456039,-0.0442610684099057,-0.0177232451024289,4.73146343971878e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLNK,B-cell linker protein,37598,-0.0168384522069823,0.00368540967238054,-0.0240618551648481,-0.00961504924911643,4.94634157214954e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX,Glutaredoxin-1,40260,-0.0249459515045113,0.00546294697736002,-0.035653327580137,-0.0142385754288857,4.99937480081834e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.0156764548098743,0.00343590440601803,-0.0224108274456697,-0.008942082174079,5.09236409560929e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEK,Angiopoietin-1 receptor,40411,0.00947747147809259,0.0020777864435202,0.00540501004879301,0.0135499329073922,5.1208735414215e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST7,Cystatin-F,40376,-0.0404690124435981,0.00888309074603494,-0.0578798703058266,-0.0230581545813696,5.25901420123398e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNF,Tumor necrosis factor,40014,-0.0174536902290531,0.00383937858452386,-0.0249788722547199,-0.00992850820338631,5.50955222953293e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0349266923017088,0.00769381298434153,-0.0500065657510182,-0.0198468188523994,5.68528679391663e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0287910940202487,0.00635139810343974,-0.0412398343029906,-0.0163423537375068,5.85638119192222e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0262829399989191,0.00580264157660663,-0.0376561174890681,-0.0149097625087701,5.95703408503801e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON1,Spondin-1,40379,0.0143939790817937,0.00317869066339774,0.00816374538153409,0.0206242127820532,5.98990113409557e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.0120529906162624,0.00266176290793036,0.00683593531671889,0.0172700459158059,5.99194690553725e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0203954740543644,0.0045082486830469,-0.0292316414731364,-0.0115593066355925,6.11879129966756e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0113367288071961,0.00250608354948032,0.00642480505021472,0.0162486525641776,6.12126749242428e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0405285070673849,0.00897623970000577,-0.0581219368793962,-0.0229350772553736,6.3754392688843e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0218741061438473,0.00484698647983297,-0.0313741996443199,-0.0123740126433746,6.44920032862887e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPD52L2,Tumor protein D54,37671,-0.0469688438465869,0.0104123574040049,-0.0673770643584365,-0.0265606233347372,6.51169067382466e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0233497460504235,0.00517632958956428,-0.0334953520459695,-0.0132041400548775,6.5129543676068e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0205588092485214,0.00456167931889294,-0.0294997007135516,-0.0116179177834913,6.63495926589947e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOLM2,Protein GOLM2,40471,-0.00972781236519123,0.00216093991054647,-0.0139632545898623,-0.00549237014052015,6.79007339964881e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0195722006415462,0.00435018656712365,-0.0280985663131085,-0.0110458349699838,6.87052085320755e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPART,Spartin,37671,-0.0334893019956484,0.00744612472556114,-0.0480837064577483,-0.0188948975335486,6.93272138534488e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICOSLG,ICOS ligand,40305,-0.00829286899688022,0.00184568753743567,-0.0119104165702541,-0.00467532142350631,7.06883303905102e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPF,Centromere protein F,37714,-0.0236315478015508,0.00526127357345664,-0.0339436440055258,-0.0133194515975758,7.1286475399248e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0208874319972959,0.00465825290994367,-0.0300176077007855,-0.0117572562938063,7.37782580770951e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRGN,Neurogranin,37987,-0.0390734800618648,0.0087213112770057,-0.0561672501647959,-0.0219797099589336,7.51737606848604e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.026505845261931,0.00591884625455792,-0.0381067839208645,-0.0149049066029974,7.59107972483847e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0166736619467342,0.00372645304211882,-0.0239775099092871,-0.00936981398418135,7.71693281742185e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0220248937018193,0.00492721854718784,-0.0316822420543074,-0.0123675453493311,7.8741571720414e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.0172764574233172,0.00386843602915978,0.00969432280616406,0.0248585920404704,8.02428671991355e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0238861721341647,0.00535498958211386,-0.0343819517151079,-0.0133903925532216,8.23232039751984e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCT,Secretin,37572,-0.0197734947262397,0.00443409372945838,-0.0284643184359781,-0.0110826710165013,8.28636156599934e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0269769616213341,0.0060527885890772,-0.0388404272559254,-0.0151134959867428,8.38245003272393e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0209265081519105,0.00469599155919052,-0.0301306516079239,-0.0117223646958971,8.40956364924781e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRIB,Protein scribble homolog,37628,-0.039842168834484,0.00895429712830658,-0.0573925912059649,-0.0222917464630031,8.67751688243412e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0295719061556543,0.00664895812444951,0.0165399482317333,0.0426038640795754,8.75314765944742e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0254269487616509,0.00571947883097859,-0.036637127270369,-0.0142167702529329,8.8223351366507e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMSB10,Thymosin beta-10,40332,-0.032448988703369,0.00732542565774475,-0.0468068229925487,-0.0180911544141893,9.50220969319849e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0127893056578186,0.00288995088268006,-0.0184536093878715,-0.00712500192776571,9.68867404603081e-06
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0349637147356237,0.00791800721754195,-0.0504830088820059,-0.0194444205892415,1.014591556651e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLFM4,Olfactomedin-4,37177,-0.0525098359281694,0.0119017560839375,-0.0758372778526868,-0.0291823940036519,1.03290582676161e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD70,CD70 antigen,40341,0.0176734207281019,0.00400672161272134,0.00982024636716809,0.0255265950890357,1.0359797343938e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0332678787029171,0.00754627350111577,-0.048058574765104,-0.0184771826407302,1.04779282505469e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0237638462106766,0.00541347495368296,-0.0343742571198952,-0.013153435301458,1.14210756588815e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CR2,Complement receptor type 2,40403,0.0197151248746632,0.0044972119534239,0.0109005894459524,0.0285296603033741,1.17343114958721e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.050909209018344,0.0116303682118554,-0.0737047307135807,-0.0281136873231074,1.20969982491414e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0323797415707944,0.00739806370934884,-0.0468799464411182,-0.0178795367004707,1.21350485848901e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0123663736560016,0.002826220379774,0.00682698171164457,0.0179057656003586,1.21868603261909e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NADK,NAD kinase,40359,-0.0225951898505641,0.00516531471626709,-0.0327192066944476,-0.0124711730066806,1.2253737494925e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0284238259730405,0.00650756061614183,-0.0411786447806785,-0.0156690071654026,1.26289784741747e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRDL1,Chordin-like protein 1,40396,0.0128374464771984,0.00294743108915257,0.00706048154245939,0.0186144114119375,1.3361066588385e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0373799888917055,0.00858612432667614,-0.0542087925719907,-0.0205511852114203,1.34949888280621e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0216978640827118,0.00499644792826856,-0.0314909020221181,-0.0119048261433054,1.41640702700591e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0285233009910383,0.00656805142481789,-0.0413966817836813,-0.0156499201983952,1.41746001809638e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0276857352122428,0.00638761278654908,-0.040205456273879,-0.0151660141506066,1.47150615353263e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0196666423204742,0.00454487671687478,-0.0285746006855487,-0.0107586839553996,1.51924006439935e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0292684006573739,0.00677483432153293,-0.0425470759275784,-0.0159897253871693,1.5705958104494e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0305080500930325,0.00706260687113323,-0.0443507595604536,-0.0166653406256114,1.57414880550953e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0189053358319639,0.00438001547990126,-0.0274901661725704,-0.0103205054913575,1.5966924232739e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0118386390999141,0.00274400342116988,-0.017216885805407,-0.00646039239442112,1.61232564694986e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.052761297235166,0.0122311107301282,-0.0767342742662173,-0.0287883202041147,1.61515455615203e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0226726644371226,0.00526055864663698,-0.0329833593845311,-0.0123619694897141,1.64484163106516e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.030674479818853,0.00711966897094947,-0.0446290310019139,-0.016719928635792,1.65617538004264e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0243557863336782,0.0056554971325206,-0.0354405607134186,-0.0132710119539378,1.6698198886051e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLIN3,Perilipin-3,40359,-0.0176339338362544,0.00409495652410289,-0.0256600486234961,-0.00960781904901274,1.67034933887641e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0382856352043508,0.00889194199374787,-0.0557138415120967,-0.020857428896605,1.67668075278665e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0425052639051588,0.00988896441671785,-0.0618876341619258,-0.0231228936483918,1.73385452187296e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB2,Calretinin,39961,-0.0130545058511497,0.0030400488447819,-0.0190130015869222,-0.00709601011537719,1.7640884229412e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0111809107611569,0.00260543898159214,-0.0162875711650774,-0.00607425035723628,1.78805731497903e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0388643360314986,0.00906418914655971,-0.0566301467587556,-0.0210985253042416,1.81808266577387e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.0104464160756909,0.00243886577510478,-0.0152265929948963,-0.00566623915648555,1.85213805233147e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00937286465476257,0.00218886705288447,-0.0136630440784161,-0.00508268523110901,1.86249143091561e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMTN,Smoothelin,37905,-0.0395914857897277,0.00924750954649963,-0.057716604500867,-0.0214663670785884,1.87081042154625e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0240371896240918,0.00561810799444747,-0.0350486812932089,-0.0130256979549748,1.89435049702381e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.00935024921568424,0.0021889972724766,-0.0136406838697384,-0.0050598145616301,1.95320493265731e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0176672754791247,0.00413599618875072,0.00956072294917331,0.0257738280090761,1.95449649118028e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REN,Renin,40359,-0.0293551761433657,0.00688395592220225,-0.0428477297508821,-0.0158626225358493,2.01697018120979e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0265365084765029,0.00622546221572174,-0.0387384144193175,-0.0143346025336883,2.0327750397783e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD160,CD160 antigen,40516,-0.0187706119310181,0.00440636855183058,-0.0274070942926061,-0.0101341295694302,2.05698450312976e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0343841670279279,0.00807699849872626,-0.0502150840854313,-0.0185532499704244,2.08543262663848e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0394630365608721,0.0092751695449135,-0.0576423688689025,-0.0212837042528416,2.10531081758831e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0287687230859017,0.00676822191838227,-0.0420344380459309,-0.0155030081258725,2.14713401266076e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAX,Protein max,39961,-0.0427970532085419,0.0100764065625795,-0.0625468100711976,-0.0230472963458861,2.17668377088444e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0252984708016558,0.00595877742153812,-0.0369776745478705,-0.0136192670554411,2.19296832803331e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0168069762441195,0.00395874143043953,-0.024566109447781,-0.00904784304045804,2.19536292028785e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.0114350804099241,0.00269525615057145,0.00615237835480403,0.0167177824650441,2.2212892095758e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0243819720952232,0.00575023688347232,-0.035652436386829,-0.0131115078036175,2.24619857912376e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0371301476712564,0.00876308713008481,-0.0543057984462226,-0.0199544968962901,2.27960462435685e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0239178525045094,0.00564525427883401,-0.034982550891024,-0.0128531541179947,2.28238485598729e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0361895313137343,0.0085504824470208,-0.0529484769098951,-0.0194305857175736,2.32437723055292e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0141932378839269,0.00335593978543061,-0.0207708798633709,-0.00761559590448289,2.35971229050143e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0227168833708969,0.00539521357002723,-0.0332915019681502,-0.0121422647736435,2.5640652711027e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0162158131405443,0.00385440450829349,-0.0237704459767995,-0.00866118030428901,2.60094943530738e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0137974775736557,0.00328129157058482,0.00736614609530949,0.020228809052002,2.62636771746398e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.039011969201418,0.00928181543544464,-0.0572043274548895,-0.0208196109479465,2.65034123025795e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0394929170829605,0.00940747234599449,-0.0579315628811097,-0.0210542712848113,2.70958728766102e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0243814652492761,0.00581100085716085,-0.0357710269293114,-0.0129919035692409,2.73446991594185e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST1,Cystatin-SN,36179,-0.0421315254723467,0.0100419906569955,-0.0618138271600579,-0.0224492237846356,2.74231915893741e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.032825520098781,0.00783278835019109,-0.0481777852651555,-0.0174732549324064,2.79763479433123e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.013500389476934,0.00322749873106812,-0.0198262869898275,-0.00717449196404047,2.89321553491886e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.0129564836181892,0.00309867607568801,0.00688307850984067,0.0190298887265377,2.91434780815928e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB6,Serpin B6,40433,-0.0239932696445188,0.00575158322276472,-0.0352663727611377,-0.0127201665278999,3.0407384253195e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0293654499918716,0.00704973936606912,-0.043182939149367,-0.0155479608343761,3.1268438397699e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0113362172182349,0.00272594555704436,0.00599336392642793,0.0166790705100418,3.21831375821614e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0254822191566383,0.0061280579826275,-0.0374932128025882,-0.0134712255106884,3.22678702258793e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD83,CD83 antigen,40341,-0.0134434706665028,0.00323877937121594,-0.019791478234086,-0.00709546309891956,3.33066568364308e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAN,Versican core protein,40471,0.0120209025478777,0.00289817190264975,0.00634048561868421,0.0177013194770712,3.37484535398118e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0164347544841328,0.00396326941814528,-0.0242027625436975,-0.00866674642456803,3.39329796667305e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0206570307878863,0.00498841486035862,-0.0304343239141892,-0.0108797376615834,3.47972424739736e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00813664873548866,0.00196856696855398,-0.0119950399938545,-0.00427825747712287,3.59431663154214e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRLB,Fc receptor-like B,39980,-0.024252418500946,0.00588661554512758,-0.0357901849693961,-0.0127146520324959,3.80959344050714e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0277531638226226,0.00673787502123985,0.0145469287809925,0.0409593988642527,3.82479307721772e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0411809747898039,0.0100208068980239,-0.0608217563099307,-0.021540193269677,3.98828210911062e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C19orf12,Protein C19orf12,39961,-0.0246373297131299,0.00599604636678904,-0.0363895805920364,-0.0128850788342233,3.99540273832175e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0208899665855437,0.00510372822938874,-0.0308932739151456,-0.0108866592559418,4.28159678832845e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRD2,Protein ZNRD2,37901,-0.026739261148035,0.00653909286974036,-0.0395558831727261,-0.0139226391233439,4.35496282043859e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN8,Septin-8,37921,-0.0125114353773223,0.00306419192774971,-0.0185172515557117,-0.00650561919893288,4.46935433119977e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0200955881543434,0.00493442421381181,-0.0297670596134146,-0.0104241166952723,4.67786577415014e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,-0.0251614540018052,0.0061788249110575,-0.0372719508274779,-0.0130509571761325,4.67946300467282e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0101033543043921,0.00248845076719492,0.00522599080069009,0.0149807178080942,4.93281177789322e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00884504980293448,0.00217925300320638,0.00457371391664999,0.013116385689219,4.95687006732976e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0345301161123538,0.00850799429566188,-0.0512057849318511,-0.0178544472928565,4.9658052229035e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTC,Probetacellulin,39980,-0.0294180152040535,0.00726277647662909,-0.0436530570982465,-0.0151829733098605,5.13524836269957e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0408572582099125,0.0100955703226142,-0.0606445760422364,-0.0210699403775886,5.21148882252934e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0238901460419105,0.00590322361379887,-0.0354604643249563,-0.0123198277588647,5.21835089109398e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0104004467924256,0.00257002368215628,0.0053632003753993,0.0154376932094519,5.22055933544887e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0585531343084513,0.0144983183938034,-0.0869698383603059,-0.0301364302565967,5.40201189193207e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0205158953598108,0.00508167315795962,-0.0304759747494117,-0.0105558159702099,5.4345078241085e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0235547436244516,0.00584022258061465,-0.0350015798824563,-0.0121079073664469,5.53355745852615e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB7,Integrin beta-7,40489,0.0177058661524408,0.0043947753186939,0.00909210652780071,0.0263196257770808,5.63101123511715e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.0108549436702572,0.00270085254320982,0.00556127268556591,0.0161486146549484,5.86948038749788e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.021949117676935,0.00546314696373373,-0.0326568857258531,-0.0112413496280169,5.90472766024059e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX5,Sorting nexin-5,37628,-0.011589393951246,0.00288596774702596,-0.0172458907354169,-0.00593289716707516,5.95795718130829e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0299674131778126,0.00747460773759065,-0.0446176443434903,-0.0153171820121349,6.11957851058292e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0231523081416108,0.0057771065430367,-0.0344754369659628,-0.0118291793172589,6.16217540873325e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0339842858352867,0.00849131122682812,-0.0506272558398698,-0.0173413158307036,6.3030240213122e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0128384300814341,0.00320854332456068,-0.0191271749975731,-0.00654968516529518,6.32726551784627e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.023753621474528,0.00593647607577126,-0.0353891145830396,-0.0121181283660163,6.33307493781941e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0233503439984487,0.00583621539459068,0.011911361825051,0.0347893261718465,6.34284241834366e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMS,Spermine synthase,37541,-0.0245591248420015,0.00615593102311636,-0.0366247496473095,-0.0124935000366934,6.65714750061205e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0285200378532893,0.00714991582400963,-0.0425338728683482,-0.0145062028382305,6.67471405704562e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0357807425600815,0.00897103392706334,-0.0533639690571256,-0.0181975160630374,6.68587741081793e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD84,SLAM family member 5,40341,-0.0118178315216859,0.00296637266674644,-0.017631921948509,-0.0060037410948629,6.80861405954966e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0139643863632042,0.00350699891702404,-0.0208381042405713,-0.00709066848583705,6.86820229391509e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0216325273653629,0.0054450736363524,-0.0323048716926136,-0.0109601830381122,7.13927360823845e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0411988462340131,0.0103701522480994,-0.061524344640288,-0.0208733478277383,7.13943157272165e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0178397534341203,0.00449220928539857,-0.0266444836335015,-0.00903502323473909,7.1864274422538e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.012817089762983,0.00322857228290006,-0.0191450914374671,-0.00648908808849891,7.22287922708689e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0289412261676852,0.0073063953777984,-0.0432617611081701,-0.0146206912272004,7.50013023285052e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0219223223617978,0.00553639568824968,-0.0327736579107671,-0.0110709868128284,7.54369670590615e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST13,Hsc70-interacting protein,37671,-0.0217734837912966,0.00549948629670405,-0.0325524769328366,-0.0109944906497567,7.55998181697337e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.018201102151085,0.00459902658201315,-0.0272151942518308,-0.00918701005033922,7.60948877429753e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELOB,Elongin-B,37562,-0.0152433805410558,0.00385940446171075,-0.0228078132860088,-0.00767894779610271,7.86679714855307e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0196386445239771,0.00497300741868033,-0.0293857390645905,-0.00989154998336362,7.88040556692847e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCXR,L-xylulose reductase,40411,-0.0199041737248648,0.00504105823459321,-0.0297846478646675,-0.0100236995850622,7.90090579099687e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL22,Interleukin-22,37900,-0.0247910822100925,0.00627873443195592,-0.0370974016967261,-0.0124847627234589,7.90694234190654e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0244757773130066,0.00620362584696884,-0.0366348839730656,-0.0123166706529477,8.00069792223342e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNC,Tenascin,40403,0.018039356223522,0.0045725027944584,0.0090772507463835,0.0270014617006604,8.00807113121962e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.00734564060666603,0.00186686973001294,-0.0110047052774914,-0.00368657593584067,8.37039174847149e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.032307557283298,0.00821115528963631,-0.0484014216509852,-0.0162136929156108,8.37548244815848e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JUN,Transcription factor AP-1,40044,-0.0196076773698251,0.00500187893568198,-0.0294113600837618,-0.00980399465588841,8.8904507180798e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0093159372122319,0.00237718557725437,-0.0139752209436505,-0.00465665348081334,8.93246154533853e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN1,Tetraspanin-1,40042,-0.0115407809704111,0.00294848700247703,-0.0173198154952661,-0.00576174644555611,9.11139554474763e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX18,Sorting nexin-18,37901,-0.0170885602369459,0.00437498835432127,-0.0256635374114156,-0.00851358306247621,9.43082597314971e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTN2,Contactin-2,40489,0.0169072763584825,0.00432908188992354,0.00842227585423232,0.0253922768627326,9.44118686631187e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0198613154300319,0.00508633693689135,-0.0298305358263389,-0.0098920950337248,9.46883353309744e-05
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.037962354651537,0.009759237661433,-0.0570904604679457,-0.0188342488351283,0.000100701469240647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6,Interleukin-6,40305,-0.0273911397724087,0.00704499671772544,-0.0411993333391506,-0.0135829462056669,0.00010147418460389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0303911291231346,0.007831257397437,-0.0457403936221111,-0.0150418646241581,0.000104554082297376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX6,Peroxiredoxin-6,40489,0.0223805875793364,0.00577090192435686,0.011069619807597,0.0336915553510759,0.000105661498826372
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0259144751748001,0.00668335954434375,-0.0390138598817139,-0.0128150904678864,0.000106066723447197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0208582957718548,0.00538134836560078,-0.0314057385684323,-0.0103108529752772,0.000106687116105517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0114265967205201,0.00294967260375165,-0.0172079550238733,-0.00564523841716688,0.000107556271028201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP10,Caspase-10,39961,-0.026821645550747,0.00692427894172918,-0.0403932322765362,-0.0132500588249578,0.000107695356496283
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.0103408832973749,0.00267036210402183,-0.0155747930212577,-0.00510697357349215,0.000108246566785483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0333841348765089,0.00862937306706574,-0.0502977060879578,-0.0164705636650601,0.00010987156268325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX4,Syntaxin-4,40305,-0.0222586091461017,0.00576190390949008,-0.0335519408087022,-0.0109652774835011,0.000112418645948142
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.025843564279374,0.006692242837398,-0.0389603602406741,-0.0127267683180739,0.000113116940499394
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.0101513452619556,0.00263566948594794,0.00498543306949769,0.0153172574544136,0.000117843488377488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0160955748406191,0.00418314568163346,-0.0242945403766207,-0.00789660930461753,0.000119685788959351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMOX1,Heme oxygenase 1,40184,0.0174066469441983,0.00452417708093444,0.00853925986556678,0.0262740340228298,0.000119813817969115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR1,Folate receptor alpha,40299,-0.0105307237810904,0.00273864773466475,-0.0158984733410333,-0.0051629742211475,0.000120911602563926
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0189403532272914,0.00493346418611275,-0.0286099430320724,-0.00927076342251039,0.000123946276111052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0182644815741569,0.0047627955887794,-0.0275995609281645,-0.0089294022201493,0.000126151369903898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.00646718437310987,0.00168703449754165,0.00316059675792823,0.00977377198829151,0.000126838382525756
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.0183069608240069,0.00477688447937434,-0.0276696544035806,-0.00894426724443318,0.000127488119349544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH6,Cadherin-6,40359,0.0140267133380387,0.0036607729104678,0.00685159843352178,0.0212018282425555,0.000127788401810226
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.00986347083712373,0.00257659858729529,0.00481333760602496,0.0149136040682225,0.000129736309210237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0365958747415523,0.00958269053224772,-0.0553779481847578,-0.0178138012983468,0.000134617662127462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00804143962228339,0.00210966190152071,-0.012176376949264,-0.00390650229530281,0.00013861688405243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0207407170902664,0.00544833857898919,-0.0314194607050852,-0.0100619734754476,0.000141423225410804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.00825619683104457,0.00216979453081229,-0.0125089941114367,-0.00400339955065249,0.000142409196209529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00977945304527217,0.00257297053433101,0.0047364307979834,0.0148224752925609,0.000144743345839189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LXN,Latexin,40183,0.024386411620187,0.0064163543184872,0.0118103571559521,0.0369624660844219,0.000144852476724929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0178065793511156,0.0046864099567824,-0.0269919428664091,-0.00862121583582212,0.000145470747130556
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0179821443583917,0.00473433489928037,0.00870284795580219,0.0272614407609813,0.000146269273621754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0281768360783219,0.00743672973146006,-0.0427528263519836,-0.0136008458046602,0.000152004675023892
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0148388445062572,0.00392119461715588,-0.0225243859558828,-0.00715330305663171,0.000154830322723303
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.0108214490296464,0.00285974600056973,-0.0164265511907631,-0.00521634686852974,0.000154868165492404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGCR6,Protein DGCR6,37541,-0.0165685503030027,0.00437944763237636,-0.0251522676624604,-0.00798483294354505,0.000155482572712562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLN,Mesothelin,40271,-0.0197464114393196,0.00523144394716293,-0.0300000415757589,-0.00949278130288026,0.000160874314798019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0229872052375761,0.00609204171196432,-0.0349276069930262,-0.0110468034821261,0.000161778194262659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0184340366291474,0.00488797440877612,-0.0280144664703486,-0.00885360678794619,0.000163106858807989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0259877421763429,0.00689129579634159,-0.0394946819371724,-0.0124808024155134,0.000163223213896774
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0176947199814254,0.00469527734911604,-0.0268974635856929,-0.00849197637715796,0.000164741715251062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0146959800904948,0.00390612571021775,-0.0223519864825216,-0.007039973698468,0.000169095465895721
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0101118308351817,0.00268858428515934,-0.015381456034094,-0.00484220563626939,0.000169825428337801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0140159151549455,0.00373059650102674,-0.0213278842969579,-0.0067039460129331,0.000172672011238308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0213937438529044,0.00570176664158113,0.0102182812354053,0.0325692064704034,0.000176073768165877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.00979796040495669,0.00261524510039966,0.00467208000817335,0.01492384080174,0.00017996699573197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.0102869988881925,0.00275618704010124,-0.015689125486791,-0.00488487228959411,0.000190515036961744
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0140424927758874,0.00377052191595929,-0.0214327157311676,-0.00665226982060723,0.000196549302666995
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0319093244969443,0.00857953485252103,-0.0487252128078855,-0.0150934361860031,0.000200515161904672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0163207129073031,0.00438845275595756,-0.0249220803089799,-0.00771934550562625,0.000200684266678036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG2,Bone marrow proteoglycan,37998,0.0186521393096981,0.00501764071276162,0.00881756351268537,0.0284867151067109,0.000202164264835959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INHBB,Inhibin beta B chain,37671,0.0184840392756592,0.00497932863055526,0.00872455515977085,0.0282435233915475,0.00020634599826088
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0248430766899576,0.00669917299172726,-0.0379734557537431,-0.0117126976261722,0.00020930106327093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0175011636897711,0.00472170302751964,-0.0267557016237096,-0.0082466257558326,0.00021095639797691
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0133602248113283,0.00361020281750055,-0.0204362223336294,-0.00628422728902727,0.000215873095356418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0111633527249873,0.00302041222738986,0.00524334475930314,0.0170833606906714,0.000219940431508927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPA33,Cell surface A33 antigen,40305,-0.048608487304565,0.0131563241662768,-0.0743948826704675,-0.0228220919386626,0.000220899066886941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN2,Prorelaxin H2,37643,-0.0503761125587571,0.0136343140109844,-0.0770993680202865,-0.0236528570972278,0.000220946549661208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS1,Nephrin,37598,0.012334712270072,0.0033388346898141,0.00579059627803632,0.0188788282621076,0.000221373053833361
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0235675503350895,0.00638381896806866,-0.0360798355125041,-0.0110552651576749,0.000223603534683603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10,Interleukin-10,40044,-0.0305940488498369,0.00830124314601551,-0.0468644854160273,-0.0143236122836465,0.000229047110775251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.012653145556706,0.00343603977818948,0.00591850759145458,0.0193877835219574,0.000231874610238427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0223789932152037,0.00609426120210383,-0.0343237451713272,-0.0104342412590802,0.00024130599342764
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB9,Serpin B9,40228,-0.0118560255571482,0.00324019474989688,-0.0182068072669461,-0.00550524384735035,0.000253979671227095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0160320746194387,0.00440119359362926,-0.0246584140629521,-0.00740573517592536,0.000270841046071066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.00914816312188255,0.00251672746595273,-0.0140809489551499,-0.0042153772886152,0.000278911593060337
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0386981617754276,0.0106660642063659,-0.0596036476199047,-0.0177926759309504,0.000286362865812987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0256062428351278,0.00706897080477004,-0.0394614256124771,-0.0117510600577785,0.000292877560864974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0325187496569723,0.0089814873749624,-0.0501224649118986,-0.014915034402046,0.000294786423397523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA3,Annexin A3,40442,-0.0243944567353045,0.00673913421570563,-0.0376031597980875,-0.0111857536725215,0.000295717631535313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0129073061575047,0.00357266870355995,0.00590487549852716,0.0199097368164822,0.000304043352395362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBN1,Drebrin,37598,-0.0179685331988911,0.00497479737055504,-0.0277191360451789,-0.00821793035260319,0.000305079487965456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0129645434562415,0.00359137399345051,-0.0200036364834045,-0.00592545042907853,0.000307245297130218
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0200261152799229,0.00554762095476172,-0.0308994523512559,-0.00915277820858997,0.000307307635685041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0295676125606895,0.008209355282604,-0.0456579489145933,-0.0134772762067857,0.000317139474890143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0158146766410009,0.00439219317037111,-0.0244233752549283,-0.00720597802707354,0.000318615288454878
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0273250089717038,0.00761415676459512,-0.0422487562303102,-0.0124012617130973,0.000333321084233567
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0193813179301422,0.00541007373321394,-0.0299850624472416,-0.00877757341304292,0.000341423846318146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0238490590978142,0.00666990011253718,-0.0369220633183871,-0.0107760548772414,0.000350639197548046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.016529474510653,0.00462543529039016,-0.0255953276798177,-0.00746362134148826,0.000353337465566808
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0264158273317954,0.0073963489208865,-0.0409126712167329,-0.0119189834468579,0.000356224598679139
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0250413574023325,0.00701939456245257,-0.0387993707447395,-0.0112833440599254,0.000361524494500222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0450095983046055,0.0126248040571397,-0.0697542142565993,-0.0202649823526116,0.000364676241788852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DMD,Dystrophin,37628,-0.017828278318535,0.00500636322318389,-0.0276407502359755,-0.0080158064010946,0.000370572952503336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.00730220416724933,0.00205066809125588,0.0032828947083878,0.0113215136261109,0.000370681898523534
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDN1,Endothelin-1,37628,-0.00997242700453358,0.00280274224520473,-0.0154658018051349,-0.00447905220393231,0.000374864966880941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0306944520637816,0.0086285241117043,-0.047606359322722,-0.0137825448048411,0.000375932865147077
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP1,Caspase-1,39961,-0.0230591666029772,0.00649751573371218,-0.0357942974410531,-0.0103240357649013,0.000387957412275188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0275831024552284,0.00779907363973786,-0.0428692867891146,-0.0122969181213422,0.000406290316167423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0189944638840158,0.00537635687021873,-0.0295321233496445,-0.00845680441838705,0.000412100299280251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0127202260448015,0.00360326590096126,-0.0197826272106856,-0.00565782487891743,0.00041643051737163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0179214950237759,0.0050818264230277,-0.0278818748129102,-0.00796111523464159,0.000422348215387829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN4,Cerebellin-4,40489,0.0107064698248432,0.0030399283556687,0.0047482102477325,0.0166647294019538,0.000429578305478951
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0296538635056776,0.00842210374864112,-0.0461611868530142,-0.013146540158341,0.00043144886854865
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0261280086397408,0.00742349430466057,-0.0406780574768756,-0.0115779598026061,0.000433604841510392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH17,Cadherin-17,40359,-0.0230083306404942,0.00653831136025085,-0.0358234209065858,-0.0101932403744025,0.000434383089441978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0129436995605258,0.00367881678556249,-0.0201541804602283,-0.00573321866082334,0.000435560640456592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0182947485220334,0.00520055474706334,-0.0284878358262775,-0.00810166121778924,0.000436500870301646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.011187568631995,0.00318213180884532,-0.0174245469773318,-0.00495059028665813,0.000439996438294423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0186375209980488,0.00530299146674218,-0.0290313842728635,-0.00824365772323416,0.000441761926565285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0237655647229126,0.00677045923480616,-0.0370356648231327,-0.0104954646226925,0.000449262788956258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.011588689342382,0.0033085337651472,0.00510396316269348,0.0180734155220705,0.000462155542909013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17A,Interleukin-17A,40028,-0.0144234428604363,0.00411820454850224,-0.0224951237755007,-0.00635176194537194,0.000462444776882462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0394151549647619,0.011268856201481,-0.0615021131196646,-0.0173281968098592,0.000470823605610779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0224194859889956,0.00642161512040253,-0.0350058516249845,-0.0098331203530066,0.000482351433572167
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.0345502036861533,0.00991181406452873,-0.0539773592526296,-0.015123048119677,0.000492305959449012
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.0108388864390661,0.00311594490251289,-0.0169461384479914,-0.00473163443014086,0.000505549804084352
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.00906980542710698,0.00261020226552813,0.00395380898667184,0.0141858018675421,0.000512672904579667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0172956639711228,0.00497756325660955,-0.0270516879540775,-0.00753963998816809,0.00051298850455658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0316208302375785,0.00910248335651469,-0.0494616976163473,-0.0137799628588097,0.000514390041697618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0288853701206612,0.00832717487722213,-0.0452066328800166,-0.0125641073613058,0.00052440993817709
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0250136947041892,0.00721192185123604,-0.0391490615326119,-0.0108783278757666,0.000524993728353998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.0076437268968332,0.00220904052159232,0.00331400747451225,0.0119734463191541,0.000541169725098163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0141323242271477,0.00408612833412975,-0.022141135762042,-0.00612351269225339,0.000544422531320148
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0200602708484129,0.00580655637663467,-0.0314411213466168,-0.00867942035020892,0.00055246495320571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0163087867886793,0.00473366390526661,-0.0255867680430018,-0.00703080553435671,0.000571974742184015
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0196771323536662,0.00572543609548361,-0.0308989871008141,-0.00845527760651836,0.000590473458564109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0140552016555665,0.00409037203874044,-0.0220723308514977,-0.00603807245963522,0.000591790317351998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AZU1,Azurocidin,39809,-0.025746263183161,0.00749868487908145,-0.0404436855461607,-0.0110488408201614,0.000597553056621116
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0175185114237318,0.0051063847128127,-0.0275270254608447,-0.00750999738661897,0.000603860290236544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0272099996827859,0.00793984447429766,-0.0427720948524094,-0.0116479045131625,0.000612103891170338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0143150917632174,0.0041833433597428,-0.0225144447483133,-0.00611573877812148,0.000623642793777552
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00844337434912764,0.00247171614345773,-0.0132879379903048,-0.00359881070795049,0.000637357174049488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0277925712873414,0.00814797235060165,-0.0437625970945206,-0.0118225454801621,0.000648946744954561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.0142110369403715,0.00416961571349538,-0.0223834837388224,-0.00603859014192051,0.000655764233313362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0202276108473025,0.00594478892219838,-0.0318793971348113,-0.00857582455979363,0.000669517303571802
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.0199277799006237,0.00586239596808633,-0.0314180759980729,-0.00843748380317447,0.00067734137852154
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0311136038692437,0.00915498318338528,-0.0490573709086788,-0.0131698368298085,0.000679423548675152
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0178773987612875,0.00526559797422826,-0.0281979707907749,-0.00755682673180008,0.000688001993698916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOE,Apolipoprotein E,38013,0.0245061285440431,0.00722108052034252,0.0103528107241718,0.0386594463639145,0.000691543618136874
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0173409722677363,0.00511416320584148,-0.0273647321511856,-0.00731721238428703,0.000699001549650432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0345143828699439,0.0101791621784591,0.0145632250001641,0.0544655407397236,0.000699164684896752
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0131324393264213,0.00387928732445392,-0.020735842482351,-0.00552903617049159,0.000712800519403766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,-0.00852909498239946,0.00252363467700021,-0.0134754189493199,-0.00358277101547905,0.00072741081127015
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IST1,IST1 homolog,37812,-0.0324060056373831,0.00962056262708774,-0.051262308386475,-0.0135497028882911,0.000758165025693593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GKN1,Gastrokine-1,39602,-0.00909243437620784,0.00269971295278949,-0.0143838717636753,-0.00380099698874044,0.000759244056179643
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0113164657876467,0.00336166033199175,0.00472761153694289,0.0179053200383505,0.00076353217545233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSC2,Desmocollin-2,40177,-0.0109551509991938,0.00325716884715279,-0.0173392019396133,-0.00457110005877432,0.000771734046827028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.021462784846052,0.00638148870977914,-0.0339705027172191,-0.00895506697488486,0.000772053324722421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0118301059776896,0.0035209326975648,-0.0187311340649166,-0.0049290778904626,0.000781820002248896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFH,Complement factor H,37301,-0.00749398695396754,0.00223171348438415,-0.0118681453833605,-0.00311982852457461,0.000787502581301968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.0124446198033854,0.00370966364589536,-0.0197155605493403,-0.00517367905743049,0.00079690451098808
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA1,Annexin A1,37608,-0.0134390034052769,0.00400790867300206,-0.021294504404361,-0.00558350240619286,0.000801311429822308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0134355381838816,0.00400922695910384,0.00557745334403812,0.0212936230237252,0.000806607165366633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.012396861124181,0.00370057600427498,-0.01964999009256,-0.0051437321558021,0.000810423474152771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0136998946081505,0.00409057043804115,-0.0217174126667111,-0.00568237654958983,0.000812893115994646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0222585171339167,0.00664893852119678,-0.0352904366354624,-0.00922659763237097,0.000816806971456868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0238007975108804,0.00712004204194651,0.0098455151086652,0.0377560799130955,0.00083170442132072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0126580761670563,0.00379151157760982,-0.0200894388591715,-0.00522671347494103,0.000844515461562561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A11,Protein S100-A11,40207,-0.0144093732864642,0.00433738170255448,-0.0229106414234709,-0.00590810514945737,0.00089534328780417
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0376647759516249,0.0113564856477126,-0.0599234878211417,-0.0154060640821082,0.000913711403546796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0222402727017709,0.00671159223928589,-0.0353949934907712,-0.00908555191277056,0.000922780400625014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.00928973733557633,0.00280473030689007,0.00379246593407179,0.0147870087370809,0.000927803397704009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.00771618130020681,0.00233967755187148,-0.0123019493018749,-0.00313041329853871,0.000976385734945867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0107914698085037,0.00327834970846823,0.00436590437990601,0.0172170352371015,0.000997870744291313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.0158137485532911,0.00481344500617285,-0.0252481007653899,-0.00637939634119236,0.0010208828956111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNW1,Interferon omega-1,37562,0.0116482720064295,0.00354607447631803,0.00469796603284612,0.0185985779800128,0.00102309529410791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0125369765108066,0.0038176865547111,-0.0200196421580403,-0.00505431086357283,0.00102634419395761
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.00904074111722139,0.00275401303477629,0.00364287556905986,0.0144386066653829,0.00103068604309065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.0206552622919373,0.00629505916128349,-0.032993578248053,-0.00831694633582168,0.00103602706316591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0184439783733789,0.00562154591486864,-0.0294622083665215,-0.0074257483802364,0.0010372360201541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0214863429380542,0.00655096755977983,-0.0343262393552226,-0.0086464465208857,0.00104076989222313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.036907038387621,0.0112549838547798,-0.0589668067429894,-0.0148472700322526,0.00104383176759841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0109792213018058,0.00334878936013121,-0.0175428484476629,-0.00441559415594858,0.00104605227492456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0265080902452741,0.00808836872096531,-0.0423612929383661,-0.0106548875521821,0.00105031695761093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0166122641190561,0.00507160730170134,-0.0265526144303908,-0.0066719138077215,0.00105690422245644
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0193606310224481,0.00591666037961888,-0.0309572853665011,-0.0077639766783951,0.0010693361914387
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00959706816502882,0.00293308617222911,-0.0153459170625979,-0.00384821926745976,0.00107056231696787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.0102712898386487,0.00314027964265255,0.00411634173904971,0.0164262379382477,0.00107464647622416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0184171774030548,0.00563111410370593,-0.0294541610463185,-0.00738019375979122,0.00107546062374377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0181563537781189,0.0055596937537033,0.00725935402086046,0.0290533535353774,0.00109471592198218
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0233347551532576,0.00714564698382172,-0.0373402232415481,-0.00932928706496698,0.00109513349860539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP2,Caspase-2,40341,-0.0212429468850217,0.00650844811329223,-0.0339995051870745,-0.00848638858296893,0.00110120814087482
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0101206087442481,0.0031119661085606,-0.0162200623170269,-0.00402115517146934,0.00114812276926555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0167707131206507,0.00515813890678122,-0.0268806653779419,-0.00666076086335948,0.00115155105823576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0166256097169146,0.00512133244605155,-0.0266634213111757,-0.00658779812265359,0.00117184227163976
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0148227342761065,0.00457164067979607,-0.0237831500085068,-0.00586231854370624,0.0011884669271804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0298655971302021,0.00921719779128554,-0.0479313048011218,-0.0117998894592824,0.00119688132569113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTF1,Cardiotrophin-1,40042,-0.0264133145609297,0.00815884237574077,-0.0424046456173816,-0.0104219835044778,0.00120882638913614
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0164301314783755,0.00508489746158369,-0.0263965305030795,-0.00646373245367148,0.00123544576009104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.036861740382996,0.0114350205834111,-0.0592743807264818,-0.0144491000395102,0.00126904713384207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CX3CL1,Fractalkine,40228,0.010631339047525,0.00330266551197544,0.00415811464405319,0.0171045634509969,0.00128890653211618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0203074377698448,0.00631800746588949,-0.0326907324029883,-0.00792414313670144,0.00131110108503639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0219379630436711,0.00682606381122359,-0.0353170481136693,-0.00855887797367282,0.00131229140712177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0135015785700354,0.00420687456629561,-0.0217470527199748,-0.005256104420096,0.0013331919618358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD59,CD59 glycoprotein,39665,-0.00697825077847812,0.00217569340972937,-0.0112426098615477,-0.00271389169540855,0.00134232446232274
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNN,Tenascin-N,37998,0.0135022693660337,0.00420973176067735,0.00525119511510612,0.0217533436169613,0.00134254640980817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.0126326464256339,0.00394248425817627,-0.0203599155716594,-0.00490537727960838,0.00135737765822539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.00940756079813206,0.00293660246945358,-0.0151633016382611,-0.00365181995800305,0.00136057504159371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00664870203027543,0.00207600221952038,-0.0107176663805354,-0.00257973768001548,0.00136495215099125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.0131952431406274,0.00412597281281164,-0.0212821498537382,-0.00510833642751653,0.00138618732158694
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0228320493931336,0.00714116900508492,-0.0368287406431001,-0.00883535814316719,0.00139067150292748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0235578841968145,0.00737504277996622,-0.0380129680455483,-0.00910280034808076,0.00140464489077969
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.012772792012151,0.00399955512388228,-0.0206119200549603,-0.00493366396934173,0.00140806434407475
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.011273522326699,0.00353025404323639,-0.0181928202514423,-0.0043542244019557,0.0014093882543385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP5,Platelet glycoprotein V,37671,-0.0110415833789803,0.0034664190633763,-0.0178357647431979,-0.00424740201476278,0.00144939969120511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFRC,Transferrin receptor protein 1,40391,0.0121879791707406,0.00382689555053541,0.00468726389169115,0.01968869444979,0.00145122072379234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0193786809969344,0.00608491627536553,-0.0313051168966508,-0.00745224509721794,0.00145177293793171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0161840076611012,0.00508588148726944,-0.0261523353761493,-0.00621567994605308,0.00146467666760586
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITM2A,Integral membrane protein 2A,40341,0.018117169715671,0.0057001441529116,0.00694488717596427,0.0292894522553777,0.00148389181018486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0161086492608918,0.0050816170167731,-0.026068618613767,-0.00614867990801647,0.00152741687532121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5E,5'-nucleotidase,40411,-0.0176663567715954,0.00558330344674452,-0.0286096315272146,-0.0067230820159761,0.00155833537434409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,0.0314253050784703,0.00994216704673975,0.0119386576668604,0.0509119524900803,0.00157626454055764
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.011738861436153,0.00371527417545049,-0.0190207988200359,-0.00445692405226999,0.00158323458118704
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0179990563714026,0.00570709779244273,-0.0291849680445903,-0.00681314469821481,0.00161517981257975
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0110682653067526,0.0035107597522792,-0.0179493544212199,-0.00418717619228541,0.00162138106985739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0139999057435613,0.00444377019014517,-0.0227096953162458,-0.00529011617087676,0.00163380077820635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP3,Caspase-3,40536,-0.0267221232277956,0.00849093039425804,-0.0433643468005414,-0.0100798996550499,0.00165178510259095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0309226767833129,0.00985621492279054,-0.0502408580319823,-0.0116044955346434,0.00170841467744841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0157947076717389,0.00503788960530764,-0.0256689712981419,-0.00592044404533593,0.00172124993041549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.011302793277218,0.00361538058875784,-0.0183889392311834,-0.00421664732325267,0.00177392035511872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0101147222010497,0.00323743567215405,-0.0164600961184716,-0.00376934828362777,0.00178548896579374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0197608802523844,0.00636879941467292,-0.0322437271051434,-0.00727803339962552,0.0019205845593451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NID1,Nidogen-1,40355,-0.0118555071921588,0.00382576779486077,-0.0193540120700859,-0.00435700231423168,0.00194607620080912
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0191024571112284,0.00617422626888845,-0.0312039405982497,-0.00700097362420699,0.00197891433572787
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.022850143630561,0.00739466724728874,-0.037343691435247,-0.00835659582587509,0.00200448807621003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0197208456605527,0.00638336569155533,-0.0322322424160012,-0.00720944890510424,0.00200908725942889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0151461862941932,0.00490814841292508,-0.0247661571835264,-0.00552621540486007,0.00203330999741014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.00766348141912449,0.00248453673467443,-0.0125331734190864,-0.0027937894191626,0.00204326975665234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0138327907340602,0.00448604217299778,-0.0226254333931358,-0.00504014807498451,0.00204928167750911
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0173919825470445,0.00564647083968683,-0.0284590653928307,-0.00632489970125831,0.00207249149794898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0105217933762293,0.0034249776117128,-0.0172347494951864,-0.00380883725727219,0.00212931357146412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR15L,Protein GPR15L,37901,-0.0178168038895999,0.00579985909100257,-0.029184527707965,-0.0064490800712349,0.00213099189254839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.012116442125579,0.00395113908816204,-0.0198606747383766,-0.00437220951278143,0.00216896917179661
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.0123984738282226,0.0040497753659186,-0.0203360335454231,-0.00446091411102217,0.00220649741745695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0142131807955869,0.00464702511298697,-0.0233213500170414,-0.00510501157413247,0.00222842173945206
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSTN,Growth/differentiation factor 8,40042,-0.0150690331645397,0.00493862088052438,-0.0247487300903675,-0.00538933623871193,0.00228263647915901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PI16,Peptidase inhibitor 16,37987,0.00724558152146,0.00237569421202364,0.00258922086589367,0.0119019421770263,0.00229375635089755
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.0101871790664423,0.00334086872563483,0.00363907636419804,0.0167352817686866,0.00229780341789559
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK8,Kallikrein-8,39801,-0.0104220384820114,0.00342449597824,-0.0171340505993618,-0.00371002636466098,0.00234333327859722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.034033737648499,0.011190854827869,-0.0559678131111223,-0.0120996621858757,0.00236083251850645
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.00906818541177746,0.00298220086822813,-0.0149132991135046,-0.00322307171005032,0.00236426572863946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA4,Carbonic anhydrase 4,40536,0.00685550667226211,0.00225473277982661,0.00243623042380196,0.0112747829207223,0.00236568496909255
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK10,Kallikrein-10,40354,-0.0115079051691925,0.00379026110342165,-0.018936816931899,-0.00407899340648609,0.00239986112728662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0121266879851625,0.00399631730353467,-0.0199594699000905,-0.0042939060702346,0.00241430326592067
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.0146027656271319,0.00482113540712981,-0.0240521910251063,-0.00515334022915745,0.00245844842248031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0118601873587462,0.00391899582592649,-0.0195414191775622,-0.00417895553993032,0.00247944756747529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TG,Thyroglobulin,37900,0.034204055409627,0.0113058067651212,0.0120446741499894,0.0563634366692646,0.00248812310015889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.0203375143076932,0.00673255923670888,0.00714169820374378,0.0335333304116426,0.0025253637887618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00912012475243865,0.00301953808502567,-0.015038419399089,-0.00320183010578833,0.00252951293805388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSV,Cathepsin L2,40444,0.0123574610512603,0.00409524888379171,0.00433077323902852,0.020384148863492,0.00255260287990887
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0165751603420451,0.0055163699515576,-0.027387245447098,-0.00576307523699218,0.00266247474858456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0213957407517566,0.0071352107752885,-0.0353807538713221,-0.00741072763219119,0.00271640466522359
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0178863728983457,0.00596502530875243,-0.0295778225035004,-0.00619492329319093,0.00271768136076292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFB,Complement factor B,37770,0.00947946235701929,0.00316142677006655,0.00328306588768885,0.0156758588263497,0.00271834485127925
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH15,Cadherin-15,40435,-0.0128067489291258,0.00427276979559554,-0.0211813777284931,-0.0044321201297586,0.00272805963697678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.010484434091911,0.00349844376182481,0.00362748431873434,0.0173413838650876,0.00273261510141672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL7,Interleukin-7,40341,-0.0185904190525521,0.00620485377464544,-0.0307519324508572,-0.00642890565424709,0.00273870486992654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX16,Syntaxin-16,39980,-0.0170683717344149,0.00569712252104872,-0.0282347318756704,-0.00590201159315944,0.00274010960641637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIFBP,KIF-binding protein,40305,-0.0238053454822794,0.00794611800627354,-0.0393797367745755,-0.00823095418998322,0.00274107777117322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.028436077913031,0.00951780761460108,-0.0470909808376491,-0.00978117498841285,0.00281617039775106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0100157549028295,0.00335385385387655,-0.0165893084564275,-0.00344220134923145,0.00282770191028029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLU,Clusterin,38013,0.00951096804992651,0.0031882439864857,0.00326200983641455,0.0157599262634385,0.00285818158087963
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.00778411663547027,0.00260956506983255,0.00266936909859847,0.0128988641723421,0.00286028384161139
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,0.00569213882991152,0.00191018511462981,0.00194817600523709,0.00943610165458596,0.0028886674640949
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.0133033108588325,0.00446461198320179,-0.022053950345908,-0.00455267137175702,0.00288953002173893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0128366308013186,0.00430887463884769,-0.0212820250934601,-0.00439123650917718,0.00289516105109108
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,-0.00842995960578479,0.00283428782423368,-0.0139851637412828,-0.00287475547028677,0.00294114849758745
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCHE,Cholinesterase,37748,-0.00809861760490561,0.00272393784305712,-0.0134375357772976,-0.00275969943251366,0.0029530942113793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0243963617412585,0.00821350946702694,-0.0404948402966313,-0.00829788318588571,0.00297980463371462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.017598974687261,0.00593052034128312,-0.0292227945561759,-0.00597515481834611,0.00300662492956884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.0111816096442391,0.00376849453526764,-0.0185678589333636,-0.0037953603551145,0.00301135870927369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0154007022743315,0.005193346285398,-0.0255796609937116,-0.00522174355495141,0.00302672967524486
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.0125175404675269,0.00422241933151808,-0.0207934823573024,-0.0042415985777515,0.00303594102818462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.0081554700582715,0.00275191256956252,-0.013549218694614,-0.00276172142192895,0.00304642235590188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0239880455503488,0.00809787008429593,-0.0398598709155689,-0.00811622018512882,0.00305835368869131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0147223860986232,0.00497457440612721,-0.0244725519346325,-0.00497222026261387,0.00308577099570219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0238976896082677,0.00807552021478767,-0.0397257092292515,-0.00806966998728384,0.0030881605410396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD48,CD48 antigen,40396,-0.00838774539956203,0.0028347854328289,-0.0139439248479067,-0.00283156595121738,0.00309228669650729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0106953851747429,0.00361775398895822,-0.017786182993101,-0.00360458735638477,0.00311847480343234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0320034266381364,0.0108373230303243,-0.0532445797775721,-0.0107622734987007,0.00315097425615613
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0148479236295625,0.00503226844353111,-0.0247111697788835,-0.00498467748024154,0.00317677204515581
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRL,Prolactin,40471,-0.0218092445799539,0.00739622248836739,-0.036305840657154,-0.00731264850275379,0.00319573925259089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0117341183525076,0.00398521125904498,-0.0195451324202358,-0.00392310428477949,0.00324136576363377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1B,Interleukin-1 beta,39946,-0.0159949079956688,0.00543960898799356,-0.0266565416121362,-0.00533327437920142,0.0032821832891272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0124354116167005,0.00423165221972275,-0.0207294499673571,-0.00414137326604389,0.0033011502482564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0246816240835739,0.00841223632531501,-0.0411696072811913,-0.00819364088595651,0.00335183511681182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX6,Syntaxin-6,39980,-0.0194749438611917,0.00664043565233137,-0.0324901977397611,-0.00645968998262216,0.00336431396789196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CERT,Ceramide transfer protein,39961,-0.0173697877125823,0.00593719852944096,-0.0290066968302866,-0.00573287859487804,0.0034430593152926
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN1,Calsyntenin-1,39961,0.0148313318104035,0.00508208511719966,0.00487044498069211,0.0247922186401148,0.0035238821384626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PODXL,Podocalyxin,40305,0.00428302784625762,0.00146799049981644,0.00140576646661741,0.00716028922589784,0.00353217272614235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0166451325702385,0.00570598798020767,0.00546139612903151,0.0278288690114456,0.00353753749035284
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0145663044430377,0.00500141002878967,-0.0243690680994655,-0.00476354078660998,0.00359127358087082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.00753741010091617,0.00259261850726343,-0.0126189423751525,-0.00245587782667985,0.00365115868000241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0116050336686719,0.0039970038421041,-0.019439161199196,-0.00377090613814789,0.00369708279100872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0154151295518268,0.0053114123963165,-0.0258254978486071,-0.00500476125504643,0.0037109513237381
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0278334319301622,0.00959299047520729,-0.0466356932615685,-0.00903117059875591,0.0037207767629496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A12,Protein S100-A12,40139,-0.0214378465746383,0.00739004596647904,-0.0359223366689372,-0.00695335648033934,0.00372599622326986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC4,Syndecan-4,40359,-0.0126511487146672,0.0043646819242302,-0.0212059252861584,-0.004096372143176,0.00375432166090236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0152329132813657,0.00526242478769761,-0.025547265865253,-0.00491856069747838,0.00380183854789617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN4,Nectin-4,40411,-0.00853419665505806,0.00295244068726621,-0.0143209804020998,-0.00274741290801629,0.00385078857685278
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0149361672950271,0.00516770129902259,-0.0250648618411114,-0.00480747274894283,0.00385405086385687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0156385251420701,0.00541239523971983,-0.026246819811921,-0.00503023047221925,0.00386520889175489
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00702217472848736,0.00243696922160813,0.00224571505413542,0.0117986344028393,0.0039628599043384
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.0332689347148111,0.0115493379956741,-0.0559056371863324,-0.0106322322432898,0.00397457996259839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOA1,Apolipoprotein A-I,38013,0.00765163727274421,0.00265640614651025,0.00244508122558411,0.0128581933199043,0.00397733787676414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNA1,Ephrin-A1,40303,-0.00758295420703549,0.00263759593285903,-0.0127526422354392,-0.00241326617863179,0.00404630415419958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0239849700888246,0.00834392317482996,-0.0403390595114913,-0.00763088066615789,0.00405259629628594
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0173335763570164,0.00603521940844689,-0.0291626063975723,-0.00550454631646052,0.00408445751809589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0170667591580041,0.00595726677733808,-0.0287430020415867,-0.00539051627442145,0.00417850791011532
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CIAPIN1,Anamorsin,40411,-0.0176245048853329,0.00615735981330858,-0.0296929301194177,-0.0055560796512481,0.00421062409765441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0134376063685792,0.00469981344558018,-0.0226492407219163,-0.00422597201524202,0.00425305882015631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRN,Progranulin,40262,0.00668943920983875,0.00234440079423543,0.00209441365313731,0.0112844647665402,0.00433146092038851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0152071001086719,0.00535348005967012,-0.0256999210256254,-0.00471427919171849,0.00450970516221276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,-0.0162419687464959,0.00572220161033604,-0.0274574839027546,-0.00502645359023729,0.00453966870363809
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0130258334253354,0.00459331868391141,-0.0220287380458017,-0.00402292880486898,0.00457670335104427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.0146581447170977,0.00517195585689064,-0.0247951781966033,-0.00452111123759201,0.00460161175311136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0106776334230649,0.00376791679757798,0.00329251649981205,0.0180627503463177,0.00460637857950605
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.00737148753981918,0.00260559648800568,-0.0124784566563103,-0.00226451842332804,0.00467480540181065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0164295089923611,0.00581170035604853,-0.0278204416902162,-0.00503857629450594,0.00470503932908039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.0118888522982546,0.00420887360050691,0.00363946004126106,0.0201382445552482,0.00473828157877337
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR3,Toll-like receptor 3,40516,-0.0165866452287179,0.00587291770220458,-0.0280975639250389,-0.00507572653239694,0.00474483163477611
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.00756288856805323,0.00268452769133712,0.00230121429303248,0.012824562843074,0.00485148206158997
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SULT1A1,Sulfotransferase 1A1,40471,0.0348782685639572,0.0123995031177037,0.010575242453258,0.0591812946746565,0.00491602904858499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0140036540595165,0.00498280727963443,-0.0237699563276,-0.00423735179143306,0.00495523137316726
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0228553403136144,0.0081341937267514,-0.0387983600180472,-0.00691232060918166,0.00496479472320363
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MARCO,Macrophage receptor MARCO,40359,0.00720482665168473,0.00256441692820518,0.00217856947240257,0.0122310838309669,0.00496732157444923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0316962851642629,0.0112871245964505,0.00957352095521988,0.053819049373306,0.00498834643293274
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0203752300273507,0.00727238305265784,-0.03462910081056,-0.0061213592441413,0.00508928946224672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSTN3,Calsyntenin-3,37942,0.00822915872907113,0.00293919996796921,0.00246832679185147,0.0139899906662908,0.00512076657942495
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBD,Thrombomodulin,40359,-0.00750017509428989,0.0026789041276675,-0.0127508271845182,-0.0022495230040616,0.00512089604504637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0174225635871925,0.00622942925665168,-0.0296322449302298,-0.00521288224415524,0.00516818161220732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0272504423939407,0.00974686986015883,-0.046354307319852,-0.00814657746802941,0.00518443831280001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0253491728509293,0.00907373241072613,-0.0431336883759525,-0.00756465732590605,0.00521731987159805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.00798015046866502,0.00286175922888429,-0.0135891985572782,-0.00237110238005182,0.00530094652497968
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMPD3,AMP deaminase 3,37942,-0.019420490443346,0.00697487130435524,-0.0330912381998822,-0.00574974268680969,0.00537096606789301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.00900997414467372,0.00323778487281868,-0.0153560324953983,-0.0026639157939491,0.00539625187535056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPPB,Natriuretic peptides B,40042,-0.0345016801332531,0.0124018220771323,-0.0588092514044323,-0.0101941088620738,0.00540924983829785
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.0069210591644141,0.00249193777532412,0.00203686112477883,0.0118052572040494,0.00548743395383323
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA2,Integrin alpha-2,37671,-0.00907226884544812,0.0032697451516065,-0.0154809693425969,-0.00266356834829938,0.00553454587449801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0209309345519063,0.00754676476197425,-0.0357225934853758,-0.00613927561843679,0.00555219063185775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0182354077076536,0.00657731126830734,-0.031126937793536,-0.00534387762177126,0.00556984219042052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMH,Granzyme H,40042,-0.0199797119495159,0.00720778853976302,-0.0341069774874514,-0.00585244641158038,0.00557857261924602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0107358470244006,0.00389482246176576,-0.0183696990494615,-0.00310199499933969,0.00585014206024642
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C5,Complement C5,38013,0.00405455324241387,0.00147307983393169,0.00116731676790775,0.00694178971691999,0.00592329252138702
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.0125680157705531,0.0045678437884513,0.00361504194518858,0.0215209895959177,0.00594180670492419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.0119561760861235,0.00435473421543694,0.00342089702386714,0.0204914551483799,0.00604879622427646
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THPO,Thrombopoietin,40042,-0.0101150607618629,0.00368425851513936,-0.017336207451536,-0.0028939140721897,0.00604915502563307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.00987002437842838,0.00359739271590989,-0.0169209141016118,-0.00281913465524498,0.00608281510633899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0253057176625722,0.00922375118500524,-0.0433842699851825,-0.00722716533996196,0.00608611828994185
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0146439172086448,0.00534833660379013,-0.0251266569520734,-0.0041611774652161,0.00618914512484789
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.0134414415805467,0.00491816673191036,-0.023081048375091,-0.00380183478600239,0.00628387860780896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSPN,Persephin,40341,-0.0261249211779164,0.00958155826858217,-0.0449047753843375,-0.0073450669714954,0.00640638908558481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.00743083123289504,0.00272878987959993,0.00208240306887918,0.0127792593969109,0.00647402706808428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0112774317705019,0.00414887453673008,-0.0194092258624929,-0.00314563767851094,0.00657253160770561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0304781259923952,0.0112244350258222,-0.0524780186430067,-0.00847823334178374,0.00662807223329276
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.016076258729213,0.0059292266914539,0.00445497441396336,0.0276975430444627,0.00670955880780034
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCOF1,Treacle protein,37990,-0.00787540771225114,0.0029073184575131,-0.0135737518889768,-0.00217706353552547,0.00676074897263627
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RILPL2,RILP-like protein 2,37990,-0.0253205278882019,0.00934861393031155,-0.0436438111916125,-0.00699724458479124,0.00676772658408568
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.0120045035188195,0.00443430207425343,-0.0206957355843562,-0.0033132714532828,0.00679406043036899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0765894250512015,0.0283165875756688,-0.132089936699512,-0.0210889134028906,0.00684275927460602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.00956865481823301,0.00354170628640684,0.0026269104968756,0.0165103991395904,0.00690721111496766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.024607904903628,0.00911940533057565,-0.0424819393515563,-0.00673387045569973,0.00697598226157393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENAH,Protein enabled homolog,40044,-0.0122872172012513,0.00456124624169102,-0.0212272598349657,-0.00334717456753691,0.00707119967761163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.00682990557145825,0.00253935208807731,-0.0118070356640898,-0.00185277547882672,0.00716066141481783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA11,Annexin A11,40312,-0.0174021312042886,0.00648435639985091,-0.0301114697479963,-0.00469279266058077,0.0072885839839797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0152191457656831,0.00567432182638927,-0.0263408165454061,-0.00409747498596014,0.00732368575689082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RSPO1,R-spondin-1,40228,-0.00916430614367274,0.00342267273712051,-0.0158727447084289,-0.00245586757891654,0.00742441499712964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA4D,Semaphorin-4D,40471,-0.00768961409140564,0.00287487176634226,-0.0133243627534365,-0.00205486542937482,0.00748569895344767
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.02302011095032,0.00860758973029128,-0.0398909868216909,-0.00614923507894913,0.00749574005271429
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRTN,Neurturin,40044,-0.012778099920257,0.00477873747369831,-0.0221444253687057,-0.00341177447180832,0.00750419921943188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUK1,Guanylate kinase,37562,0.0103353057225523,0.0038696706504386,0.00275075124769264,0.017919860197412,0.00757530819243811
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.00716499541629328,0.00268710925397976,-0.0124317295540936,-0.00189826127849294,0.00767380717833227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00968968831735529,0.00363788670347068,-0.0168199462561578,-0.00255943037855276,0.00774154787691057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA5,Annexin A5,39896,-0.00787121558063255,0.00295712823813901,-0.013667186927385,-0.0020752442338801,0.00778098416829939
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0116352428851347,0.00437834918374168,-0.0202168072852684,-0.00305367848500097,0.00788273787460223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0141935960459759,0.00534310291934443,-0.024666077767891,-0.00372111432406082,0.0079052911868458
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0102935842389281,0.00388261224703933,-0.0179035042431252,-0.00268366423473104,0.00803001697144769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.0089545114693857,0.00338037533289607,-0.015580047121862,-0.0023289758169094,0.00808189596299959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAB2,Stabilin-2,37998,-0.00710759219261363,0.00268424580948838,-0.0123687139792108,-0.00184647040601641,0.00810892876894466
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0169109973410232,0.00638980302789494,-0.0294350112756973,-0.00438698340634917,0.00813946613726587
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.00912728494310836,0.00345932281613443,-0.0159075576627318,-0.00234701222348487,0.00833825409747936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0088892596966813,0.00336935116722299,0.00228533140892423,0.0154931879844384,0.00834116062329891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A16,Protein S100-A16,39934,-0.0158529347586062,0.00601119282168113,-0.0276348726891012,-0.00407099682811117,0.00836681291610686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00415154615024209,0.00157422332998746,-0.00723702387701751,-0.00106606842346667,0.00836881767689875
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAL,Integrin alpha-L,37598,-0.0110625705297455,0.00419486502164584,-0.0192845059721713,-0.00284063508731964,0.00836993697683066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0240000364357618,0.00911588699926092,-0.0418671749543132,-0.00613289791721038,0.0084773730845854
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRBP,Acrosin-binding protein,37900,-0.00956219572356669,0.00363948554144773,-0.0166955873848042,-0.00242880406232914,0.00861508825356147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0222754133440488,0.00847931147518243,-0.0388948638354064,-0.00565596285269129,0.00862177829041793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD22,B-cell receptor CD22,40516,0.0103597706095284,0.00395096711601209,0.00261587506214472,0.0181036661569121,0.00874761234457258
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RLN1,Prorelaxin H1,37959,-0.0208005025465467,0.00794847690371776,-0.0363795172778335,-0.00522148781525988,0.00888268058915883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOSB,Protein fosB,39961,-0.00988092121487265,0.00377937976475363,-0.0172885055537898,-0.00247333687595554,0.0089463063733816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0220301062278616,0.00842983741713435,-0.0385525875654449,-0.00550762489027828,0.00897612767642436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0132338305581585,0.00507985657282219,-0.02319034944089,-0.00327731167542705,0.0091935011257169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0148889724793586,0.00571697702490536,-0.0260942474481731,-0.00368369751054406,0.00921513421762619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0103048888878171,0.00395873075553131,-0.0180640011686585,-0.00254577660697574,0.00924786116830658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.00791087953381198,0.003043854458966,0.00194492479423862,0.0138768342733853,0.00935908564453903
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.031327426394362,0.0120711262019023,-0.0549868337500905,-0.00766801903863346,0.00946280909213522
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.0113976870182988,0.00440116974118882,0.00277139432556874,0.0200239797110289,0.00961486494977753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0185052189173056,0.00716047551709866,-0.032539750930819,-0.00447068690379224,0.00976501808209171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY75,Lymphocyte antigen 75,40341,0.00966380039853712,0.00375038766348533,0.00231304057810588,0.0170145602189684,0.00998242800443191
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.00971781354785463,0.00377836035882245,-0.0171233998511466,-0.00231222724456264,0.0101228791920427
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MESD,LRP chaperone MESD,40332,-0.0299782977385637,0.0116812921367693,-0.0528736303266316,-0.0070829651504959,0.0102865559996905
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM25,RNA-binding protein 25,37482,0.011479979983401,0.00447656953914088,0.00270590368668491,0.0202540562801172,0.0103447753030447
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,-0.012037334788479,0.00469431712444916,-0.0212381963523994,-0.00283647322455868,0.010349448769826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPN3,Calpain-3,37900,-0.00915407273708447,0.00357537944733085,-0.0161618164538529,-0.002146329020316,0.0104687667050229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGN,Mimecan,40332,-0.0100518893407959,0.00393586544835636,-0.0177661856195744,-0.00233759306201741,0.0106609967423251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.0173860784941081,0.00681023276453255,-0.0307341347125919,-0.00403802227562428,0.0106928279111855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00563921922515067,0.00221101031229001,0.00130563901306226,0.00997279943723908,0.010767233725623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPB2,Coatomer subunit beta',37562,-0.0105935219913264,0.00415626900060141,-0.0187398092325052,-0.00244723475014765,0.0108205462622488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNLY,Granulysin,40332,0.0125044271095761,0.00490636450424894,0.00288795268124813,0.022120901537904,0.010824533828812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0180978321500188,0.00710243385626225,-0.0320186025082929,-0.00417706179174484,0.0108398895500404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.00895874857364982,0.00351801786226465,-0.0158540635836885,-0.0020634335636111,0.0108911317624245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.013202478704552,0.00519092706188811,-0.0233766957458527,-0.00302826166325128,0.0109900821746991
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLVRB,Flavin reductase,40332,-0.0163010944293453,0.00641125224594337,-0.0288671488313943,-0.00373504002729626,0.0110132851398678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.00662067894455298,0.00261211865424588,-0.0117404315068749,-0.00150092638223105,0.0112670982009467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0162563739221305,0.00641953441830526,-0.0288386613820088,-0.00367408646225221,0.0113419889840729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0212697064000608,0.00840567088709824,-0.0377448213387734,-0.00479459146134826,0.0114047383285725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROCR,Endothelial protein C receptor,37562,0.00899220785459109,0.00355890410094628,0.00201675581673639,0.0159676598924458,0.0115263389984004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.00833554952891395,0.00330552628450443,0.00185671801128526,0.0148143810465426,0.0116906560980826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00695177392853297,0.00275847171452216,-0.0123583784889964,-0.00154516936806954,0.0117420623739878
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0215429021753964,0.00856012586699858,-0.0383207488747136,-0.00476505547607917,0.0118571695416105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.0108168764399596,0.00429913569533593,-0.0192431824028181,-0.0023905704771012,0.0118790997749586
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.00933976242944571,0.00372633683406732,0.00203614223467376,0.0166433826242177,0.0122077134982262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.00999755277494152,0.00398984878962929,-0.0178176564026149,-0.0021774491472681,0.0122292811575863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0114059790521551,0.00455690592431636,-0.0203375146638151,-0.00247444344049501,0.0123262292153659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSNL1,Visinin-like protein 1,37942,-0.00899784908984363,0.00359999737224868,-0.016053843939451,-0.00194185424023622,0.0124520151212628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0147378904827488,0.00589927657053893,-0.0263004725610051,-0.00317530840449248,0.0124927266739658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB1A1,Uteroglobin,40384,0.0136733240589445,0.00548171859202083,0.0029291556185837,0.0244174924993054,0.0126288610550168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0233748000665545,0.00937954149487014,-0.0417587013965,-0.00499089873660899,0.0127089755790815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR4,Toll-like receptor 4,37598,0.00680438512783328,0.00274004264572695,0.00143390154220846,0.0121748687134581,0.0130290154930608
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.0124661547888408,0.00502438793153122,-0.022313955134642,-0.00261835444303959,0.0131091285239578
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.0159749446156007,0.00644457980853624,-0.0286063210403318,-0.00334356819086968,0.0131943039003794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0105662101179268,0.00426926553735863,0.00219844966470386,0.0189339705711497,0.0133380733090456
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.0106453449566067,0.00430288190340047,-0.0190789934872716,-0.00221169642594181,0.0133733694125876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.00827780558989781,0.00335778566826296,-0.0148590654996932,-0.0016965456801024,0.0137020574714866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FADD,FAS-associated death domain protein,40359,-0.0181505392926343,0.00736669716618406,-0.0325892657383551,-0.00371181284691359,0.013755329183765
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00479457646165071,0.00194603855327298,0.000980340897235663,0.00860881202606576,0.0137614676754033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00550084831774533,0.00223594475962192,0.00111839658888636,0.00988330004660429,0.0138969696715317
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN1,Transcobalamin-1,37766,0.00784149033058385,0.00318767823800065,0.00159364098410258,0.0140893396770651,0.0139087208975377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.00663966618330044,0.0027012218230288,-0.0119340609564369,-0.00134527141016399,0.0139809209088309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.00990658709764995,0.00403053901142146,0.00200673063526389,0.017806443560036,0.0139885598495818
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0137127413259459,0.00558251437358217,-0.024654469498167,-0.00277101315372484,0.0140455803065897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0230656116117005,0.0094034851951715,-0.0414964425942366,-0.00463478062916435,0.0141844048584368
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.007145779962953,0.00291508085132321,-0.0128593384315465,-0.0014322214943595,0.0142444937827803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.00728762490107978,0.00298503645894471,0.00143695344154815,0.0131382963606114,0.0146437870858803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,0.00318836545464247,0.00130799538496822,0.000624694500104756,0.00575203640918018,0.0147982591880176
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMCN2,Hemicentin-2,37648,0.0134737022024354,0.00552937368024773,0.00263612978914987,0.024311274615721,0.0148330418526347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00705968981915027,0.00290022464436181,-0.0127441301220994,-0.00137524951620112,0.0149381405600962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00767597791072687,0.00316101509108801,0.00148038833219438,0.0138715674892594,0.0151820257261647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.0139423881867923,0.00574417222765856,-0.0252009657530031,-0.00268381062058149,0.0152281181939625
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00605846644908527,0.00249783803723954,0.00116270389609578,0.0109542290020748,0.0153014782615348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.023465271241106,0.00968815278875703,-0.0424540507070698,-0.00447649177514223,0.0154439871708006
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX1,Peroxiredoxin-1,39953,0.0208909294364372,0.00862544053062757,0.0039850659964072,0.0377967928764673,0.0154461899767033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0165401475705059,0.00683233642831831,-0.0299315269700098,-0.00314876817100203,0.015495133977964
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0203345283050429,0.00840425832439979,-0.0368068746208665,-0.00386218198921929,0.0155507925440759
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.0111382883164485,0.00460806846778185,-0.0201701025133009,-0.0021064741195961,0.0156550296005103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL3,Myosin light chain 3,37628,-0.0158966790004751,0.00658780256440187,-0.0288087720267027,-0.00298458597424742,0.0158333284741029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.0213467977557489,0.00884951993945745,-0.0386918568370855,-0.00400173867441233,0.0158679081166481
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BSND,Barttin,37482,0.00799002640754437,0.0033134510915377,0.00149566226813049,0.0144843905469583,0.0159055398602913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00786202424377133,0.00326923870461778,0.00145431638272049,0.0142697321048222,0.0161925033963078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0157023246857685,0.00653522067218432,-0.0285113572032498,-0.00289329216828724,0.0162850701018792
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.0106244185393655,0.00442310483626798,-0.0192937040184508,-0.0019551330602803,0.0163161622692342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM,Paralemmin-1,37824,-0.0067650387305394,0.00281733472272847,-0.0122870147870872,-0.0012430626739916,0.0163541031883333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00661396033813077,0.00275528182209695,0.00121360796682075,0.0120143127094408,0.0163880624836163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLINT1,Clathrin interactor 1,37482,0.010641722268924,0.00443754190500508,0.00194414013511407,0.019339304402734,0.0164938052585992
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL4,Delta-like protein 4,37628,-0.0194426496561646,0.00812805661476102,-0.0353736406210962,-0.00351165869123296,0.0167688719003416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH22,Cadherin-22,37714,0.00679209600010515,0.00284649106507251,0.00121297351256303,0.0123712184876473,0.0170407013703128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0160245863078897,0.00673533970079818,-0.0292258521214542,-0.0028233204943253,0.0173652590974123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL4,Interleukin-4,40044,-0.0206148182452616,0.0086738749137305,-0.0376156130761733,-0.00361402341434978,0.0174823642283496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0119427255150882,0.00506608624805773,-0.0218722545612813,-0.00201319646889503,0.0184164114418208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.0151127716731316,0.00641815249518615,-0.0276923505636964,-0.00253319278256674,0.0185503960240194
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0133071835091079,0.00565264919073276,-0.0243863759229441,-0.00222799109527166,0.0185770953972096
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROK1,Prokineticin-1,40341,0.015628240986223,0.00664013842166425,0.00261356967976108,0.0286429122926849,0.018604634190689
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.00985826397322808,0.00419935396892163,-0.0180889977523145,-0.00162753019414169,0.0189108368717043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0134539348468481,0.00574317013503432,-0.0247105483115154,-0.00219732138218085,0.0191625473170103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TJP3,Tight junction protein ZO-3,37541,0.00993812877772401,0.00424352449550951,0.00162082076652536,0.0182554367889227,0.0191981157624422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0107163606000706,0.00457874346020508,-0.0196906977820725,-0.00174202341806863,0.019274536404431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0144199794286114,0.0061656456711188,-0.0265046449440042,-0.00233531391321853,0.0193599749032675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.00669667020647378,0.00286830100604287,-0.0123185401783178,-0.00107480023462976,0.0195706026917127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.0112392327231849,0.00484266383432701,0.00174761160790398,0.0207308538384658,0.0203087061631286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP9,Caspase-9,37598,-0.0139175901463654,0.00600941052733115,-0.0256960347799344,-0.0021391455127963,0.0205754341821285
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC1,Glypican-1,40489,0.00655689552597494,0.00283487259199394,0.00100054524566681,0.0121132458062831,0.0207384256461058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.0149626938195204,0.00646932468104707,-0.0276425701943727,-0.00228281744466817,0.0207452604870828
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.00740855438612397,0.00320844196052382,0.00112000814349728,0.0136971006287507,0.0209545471560516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL4,Myosin light chain 4,37628,-0.0117034229822354,0.00507102718743437,-0.0216426362696067,-0.00176420969486401,0.0210201200066216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0120077981169464,0.00520623939677406,-0.0222120273346235,-0.00180356889926921,0.0211019509005922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.00610166527825999,0.00264811138780255,0.000911366958166992,0.011291963598353,0.0212265932301313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.00928565662873921,0.00403822760109299,-0.0172005827268815,-0.00137073053059696,0.0214931944435841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0190631060165462,0.00829557597297656,-0.0353224349235802,-0.00280377710951212,0.0215755763365937
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.00918357638542414,0.00400752981227648,-0.017038334817486,-0.00132881795336223,0.0219431959842338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCN15,Lipocalin-15,37959,-0.014057384087447,0.00614495039767409,-0.0261014868668882,-0.00201328130800579,0.0221743553543701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.00746272285422354,0.00326226891076514,-0.0138567699193232,-0.00106867578912386,0.0221746056264701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0243935820251089,0.0106679193216117,-0.0453027038954679,-0.00348446015474994,0.0222304674532644
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HCG22,Protein PBMUCL2,37562,0.0117596475326752,0.0051477017011821,0.00167015219835828,0.0218491428669921,0.0223612283018592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0153434321951049,0.00672000537715792,-0.0285146427343345,-0.0021722216558754,0.0224289939904231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00562183291768426,0.00246412294229984,0.000792151950776566,0.010451513884592,0.0225358597312788
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS1,Galectin-1,40359,-0.00740063050729598,0.00324654334731187,-0.0137638554680272,-0.00103740554656471,0.0226480729157677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.00628732680913748,0.00275998933803759,0.000877747706583816,0.0116969059116912,0.0227383842438002
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.0137792517801988,0.0060514624266093,-0.025640118136353,-0.00191838542404455,0.022801051133318
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.00771585353660619,0.00339042650840816,-0.0143610894930862,-0.0010706175801262,0.022872938792095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.017850503654842,0.00784559017959533,-0.0332278604068488,-0.00247314690283513,0.0229058443866889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB6,Integrin beta-6,40044,-0.00662221235141017,0.0029107344538876,-0.0123272518810299,-0.00091717282179047,0.0229134367076861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C3,Complement C3,37360,-0.0103224591797652,0.00454393357925302,-0.0192285689951011,-0.00141634936442928,0.0231209503666483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.00711671452215295,0.00313330353102434,0.000975439601345237,0.0132579894429607,0.0231412010715229
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0128074958523344,0.00564222626942085,0.00174873236426953,0.0238662593403993,0.0232271873304312
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPH1,Neurexophilin-1,39961,-0.00825971910260482,0.00364413889316149,-0.0154022313332013,-0.0011172068720083,0.0234298295998512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GZMB,Granzyme B,40341,-0.0137500771957241,0.00606660268394565,-0.0256406184562575,-0.0018595359351906,0.0234329406101414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0144254569210753,0.00637102800527751,0.00193824203073142,0.0269126718114193,0.0235763761098716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00558918108877465,0.00247255812422141,0.000742967165300695,0.0104353950122486,0.0238074822996582
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RCOR1,REST corepressor 1,40042,-0.00977056951620644,0.0043276448961769,-0.0182527535127132,-0.00128838551969972,0.023977484024598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.011834193694368,0.00524446281056548,-0.0221133408030763,-0.00155504658565967,0.0240547908633654
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.00802507926287387,0.00356158772588109,-0.0150057912056008,-0.00104436732014693,0.0242608668994305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F3,Tissue factor,40393,0.00611125915565038,0.00271443399569815,0.000790968524082009,0.0114315497872187,0.0243741837538412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,0.00479779943086077,0.0021347230585669,0.000613742236069639,0.00898185662565189,0.024623899457202
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMB,RGM domain family member B,40471,-0.00562253221133018,0.00250289468320496,-0.0105282057904119,-0.00071685863224847,0.0246912078272018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRN1,Neuritin,37959,-0.00792311684231807,0.003528447742514,-0.0148388744176455,-0.00100735926699063,0.0247523855521361
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.00727986760667052,0.00324692892045298,0.000915886922582681,0.0136438482907584,0.0249701976709571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.00553573277742623,0.00247017879071297,-0.0103772832072236,-0.000694182347628812,0.025038300012858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP10,Stromelysin-2,40341,0.0129606144552787,0.00579117568091721,0.001609910120681,0.0243113187898765,0.0252352674408731
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.00471444967193425,0.00210833145300771,0.000582120024039142,0.00884677931982935,0.0253615388221482
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0130231271601696,0.00583279064282875,-0.0244553968201139,-0.00159085750022524,0.0255822373029011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00481839114912896,0.00215861911396357,0.000587497685760363,0.00904928461249756,0.0256180449305551
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0176786172471836,0.00793282923178652,-0.0332269625414852,-0.00213027195288205,0.0258616040508331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0128519575050613,0.00577386917209692,0.0015351739277513,0.0241687410823712,0.0260389517583877
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLKB1,Plasma kallikrein,37721,-0.00540001788142198,0.00242918814067922,-0.0101612266371533,-0.000638809125690709,0.026234452388434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0132729284164733,0.00597101475262924,-0.0249761173316266,-0.00156973950131997,0.0262399012506636
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00651159864752432,0.00293044053838124,0.000767935192297097,0.0122552621027515,0.0262939186008696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00884938453850604,0.00398556321716498,0.00103768063286268,0.0166610884441494,0.0264114093546494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.00442835214961488,0.0020006092480304,-0.00834954627575446,-0.000507158023475308,0.0268774306005069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA12,Carbonic anhydrase 12,40305,-0.00690525980521049,0.00311984211623267,-0.0130201503530265,-0.000790369257394449,0.0268886541579037
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0187085686995533,0.00845838652941192,-0.0352870062972006,-0.00213013110190591,0.0269950914431683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.00545028439448221,0.00246859389977026,-0.0102887284380319,-0.000611840350932496,0.0272718559709757
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0127117848967973,0.00576210621554548,-0.0240055130792664,-0.00141805671432811,0.0273937408809871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.0131802068449185,0.00597890797274119,-0.0248988664714913,-0.00146154721834579,0.0275095478231221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0160343565180892,0.00731850730368184,-0.0303786308333056,-0.00169008220287275,0.0284715306883629
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0222100930069912,0.0101389220966543,-0.0420823803164336,-0.00233780569754887,0.0284994443874626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.00965916552478334,0.00440954406980996,-0.0183018719016109,-0.00101645914795581,0.028504074660451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOH,Beta-2-glycoprotein 1,40332,0.00746155048639544,0.00342924465480916,0.000740230962969483,0.0141828700098214,0.0295805501040247
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPL,Periplakin,37598,-0.00690941804013666,0.00317595622779544,-0.0131342922466157,-0.000684543833657604,0.0296074704838529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0199464953352274,0.00918662127175204,0.00194071764259337,0.0379522730278614,0.0299298236644419
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00731995357058797,0.00337240831611308,-0.0139298738701696,-0.000710033271006332,0.0299831444178017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00990704638360948,0.00456673966040298,-0.0188578561179993,-0.000956236649219636,0.0300708787375403
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.00986922629238688,0.00454944392326967,-0.0187861363819954,-0.000952316202778331,0.0300731281742344
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.0059069233423867,0.00272515954176081,-0.0112482360442379,-0.000565610640535502,0.0302102118405794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.01027365292018,0.00474888359725207,-0.0195814647707941,-0.000965841069565928,0.030526959322589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0232724992910459,0.0107757786263444,-0.0443930253986809,-0.00215197318341086,0.0308134633336793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0161128871926476,0.00746574232976963,-0.0307457421589961,-0.00148003222629911,0.0309271404164221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0057847814483439,0.00268636231203894,-0.0110500515799402,-0.000519511316747584,0.0313030702873048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.0145894670613577,0.00677508762222774,-0.0278686388009241,-0.00131029532179136,0.0313054966965367
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0072051542227222,0.00334644017781541,-0.0137641769712404,-0.000646131474203994,0.0313274099993377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00718106321837138,0.00333557554921911,0.000643335141901935,0.0137187912948408,0.031347049757976
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00585229857272214,0.0027202412301664,-0.0111839713838483,-0.000520625761595989,0.0314631637233
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00983024157279819,0.00456973124250226,-0.0187869148081026,-0.000873568337493762,0.031481419208851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0207271838443204,0.0096452685565461,-0.0396319102151508,-0.00182245747349005,0.0316535395165561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPGN,Epigen,37900,-0.0102327025281239,0.00476523699723818,-0.0195725670427107,-0.000892838013537074,0.0317820650202104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI2,Serpin I2,37901,-0.0115486992488556,0.00538262853742349,-0.0220986511822057,-0.000998747315505595,0.0319267376960823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO1,Alpha-enolase,40299,0.0164009013270851,0.00764599736991206,0.00141474648205746,0.0313870561721127,0.0319655235306338
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,-0.0202519803204854,0.00946987182961858,-0.0388129291065379,-0.00169103153443304,0.0324857251973018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0124124205357435,0.00582023515280079,-0.0238200814352331,-0.001004759636254,0.03297342557907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0051556798560959,0.00241821338284288,-0.00989537808646794,-0.000415981625723862,0.033023132409596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,0.0148193892544909,0.00696272239042601,0.0011724533692559,0.0284663251397259,0.0333199731682401
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0108303292864015,0.00509672639574999,-0.0208199130220715,-0.000840745550731568,0.0336083044722851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0106594602881022,0.00501781919913097,0.000824534657805482,0.0204943859183989,0.0336619466198502
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.00858085583760661,0.00405600222152681,-0.0165306201917992,-0.000631091483414066,0.0343951250473404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0134269466190505,0.00635842012723163,-0.0258894500684245,-0.000964443169676548,0.0347326378460679
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.00845967181391922,0.00400665933710451,-0.0163127241146441,-0.000606619513194379,0.0347561313961676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.011127824904159,0.00528198692516093,-0.0214805192774745,-0.000775130530843628,0.0351577462198183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0137651933160299,0.00654221116469382,-0.0265879271988298,-0.00094245943323004,0.0353894024651592
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0193324719916575,0.00920502909702571,-0.0373743290218279,-0.00129061496148716,0.0357264552935263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0139074219023166,0.00664610985047998,-0.0269337972092574,-0.000881046595375849,0.0364070998656009
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0116486923485213,0.00558758861910218,0.000697018655081061,0.0226003660419616,0.0371085117636561
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTN,Pleiotrophin,40042,-0.0101079613564531,0.00484918600162054,-0.0196123659196294,-0.000603556793276885,0.03713407358617
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOST,Sclerostin,40330,-0.00776074009354495,0.00372857632181357,-0.0150687496842996,-0.00045273050279035,0.037411295570469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00548535670898394,0.00263622588815398,0.000318353968202127,0.0106523594497657,0.0374716132353366
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0135532219782571,0.00652965281006157,-0.0263513414859778,-0.000755102470536423,0.0379459562720621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRG,Histidine-rich glycoprotein,37934,0.0062555047786737,0.0030350503933223,0.000306806007761988,0.0122042035495854,0.0393138151271823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.00377391712870653,0.00183153284344563,0.000184112755553082,0.00736372150185997,0.0393675170719353
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0114733922332215,0.00557500203497224,0.00054638824467592,0.0224003962217671,0.0396092337529725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.00995084589032205,0.00483534250091781,-0.019428117192121,-0.000473574588523143,0.0396154966709931
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGF,Beta-nerve growth factor,40228,-0.00242452980016521,0.00117897853046446,-0.00473532771987556,-0.000113731880454858,0.0397539866997442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GC,Vitamin D-binding protein,38013,-0.00514440976822591,0.00250388460428523,-0.010052023592625,-0.000236795943826853,0.039939536853087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0130480193383421,0.00635807928996966,-0.0255098547466826,-0.000586183930001566,0.0401705164060922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00674793097699219,0.00329253693878106,0.000294558576981301,0.0132013033770031,0.0404366675148699
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0155380697074827,0.00760847656333151,-0.0304506837716125,-0.000625455643352944,0.041151403165236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA3G,Semaphorin-3G,37671,0.00852697247999962,0.0041798154290808,0.000334534239001254,0.016719410720998,0.0413666098379924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,-0.00709167972626334,0.00348607121837706,-0.0139243793142824,-0.000258980138244306,0.0419390594109813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX9,Transcription factor SOX-9,37572,-0.00533077382891955,0.00262394928116139,-0.0104737144199959,-0.000187833237843223,0.0422158821850485
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00414097428549793,0.00204224565457451,-0.00814377576846397,-0.000138172802531897,0.0426119309263377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.00882665769957353,0.00435508498959492,0.000290691119967497,0.0173626242791796,0.042708424287876
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX7,Syntaxin-7,37598,-0.00981391515265016,0.00484250417870491,-0.0193052233429118,-0.000322606962388526,0.0427214498965588
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00790854895962152,0.00390394227060966,0.000256822109226588,0.0155602758100164,0.0428068357828795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGALS3,Galectin-3,40374,-0.00577622125781416,0.00285286443746489,-0.0113678355552453,-0.000184606960382984,0.0429138766087688
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.00895523009938595,0.00444482709226093,-0.0176670912002174,-0.00024336899855453,0.0439477285887123
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0101331718203176,0.00503014453156782,-0.0199922551021906,-0.000274088538444692,0.0439779348670863
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.00775206290289835,0.00385140490820479,-0.0153008165229797,-0.000203309282816967,0.0441536998428875
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.00698275437657985,0.00347109937066257,-0.0137861091430785,-0.000179399610081224,0.0442705214844357
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX9,Sorting nexin-9,40359,-0.0133218548062815,0.00662768125870747,-0.0263121100733482,-0.00033159953921489,0.0444445993190986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.00731110255524217,0.00363755850648407,0.000181487882533389,0.014440717227951,0.0444629718920434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00741039130312697,0.00369389581083212,-0.0146504270923579,-0.00017035551389601,0.0448641512236141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEPR,Leptin receptor,40359,0.00593352966900127,0.0029601516466958,0.000131632441477506,0.011735426896525,0.0450368544274383
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0108365209029283,0.00540972562465966,-0.0214395831272612,-0.000233458678595347,0.0451775775548622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00512355260125163,0.00255940604224154,-0.010139988444045,-0.000107116758458212,0.0453213223093187
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00697460106690715,0.00348480965598228,-0.0138048279926324,-0.00014437414118187,0.0453664532973748
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB1,Lamin-B1,37874,0.0109624764456033,0.00548144224859778,0.000218849638351691,0.021706103252855,0.0455284175478799
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.00513042617602531,0.0025676908100716,-0.0101631001637656,-9.77521882849827e-05,0.0457258913510959
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGLON5,IgLON family member 5,37482,0.0181578551969089,0.00910257236600928,0.000316813359530686,0.0359988970342871,0.0460849656174657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR3,Folate receptor gamma,40355,0.0355460778899255,0.0178249436243548,0.000609188386190132,0.0704829673936608,0.0461498494036657
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC16,Mucin-16,40305,-0.0360856594498261,0.0181004813085901,-0.0715626028146627,-0.000608716084989511,0.0462096277994222
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.00524834699467364,0.0026399799609842,-0.0104227077182027,-7.39862711446118e-05,0.0468289971237144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00519470604379299,0.0026188637966464,-0.0103276790852199,-6.17330023660462e-05,0.0473210375433651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPN1,Epsin-1,37714,-0.00843612951748341,0.00427022366216721,-0.0168057678953311,-6.64911396356851e-05,0.0482240974940225
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0157931461526941,0.00804115771432994,-0.0315538152727808,-3.24770326074128e-05,0.0495433250235114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0180330896099706,0.00920194152793258,-0.0360688950047185,2.71578477725395e-06,0.0500513453986566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLMH,Bleomycin hydrolase,40536,0.00610537906365183,0.00311716660946961,-4.26749090861461e-06,0.0122150256182123,0.050173275329682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENSA,Alpha-endosulfine,37900,-0.00992016162700228,0.00507828084640853,-0.019873592085963,3.32688319584443e-05,0.0507871443860478
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THBS4,Thrombospondin-4,40355,0.00851300842324645,0.00436565542443411,-4.36762086444102e-05,0.0170696930551373,0.0511942029995023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0117839990214408,0.00605111656077846,-0.0236441874805666,7.61894376849655e-05,0.0515036900366017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00517978538510669,0.00266621946074697,-0.0104055755281707,4.60047579573675e-05,0.0520676904263775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KEL,Kell blood group glycoprotein,39961,0.00667831545025915,0.00344331812123535,-7.05880673621271e-05,0.0134272189678804,0.0524585962063731
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.022303803914589,0.0115160730634994,-0.0448753071190479,0.000267699289869857,0.0527968456887044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00632084417375814,0.00327717301300391,-0.0127441032792458,0.000102414931729527,0.0537802350272549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.0100340289069281,0.0052026334800089,-0.0202311905277456,0.000163132713889324,0.05379659526001
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00557231259102285,0.00289559809052224,-0.000103059666400739,0.0112476848484464,0.0543250954586958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.0159816810362234,0.00831717100765214,-0.0322833362112216,0.000319974138774774,0.054686901914659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD1,Leiomodin-1,37959,0.00669563962955759,0.00348920044065011,-0.000143193234116624,0.0135344724932318,0.0550103168938589
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.00871937188096582,0.00455129117139868,-0.000201158814975587,0.0176399025769072,0.0554114145800737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00594906672225909,0.00311893788396348,-0.000164051530309337,0.0120621849748275,0.0564904318968292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00471519473271159,0.00247251405054631,-0.000130932806359168,0.00956132227178235,0.0565328909141144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDHB15,Protocadherin beta-15,37900,0.00738054937642174,0.00387910169592619,-0.000222489947593598,0.0149835887004371,0.0571083579604954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0199758249862777,0.0105571931033131,-0.0406679234687713,0.000716273496215971,0.0584887878290082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00776849493366863,0.00411511049256731,-0.000297121631763292,0.0158341114991006,0.0590751573061128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0131884972769281,0.00699025473365729,-0.0268893965548964,0.000512402001040144,0.0592191976664813
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB116,Beta-defensin 116,37541,0.0144028215038145,0.00763912070153484,-0.000569855071193752,0.0293754980788228,0.0593975701917659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.0160919696141108,0.00854708063677505,-0.0328442476621899,0.000660308433968342,0.0597571165005171
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.00841848620836501,0.00447640883738886,-0.0171922475296472,0.000355275112917145,0.0600436311585172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00594826459706497,0.00316358837264127,-0.0121488978074419,0.000252368613311915,0.0600986350249889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPTN,Neuroplastin,39980,0.0153334641292686,0.00815836479668309,-0.000656930872230302,0.0313238591307674,0.0601980155603058
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VWF,von Willebrand factor,40536,0.0129685595451321,0.00690340943159116,-0.00056212294078657,0.0264992420310508,0.0603208732836269
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.00479596030460875,0.0025616041889236,-0.00981670451489901,0.000224783905681513,0.061193810951477
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00733549170773305,0.00392284103230258,-0.0150242601310461,0.000353276715579995,0.0615139117967598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.0101332525501006,0.00542754779621989,-0.0207712462306916,0.000504741130490354,0.0619199047145485
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.00632252440055649,0.00338684605384458,-0.0129607426660919,0.000315693864978889,0.0619534082897192
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALB1,Calbindin,40305,-0.00762649929550458,0.00409666929691661,-0.0156559711174611,0.000402972526451982,0.0626731744419514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANGPT2,Angiopoietin-2,40489,-0.00695302688074698,0.00374005159430561,-0.014283528005586,0.000377474244092023,0.0630351728054844
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARFIP1,Arfaptin-1,37959,-0.0122610440928232,0.00660652375003045,-0.0252098306428829,0.000687742457236427,0.0634896498802385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0107485810328979,0.00580154365041545,-0.0221196065877122,0.000622444521916414,0.0639428204921729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00987502208349368,0.00533211645526182,-0.000575926168819478,0.0203259703358068,0.0640457017830517
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCN2,Transcobalamin-2,40497,0.00533411701274467,0.00288326998148619,-0.000317092150968262,0.0109853261764576,0.0643285466650815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.013941350500482,0.00754447126267354,-0.0287285141753221,0.000845813174358128,0.0646408511521011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYB5A,Cytochrome b5,37482,-0.0130849932296824,0.00708940732084614,-0.0269802315785408,0.000810245119176033,0.0649569288869005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0222993493843073,0.0120879131892333,-0.0459916592352046,0.00139296046659007,0.0650942053192066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0124922317929922,0.0067753097194769,-0.000787375257182544,0.0257718388431669,0.0652324885785816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0151022647298135,0.0082103502175521,-0.0311945511562156,0.000990021696588643,0.0658757810027723
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17D,Interleukin-17D,40044,-0.00607406006239952,0.00330532040894613,-0.0125524880639339,0.000404367939134894,0.0661313162459321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.0113935622751459,0.00620055368556088,-0.000759522948553429,0.0235466474988452,0.0661578055615882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0117751547424855,0.00641334989144531,-0.0243453205297183,0.000795011044747334,0.0663706752207319
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.00855996483467595,0.00466442221076439,-0.0177022323677742,0.000582302698422256,0.0665006816283476
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00522751491050235,0.00285120043932867,-0.0108158677715865,0.000360837950581851,0.0667592855743502
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.0189643534750399,0.0103779510372822,-0.039305137508113,0.00137643055803315,0.0676668568829314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.00544603814386334,0.00299212165500547,-0.0113105965876741,0.000418520299947383,0.0687586808040532
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0102791846505052,0.00565584590165239,-0.0213646426177439,0.000806273316733492,0.0691681465047013
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00846047825966662,0.00466086432705218,-0.000674815821355647,0.0175957723406889,0.0695107812822102
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.00498628057107651,0.0027498736343336,-0.000403471752217354,0.0103760328943704,0.0698080614839928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1S,Complement C1s subcomponent,38013,-0.00361642223546072,0.00199727176685868,-0.00753107489850373,0.000298230427582288,0.0702123512562512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMM2,Phosphomannomutase 2,37562,-0.0105226093969574,0.0058151807351077,-0.0219203636377685,0.000875144843853686,0.0703951891346293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.0103732933864674,0.00573339324866567,-0.0216107441538521,0.000864157380917328,0.0704274191208021
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.00776810029111051,0.00429549124215808,-0.0161872631257403,0.000651062543519328,0.0705617462183147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00527732347317613,0.00292834585697062,-0.0110168813528385,0.000462234406486296,0.0715409502657571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.00468069313651449,0.00259874314504023,-0.000412843427764356,0.00977422970079333,0.0717034528148377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0153278501296694,0.00851311839735016,-0.0320135621884757,0.00135786192913695,0.0718043354826528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNU13,NHP2-like protein 1,37562,-0.0107859484103292,0.0060061766365477,-0.0225580546179627,0.000986157797304278,0.0725478550182515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0135657140977585,0.0075595310192318,-0.0283823948954528,0.00125096669993588,0.0727533764322602
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFP,Alpha-fetoprotein,40182,0.0120452961535019,0.00671834527312885,-0.00112266058183069,0.0252132528888344,0.073008718569684
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN2,Neuroligin-2,37541,0.00836085691571477,0.00466434613587822,-0.000781261510606543,0.0175029753420361,0.0730754289509862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALLD,Palladin,37598,0.00715824847211423,0.00400367858090241,-0.000688961546454503,0.015005458490683,0.0738122844802294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXN,Thioredoxin,37819,-0.00765190093247833,0.00429039029542884,-0.0160610659115189,0.000757264046562192,0.074528014567846
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0209628902671149,0.0117590154037276,-0.0440105604584211,0.00208477992419122,0.0746569890690678
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00701250808159785,0.00393505119122114,-0.000700192253195583,0.0147252084163913,0.0747621404809056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.00690642283676653,0.00388207062615779,-0.000702435590502732,0.0145152812640358,0.0752536692326528
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRH,Corticoliberin,39947,0.0148970558811343,0.00838725732019589,-0.00154196846644969,0.0313360802287182,0.0757272500873545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO4,Roundabout homolog 4,37628,0.00305791613197312,0.00172300303206963,-0.000319169810883364,0.0064350020748296,0.0759606768029631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0115178034337372,0.00651061356201562,-0.0242786060152878,0.00124299914781346,0.0769033948253541
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0188433216858317,0.0106899499064674,-0.0397956235025079,0.00210898013084444,0.0779684861305334
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00446775421654922,0.00254137255997008,-0.00944884443409058,0.000513336000992134,0.078765381994707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0201404190915545,0.0114662989449429,-0.0426143650236426,0.00233352684053356,0.0790242441010713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.00837965964299156,0.00477931598407608,-0.0177471189717807,0.000987799685797555,0.0795667294158172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.00682393792227592,0.00390368328883603,-0.000827281323842698,0.0144751571683945,0.080470423227307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.0142669740557982,0.0081858949225508,-0.0303113281039978,0.00177737999240137,0.0813790787633161
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.00470418831798743,0.00269919879957353,-0.000586241329176693,0.00999461796515156,0.0813861956592849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00537042091522373,0.00308844728137542,-0.000682935756272088,0.0114237775867195,0.0820803888573793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,-0.00617444443916531,0.00355431336552925,-0.0131408986356026,0.000792009757272024,0.0823806414768675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.00546645958651229,0.00314699360654355,-0.0116345670553377,0.000701647882313076,0.0824024903361336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.0108258845327194,0.00623565468615756,-0.00139599865214945,0.0230477677175882,0.0825650234583784
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0108059391413091,0.00622779714806545,-0.0230124215515174,0.0014005432688992,0.0827434212744437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RUVBL1,RuvB-like 1,39980,-0.0179847719237929,0.0103739694683154,-0.0383177520816911,0.00234820823410522,0.0830010833483156
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.00668899171075386,0.00385980365601038,-0.0142542068765342,0.000876223455026476,0.0831213949713635
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLC,Galectin-10,40333,0.0109452175518275,0.00635342064870181,-0.00150748691962804,0.023397922023283,0.0849571380843839
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00432794040737517,0.00251235097701818,-0.000596267507580455,0.00925214832233081,0.0849724937036716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYT1,Synaptotagmin-1,37942,0.00648452225540793,0.00376558383205027,-0.000896022055410606,0.0138650665662265,0.0850834506361358
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.0054104697825427,0.0031439590872402,-0.0115726295935335,0.000751690028448085,0.0852907356109069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.0068292374073069,0.0039684242006286,-0.014607348840539,0.000948874025925156,0.0852936546113692
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0435292085908883,0.0253280273603893,-0.0931721422172514,0.00611372503547476,0.0857074076672647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0171906509995866,0.0100288752029593,-0.0368472463973868,0.00246594439821363,0.0865311243309573
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.0105228105254837,0.00614070814090386,-0.0225585984816553,0.00151297743068783,0.0866193081423409
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0105686187685968,0.00617139806187447,-0.0226645589698707,0.00152732143267718,0.0868210822883302
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.00616118646610733,0.00361091545175901,-0.013238580751555,0.000916207819340321,0.0879814377307119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0104586026305015,0.0061471205609882,-0.00158975366903536,0.0225069589300384,0.0888949576064542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.0106393421783072,0.00625773912067486,-0.02290451085483,0.00162582649821549,0.0891184147397794
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00830045282205966,0.00488260381836878,-0.00126945066194315,0.0178703563060625,0.0891533594971346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.00737468048035862,0.00433819763160068,-0.015877547838296,0.00112818687757872,0.0891616201850947
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.00885509889286444,0.00521329470257582,-0.019073156509913,0.00136295872418416,0.0894250681114313
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.00576026744232262,0.00339238731533549,-0.0124093465803802,0.000888811695734946,0.0895276664959033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.0134584747358445,0.00793114582103502,-0.0020865710733841,0.0290035205450732,0.08973679373974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.014039120323326,0.00828376512042695,-0.0302752999593628,0.00219705931271086,0.0901376992012098
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00423724531965821,0.0025047155159874,-0.00914648773099351,0.000671997091677089,0.0907249780291078
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.011477828626564,0.00680201160103447,-0.00185411411146361,0.0248097713645915,0.0915470245958162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAT,Catalase,37786,-0.00884674131818014,0.00524416172560401,-0.019125298300364,0.00143181566400371,0.091632591813083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,0.0126325437034259,0.00750436452194561,-0.00207601075958747,0.0273410981664393,0.0923291980219795
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00404456812171149,0.00240299424831178,-0.000665300604979592,0.00875443684840257,0.0923716634924962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACHE,Acetylcholinesterase,37671,-0.0051938949271016,0.00308813245890034,-0.0112466345465463,0.000858844692343078,0.0926140542426261
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSB,Lupus La protein,39961,-0.00979320232490346,0.00584190839123497,-0.021243342771724,0.00165693812191708,0.0936858174913085
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.0133386112855628,0.00796231252671637,-0.0289447438379269,0.00226752126680125,0.0939149927125659
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LGMN,Legumain,40422,-0.00573687702473383,0.00342825187468401,-0.0124562506991145,0.000982496649646827,0.094265847772076
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BGLAP,Osteocalcin,37998,0.0146664827566893,0.00877063674821356,-0.0025239652698093,0.0318569307831878,0.0945029509403221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0111100469946886,0.00664822247063299,-0.0241405630371292,0.00192046904775211,0.0947198021382998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00715084479594751,0.00428349145791257,-0.0155464880534561,0.00124479846156113,0.0950589411178168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BEX3,Protein BEX3,37482,0.0076997763840514,0.00461570253584537,-0.00134700058620552,0.0167465533543083,0.0953060170064671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0229501963855506,0.0137601957963015,-0.0499201801463015,0.00401978737520029,0.0953620327926391
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLPS,Colipase,40311,0.0110250780391417,0.0066276414426879,-0.00196509918852656,0.02401525526681,0.0962322548446095
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD276,CD276 antigen,40357,0.00578389868653562,0.00348204382084242,-0.00104090720231552,0.0126087045753868,0.0967202428885051
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.0061195271480252,0.00368761809375909,-0.00110820431574262,0.013347258611793,0.0970430982281105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO1A,Coronin-1A,39990,-0.0144142313015466,0.00868671542169822,-0.0314401935280751,0.0026117309249819,0.0970670879764107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REST,RE1-silencing transcription factor,37482,0.00574087148650716,0.00346442806820421,-0.0010494075271731,0.0125311505001874,0.0975252167542599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.00880687252214462,0.00531544090599597,-0.0192251366978967,0.00161139165360749,0.0975701480849216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCLN,Nicalin,40044,-0.00852954881969428,0.00515718935441593,-0.0186376399543495,0.00157854231496095,0.098165072258531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.00468256151069106,0.00284201994882493,-0.0102529206103879,0.0008877975890058,0.099455052731967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.00798723543901553,0.00484777116525263,-0.0174888669229107,0.00151439604487963,0.0994561237133147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.0070110734300004,0.00426180416521193,-0.0153642095938158,0.00134206273381499,0.0999704279928983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00593245938317646,0.00361098311334102,-0.0130099862853249,0.00114506751897195,0.100424923287514
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.011257633698241,0.006857007738115,-0.0246973688649464,0.00218210146846443,0.10066086424418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHB,Lutropin subunit beta,39980,0.0133815314195572,0.00819229049358027,-0.00267535794786015,0.0294384207869745,0.102398907615798
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0066512539577526,0.0040734045614784,-0.00133261898274507,0.0146351268982503,0.102524098848073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.0049329113526004,0.00302583185109604,-0.0108635417807486,0.000997719075547832,0.103069207675526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.00520084730377637,0.00319065444853934,-0.00105283541536074,0.0114545300229135,0.103115742672023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.0104539541512459,0.00642120982068026,-0.0230395253997792,0.00213161709728737,0.103541224424183
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00898283745281502,0.00551856824447307,-0.00183355630635221,0.0197992312119822,0.103602436638031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.00558382912802018,0.0034306389831117,-0.0123078815349191,0.00114022327887876,0.103625664902182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,0.00704459230621748,0.00434449913008617,-0.0014706259887514,0.0155598106011864,0.104930979593849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00453879532904159,0.00280435340067569,-0.000957737336282774,0.0100353279943659,0.105582555869408
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.00786348319466151,0.00487078016197853,-0.0016832459228164,0.0174102123121394,0.106459891724511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.00341591193205212,0.00212115083363191,-0.00757336756597067,0.000741543701866433,0.107329376599811
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00830736618146159,0.0051778710481881,-0.00184126107298709,0.0184559934359103,0.10864972154919
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00570172451706554,0.00355547820523379,-0.0126704617993238,0.00126701276519268,0.108815727159487
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTTG1,Securin,37714,-0.0063980340687285,0.00399104450713658,-0.0142204813027162,0.0014244131652592,0.10893691095622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.010943687694969,0.00684139412249584,-0.0243528201750608,0.00246544478512284,0.109704885565072
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRSS53,Serine protease 53,37942,0.00565150979362648,0.00353362297810863,-0.00127439124346643,0.0125774108307194,0.109765652792981
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.00689581082226374,0.00431513542817076,-0.0153534762614784,0.00156185461695094,0.110055227118014
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00762910796215116,0.00477653088190618,-0.00173289256638496,0.0169911084906873,0.110243740477786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.00724321466627018,0.00453567104864705,-0.0161331299216184,0.00164670058907804,0.110297978518008
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,0.00569361983743912,0.00357144450837477,-0.00130641139897544,0.0126936510738537,0.110909607101178
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLTA,Clathrin light chain A,40042,-0.00729745377060846,0.00457796653653898,-0.0162702681822249,0.00167536064100794,0.110947739402841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.00562807510644844,0.00353474527438966,-0.0125561758442522,0.00130002563135529,0.111360619228989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.00900109837730816,0.00566652813466073,-0.0201074935212432,0.00210529676662688,0.11220389933791
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00689567651200662,0.00434183151405968,-0.0154056662795636,0.00161431325555035,0.112266016526094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMNB2,Lamin-B2,37942,-0.00417665803076409,0.00263027180548692,-0.00933199076951846,0.000978674707990273,0.112328139332506
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00510108818624061,0.00323076028535573,-0.00123120197305662,0.0114333783455378,0.114380226902997
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,-0.00520295836498404,0.00329920394326515,-0.0116693980937837,0.00126348136381566,0.114807881898511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.00961446810453672,0.00610328828106979,-0.0215769131354335,0.00234797692636007,0.115212729162083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00458119496044865,0.00291502396667464,-0.00113225201423364,0.0102946419351309,0.11607214117277
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.00970579106598453,0.00618955996744452,-0.0218373286021758,0.00242574647020673,0.116883453797799
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.0124794391866152,0.00796388051243634,-0.0280886449909905,0.00312976661775998,0.117137578016743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,0.011058336270517,0.00705929352460824,-0.0027778790377152,0.0248945515787491,0.117256539502871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.0092233192074919,0.00589033841038527,-0.020768382491847,0.00232174407686323,0.117406705037624
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00588137761644854,0.00376359813550867,-0.00149527472914845,0.0132580299620455,0.118147135649713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0072641452057607,0.00469639140170534,-0.0164690723531032,0.00194078194158177,0.121943375663513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR2,Toll-like receptor 2,37714,-0.00342882788907855,0.0022194508170599,-0.00777895149051596,0.000921295712358855,0.122394496685105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0119205864410497,0.00772277706154776,-0.0270572294816833,0.00321605659958388,0.122718574398536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.00934766517365835,0.00605677498976259,-0.021218944153593,0.00252361380627633,0.122768517541232
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00548161261540813,0.00355436183795786,-0.0124481618178055,0.00148493658698928,0.123043349444785
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN9,Septin-9,40305,-0.00418682280517339,0.00271789195778866,-0.00951389104243917,0.00114024543209238,0.123466525587871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0070880299938542,0.00460752636468732,-0.0161187816686414,0.00194272168093295,0.123984370159231
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.00421140763253101,0.00273779928820119,-0.00115467897234332,0.00957749423740534,0.124008637475814
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.00524076967866478,0.00340745630531775,-0.00143784467975801,0.0119193840370876,0.124061704835759
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00535965783518891,0.003487848201178,-0.00147652463911997,0.0121958403094978,0.124399247421545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.0105076724233629,0.00685304910749828,-0.00292430382733368,0.0239396486740596,0.125229996507555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RP2,Protein XRP2,40305,-0.00610386333386154,0.00398752721255901,-0.0139194166704772,0.00171169000275412,0.125853869251851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00952383470976201,0.00622681487494868,-0.00268072244513741,0.0217283918646614,0.126167517757004
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN15,Tetraspanin-15,37562,0.00752264629501307,0.00492060749204984,-0.0021217443894046,0.0171670369794308,0.126337071788263
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0066713299993492,0.00437561295128647,-0.0152475313838707,0.00190487138517227,0.127367591251529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0104342502788079,0.00685794883158726,-0.00300732943110311,0.0238758299887189,0.128162913993162
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.00457579829439785,0.00302211763271289,-0.0104991488545151,0.00134755226571942,0.130023681580249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0139213534342497,0.00920638112444863,-0.031965860438169,0.00412315356966958,0.130521973018196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.00523940973367805,0.00347257559991584,-0.0120456579095131,0.001566838442157,0.13137463022891
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00595218360658139,0.00394697206536484,-0.0017838816415337,0.0136882488546965,0.131568638409824
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00427343467360616,0.00283520001789574,-0.00128355736146949,0.0098304267086818,0.131763437851978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.00449719779747213,0.00298742502087048,-0.00135815524343402,0.0103525508383783,0.132247787074868
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,-0.00487919396632296,0.00324599284853228,-0.0112413399494462,0.00148295201680032,0.132826205726907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGA5,Integrin alpha-5,40332,-0.00360460584550211,0.00240416643277588,-0.00831677205374284,0.00110756036273862,0.133811482647106
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,0.00830420649253776,0.00554539503796873,-0.00256476778188094,0.0191731807669565,0.134288339034546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.00978352839044962,0.00654372595107256,-0.0226092312545518,0.00304217447365261,0.134908034689899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LEG1,Protein LEG1 homolog,37231,0.0100497802569058,0.00673213217473633,-0.00314519880557742,0.023244759319389,0.135512159575901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL18,C-C motif chemokine 18,40172,0.0101272293732266,0.00678987399704851,-0.00318092366098847,0.0234353824074417,0.135845225065448
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00802512985598341,0.00538104936325439,-0.018571986607962,0.00252172689599519,0.13588848354256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00505601293139998,0.0033925198923254,-0.0117053519203578,0.0015933260575578,0.136158737388428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.00649641234619021,0.00435903847315714,-0.0150401277535782,0.00204730306119778,0.136160546878064
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNX2,Sorting nexin-2,37900,-0.0111737499485587,0.00750190048272481,-0.0258774748946994,0.00352997499758188,0.136390808202661
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.00814202686484132,0.00549538859229503,-0.0189129885057396,0.00262893477605695,0.138464185899425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNPO1,Transportin-1,37714,0.00506034820749289,0.00342633656666854,-0.00165527146317746,0.0117759678781632,0.139726836307711
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.00689884121023762,0.00467250038834613,-0.0022592595509208,0.016056941971396,0.139839797171893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00698074852286376,0.00474215998692176,-0.00231388505150289,0.0162753820972304,0.141028424359321
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.0061978907376974,0.0042207961140193,-0.0144706511211752,0.00207486964578044,0.142011035423612
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00676745430330111,0.00461278679682482,-0.0158085164250778,0.00227360781847553,0.142370790084543
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTN3,Myeloblastin,39897,0.00663997845101053,0.00454138989927946,-0.00226114575157722,0.0155411026535983,0.143733413791718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.0110872487375814,0.00758827031727062,-0.00378576108426902,0.0259602585594318,0.144011029070857
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDC1,Syndecan-1,40359,-0.00564158092482138,0.0038644304439515,-0.0132158645949663,0.00193270274532357,0.144344497225942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00663081890764946,0.00455287109981236,-0.00229280844798278,0.0155544462632817,0.145301614254052
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP13,Collagenase 3,39961,0.00462370156760505,0.00318774561003386,-0.00162427982806131,0.0108716829632714,0.146950153392243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UPK3A,Uroplakin-3a,37541,0.00700948719311657,0.00483513836386708,-0.00246738400006291,0.016486358386296,0.147166898795461
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00856330523290128,0.0059072097230801,-0.0201414362901383,0.0030148258243357,0.147180102646807
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTKN2,Rhotekin-2,37562,0.00735231732276799,0.00507782427387734,-0.0026002182540316,0.0173048528995676,0.147661465972432
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00643157024058391,0.00444474458968524,-0.015143269636367,0.00228012915519915,0.147918499434049
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK1,Kallikrein-1,40209,0.0178164075018845,0.012316128380789,-0.00632320412446197,0.0419560191282309,0.148031239794924
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0165700087065958,0.0115165468127244,-0.0391424404595357,0.00600242304634412,0.150226876670911
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.00845844936222932,0.00588549636172749,-0.0199940222312152,0.00307712350675655,0.150689983121512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSLNL,Mesothelin-like protein,37572,0.00521696907705099,0.0036358962704722,-0.00190938761307452,0.0123433257671765,0.151353422605724
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTNNA1,Catenin alpha-1,37541,0.00502134396342854,0.00350349785730882,-0.00184551183689675,0.0118881997637538,0.151813905618888
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00920858579769277,0.0064344603246379,-0.0218201280339831,0.00340295643859752,0.152415205582577
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAG,S-arrestin,37541,0.00737329626290418,0.00515580553749818,-0.00273208259059226,0.0174786751164006,0.152713371492883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.00985689290900514,0.00689368223047162,-0.0233685100807295,0.00365472426271923,0.152785659741797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.0116914525626569,0.00819820324975554,-0.0277599309321778,0.00437702580686396,0.15386319602676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA7,Carbonic anhydrase 7,37714,0.00483804982583528,0.00339310817481535,-0.00181244219680281,0.0114885418484734,0.153936327098306
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RELB,Transcription factor RelB,37598,-0.00706519524330876,0.00497194349693154,-0.0168102044972946,0.00267981401067706,0.155336763720507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,0.0138836319783339,0.00980501757420665,-0.00533420246711113,0.0331014664237789,0.156806811906143
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00406386581378023,0.00287437725561394,-0.00969764523478355,0.00156991360722309,0.157437033513986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.00978658148629588,0.00692248087156373,-0.0233546439945608,0.00378148102196903,0.157462009426882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSTN,Osteocrin,37572,-0.00587428622922671,0.00416170114696855,-0.0140312204772851,0.00228264801883166,0.158117759101346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.00518705556296384,0.00367525482020277,-0.0123905550105613,0.00201644388463359,0.158165769167307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.00823348279506066,0.00583770961799157,-0.0196753936463241,0.00320842805620283,0.158446421054412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3GL3,Endophilin-A3,37643,-0.0112829238129691,0.008004362466821,-0.0269714742479383,0.00440562662200003,0.158682344202236
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.0100315366900519,0.0071297347581007,-0.0240058168159292,0.00394274343582551,0.159451137305687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.00882982226404863,0.00629686446293873,-0.00351203208331129,0.0211716766114085,0.160862231655322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.0068299179001669,0.00487291939061905,-0.0163808399057802,0.00272100410544643,0.161056456026159
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00804541873889904,0.00574059030840258,-0.0192969757433681,0.00320613826557003,0.161089392747529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENO2,Gamma-enolase,40471,-0.00888365250603434,0.00633878723651994,-0.0213076754896134,0.00354037047754474,0.161091420867576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.00608762007207608,0.00434737447648457,-0.00243323390183367,0.0146084740459858,0.161443584007729
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFNB2,Ephrin-B2,37572,-0.00783273170011267,0.00559966422189737,-0.0188080735750315,0.00314261017480617,0.161900815512048
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXTL1,Exostosin-like 1,37562,-0.0064201640736417,0.00459810391723681,-0.0154324477514259,0.00259211960414245,0.162658840153356
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.00770909586372872,0.00552831813093943,-0.01854459940037,0.00312640767291255,0.16319457411703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00816620492552487,0.00585880471213497,-0.0196494621613094,0.00331705231025967,0.163391316597766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH1,Protocadherin-1,40475,-0.00291585086232738,0.00209982950303952,-0.00703151668828485,0.00119981496363008,0.164969718371852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00364049029249613,0.00262564110559305,-0.00878674685945851,0.00150576627446625,0.165609127656113
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG3,Desmoglein-3,40419,-0.00448312348961906,0.00323425717694078,-0.010822267556423,0.00185602057718488,0.165724435302144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.00663555800474109,0.00479607332936632,-0.0160358617302991,0.00276474572081689,0.1665193223006
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00433805471268065,0.0031367913011855,-0.0104861656630042,0.00181005623764293,0.166697148524322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCLRE1C,Protein artemis,37482,0.00424230738154731,0.0030686694983126,-0.0017722848351454,0.01025689959824,0.166854743611754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPA,Apolipoprotein(a),37735,0.0234733108378037,0.0169832032039779,-0.00981376744199294,0.0567603891176004,0.166949313749307
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CENPJ,Centromere protein J,37714,-0.00969750771040993,0.00707682395102862,-0.023568082654426,0.00417306723360618,0.170610477890834
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.00731551301175322,0.00533893846814482,-0.0177798324093171,0.00314880638581063,0.170641854972836
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00416669378845035,0.00305591628410784,-0.00182290212840102,0.0101562897053017,0.172753388346848
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK7,Kallikrein-7,37352,0.00508549082376065,0.00374534835294141,-0.00225539194800452,0.0124263735955258,0.174546088460019
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.0136934760514234,0.0101080265504112,-0.00611825598738263,0.0335052080902294,0.17553158703489
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00738026549873142,0.00545525052431555,-0.00331202552892706,0.0180725565263899,0.176119424563664
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00647150941448786,0.00478632868183696,-0.0158527136308883,0.00290969480191258,0.176368763561017
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX33,Testis-expressed protein 33,37714,0.00514689667504335,0.00381315006007694,-0.00232687744270745,0.0126206707927942,0.177111031655937
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK3,Prostate-specific antigen,37998,0.00743047620888916,0.00550501975628453,-0.00335936251342851,0.0182203149312068,0.177114325282768
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.00871454055747108,0.00645713513739976,-0.0213705254267746,0.00394144431183245,0.177168076420448
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSG4,Desmoglein-4,40250,0.00662511197563337,0.00491845886596352,-0.00301506740165513,0.0162652913529219,0.178002966410121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00526533975460515,0.00392730102249344,-0.0129628497586923,0.002432170249482,0.180040503052252
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSPAN7,Tetraspanin-7,37541,0.0118453240299767,0.00884747322289904,-0.00549572348690544,0.0291863715468588,0.180647011719621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0104665769374901,0.00783758764365159,-0.0258282487190472,0.00489509484406699,0.181754112043377
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00378619020212229,0.00283651531137816,-0.00934576021242348,0.0017733798081789,0.181963207887782
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0306099276384583,0.0229610902751238,-0.0756136645777009,0.0143938093007842,0.182514382548936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00379093888640116,0.00285141158141431,-0.00937970558597322,0.00179782781317089,0.183707414978786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00668409895884097,0.00503135895036622,-0.00317736458387681,0.0165455625015588,0.184040136909396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.00459174580550522,0.00346557022141047,-0.0113842634394697,0.00220077182845929,0.18520314363251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA11,Serpin A11,40536,0.00513853949145297,0.00387897283801968,-0.0024642472710656,0.0127413262539715,0.18528400469906
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0184059499323885,0.0139176754589568,-0.00887269396716681,0.0456845938319438,0.186028259817804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.00516124616525052,0.00391379284523723,-0.00250978781141445,0.0128322801419155,0.187277387618796
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF20,Fibroblast growth factor 20,37598,0.00568247188937224,0.00431167863671829,-0.0027684182385956,0.0141333620173401,0.187551501545405
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.00725851697980548,0.00551010314554278,-0.0180583191450693,0.00354128518545837,0.187756977043662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSR,Insulin receptor,37598,-0.00213685476925402,0.00162606621922676,-0.00532394455893848,0.00105023502043043,0.188826968396672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.00972687614219825,0.00740386157459931,-0.0242384448284129,0.00478469254401641,0.188947348121455
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.00416610283384085,0.00317226587483402,-0.0103837439485155,0.00205153828083383,0.189104446725741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FOLR2,Folate receptor beta,40471,0.00372533041652906,0.0028405468258494,-0.00184214136213577,0.0092928021951939,0.189713246485395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.00970747929060272,0.00741144849240362,-0.0242339183357138,0.00481895975450837,0.190284521467621
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1A,Protein phosphatase 1A,39980,-0.00392108853900427,0.00299569022016198,-0.00979264137052176,0.00195046429251322,0.190584248090065
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.00760413389726531,0.00582479069887659,-0.00381245587253281,0.0190207236670634,0.191749243129146
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,F2,Prothrombin,38013,0.00184417910480404,0.00141707960516525,-0.00093329692131984,0.00462165513092793,0.193145684384302
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.00430929626788477,0.00332802754200428,-0.0108322302502132,0.00221363771444363,0.195390874465262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARTN,Artemin,40044,-0.00556075464007229,0.00429887282249016,-0.013986545372153,0.00286503609200843,0.195844269798889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.00607650550032445,0.00471046599722639,-0.0153090188548882,0.00315600785423927,0.197072976286371
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,0.00977173061064239,0.00763253283716579,-0.00518803375020256,0.0247314949714873,0.200470995155494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,-0.00557813218193775,0.00435711491119067,-0.0141180774078715,0.00296181304399597,0.200484487350859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.00352920504878391,0.00275974384223694,-0.0018798928820005,0.00893830297956832,0.20098024924633
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPS10,40S ribosomal protein S10,37562,0.00520900286421544,0.00407344038100861,-0.00277494028256144,0.0131929460109923,0.200999874632742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RGMA,Repulsive guidance molecule A,40471,0.00381049387789581,0.00298392300695098,-0.00203799521572811,0.00965898297151973,0.201617893894068
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00621190870890943,0.00487649916641932,-0.00334602965727243,0.0157698470750913,0.202740635785929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00578241396839066,0.00454005786267042,-0.00311609944244336,0.0146809273792247,0.202812602374496
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00562778585608885,0.00443346798648264,-0.00306181139741712,0.0143173831095948,0.204325702051337
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.00555162661472229,0.00437421625649569,-0.00302183724800927,0.0141250904774539,0.204398646703928
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.00292251000964151,0.00231180986377344,-0.00160863732335443,0.00745365734263746,0.206189134746896
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD82,CD82 antigen,37714,0.00511148135763679,0.00404399596815895,-0.00281475073995475,0.0130377134552283,0.206263740551207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00735170619335717,0.0058268776632547,-0.00406897402662204,0.0187723864133364,0.207083277703412
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FSTL1,Follistatin-related protein 1,37628,-0.00273444486409236,0.00216744160667946,-0.0069826304131841,0.00151374068499937,0.207115001508673
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHH,Sonic hedgehog protein,37598,0.00528335913444034,0.00419058289272047,-0.00293018333529179,0.0134969016041725,0.207414277923421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.00640909336707185,0.00510274028895328,-0.0164104643334203,0.00359227759927657,0.209134671738033
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00444980856362626,0.00355985178870855,-0.011427118069495,0.0025275009422425,0.211322432168542
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00357852822306672,0.00286472555132629,-0.00203633385753282,0.00919339030366625,0.211625270744118
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGB5,Integrin beta-5,40411,0.00446698976935468,0.0035791472662376,-0.00254813887247102,0.0114821184111804,0.212027474518376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00510581012063591,0.00411156641549331,-0.00295286005373097,0.0131644802950028,0.214326010940169
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.00458900252665995,0.00369965763592524,-0.0118403314930734,0.00266232643975352,0.214851522223413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.00728867458455255,0.00588571544275813,-0.0188246768523585,0.00424732768325339,0.215598159866137
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17F,Interleukin-17F,40044,-0.00948975651086704,0.00768116823211147,-0.0245448462458055,0.00556533322407144,0.216678917649271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FBN2,Fibrillin-2,37572,-0.00727397821962638,0.00589205952922289,-0.0188224148969032,0.00427445845765049,0.217024174363954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.0101073417733659,0.0081883817276002,-0.0261565699594622,0.00594188641273054,0.217090535633089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00563764409660446,0.00457450675759263,-0.00332838914827708,0.014603677341486,0.217815995455547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,0.00477678809929837,0.00388507387213235,-0.00283795669008103,0.0123915328886778,0.218897804966198
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,-0.00593842935745956,0.0048303948361634,-0.0154060032363398,0.0035291445214207,0.218948421028908
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0104948284373125,0.00859366043263358,-0.0273384028852743,0.00634874601064933,0.222021374558374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_DRA,,40288,0.00423789513668401,0.0034752475918283,-0.00257359014329946,0.0110493804166675,0.222691117538462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.00262567219685052,0.00215782150600654,-0.00685500234862334,0.0016036579549223,0.223692266396651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0068464468323607,0.00563433976710815,-0.0178897527758927,0.00419685911117129,0.224335120382965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF7,SLAM family member 7,40341,-0.00674921709718483,0.0055642159197312,-0.017655080299858,0.00415664610548832,0.225160002724989
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN3,Matrilin-3,40203,0.00366326408330986,0.00302265413356507,-0.00226113801847766,0.00958766618509739,0.225554968289483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00752830399842245,0.00622932838785706,-0.0197377876386223,0.00468117964177738,0.226866820230111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH4,Myosin-4,37562,0.00553938332232707,0.00458610769415429,-0.00344938775821534,0.0145281544028695,0.22712229545503
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.00629176133675612,0.00521574279393918,-0.0165146172128769,0.00393109453936468,0.227722194146075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00542052379513895,0.00449620997267463,-0.0142330953415812,0.00339204775130333,0.227999305595114
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERVV_1,,37562,0.00559909338706522,0.00465943876816702,-0.00353340659854213,0.0147315933726726,0.229514313078499
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MELTF,Melanotransferrin,37990,-0.00337596524433916,0.00281080711792117,-0.00888514719546466,0.00213321670678633,0.229746560428404
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00844072474335734,0.00703253171260038,-0.0222244869000541,0.00534303741333939,0.230067877441314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUC2,Mucin-2,37998,-0.0104590694864651,0.00872476686718527,-0.0275596125461482,0.00664147357321806,0.230634763426815
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTP1,Glutathione S-transferase P,39871,0.0080802536700095,0.0067476222239769,-0.00514508588898522,0.0213055932290042,0.231131518446855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.00774406753298651,0.00649383868811918,-0.00498385629572708,0.0204719913617001,0.233076867202156
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP6,Gastrotropin,40017,0.00643180486698436,0.00539710281371226,-0.00414651664789166,0.0170101263818604,0.233391439718675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171A2,Protein FAM171A2,37959,-0.0184403701371095,0.0154951448866404,-0.0488108541149248,0.0119301138407058,0.234038197541603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.00706223994311091,0.00593770164322434,-0.0187001351638306,0.0045756552776088,0.234307610994149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00382605889136902,0.0032461936247866,-0.00253648061321272,0.0101885983959508,0.238567155466805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.00555281960015682,0.00471319105022338,-0.0147906740585946,0.003685034858281,0.238756671877695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00743739657562299,0.00631518360368908,-0.0198151564388536,0.00494036328760762,0.238937282935581
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00520932426779865,0.00442537495296157,-0.00346441064000603,0.0138830591756033,0.239157481580766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.00657391532204501,0.00559311945411407,-0.00438859880801858,0.0175364294521086,0.239873068349423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.0105988226493444,0.00903298187234985,-0.0283034671191501,0.00710582182046132,0.240677919327789
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00333499087935356,0.00284233304755723,-0.00223598189385861,0.00890596365256572,0.240684656308562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.00813066824818304,0.00693487553344463,-0.00546168779736844,0.0217230242937345,0.241045062854331
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.00337800739680486,0.00288171193029091,-0.00227014798656533,0.00902616278017505,0.241125513366625
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.00590019313620565,0.00503472930941245,-0.00396787631024275,0.0157682625826541,0.241258993036599
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDHB,Succinate dehydrogenase,37901,-0.00800469516958779,0.00684255749263074,-0.021416107855144,0.00540671751596845,0.242086228482316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.0048480368281674,0.0041477491010071,-0.0129776250661413,0.00328155140980653,0.242491108500708
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00443754413296295,0.00379937263554767,-0.00300922623271049,0.0118843144986364,0.242840407899993
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RALB,Ras-related protein Ral-B,37598,0.00333218299357946,0.00285471097133648,-0.00226305051024004,0.00892741649739895,0.243127539317916
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.0031931034184269,0.00273718641285334,-0.00855798878761945,0.00217178195076565,0.243407132609322
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00379107642214054,0.00325896651722416,-0.0101786507958999,0.00259649795161881,0.244738228193438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00477476874761417,0.00410874475467403,-0.00327837097154692,0.0128279084667753,0.245216385619777
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.00807168561838508,0.00695097714126412,-0.0216956008152628,0.00555222957849259,0.245568714031488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOX2,Transcription factor SOX-2,37937,0.00260818904185537,0.00224658432861425,-0.00179511624222856,0.0070114943259393,0.245679713018954
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.00995050645761677,0.00858125036434584,-0.0267697571717346,0.00686874425650109,0.246247603971406
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00309270004498226,0.00266808748638089,-0.00832215151828882,0.00213675142832429,0.246414966488881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00572531779273982,0.00496454035511844,-0.00400518130329233,0.015455816888772,0.248832152752944
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00746778224315088,0.0064907616070141,-0.00525411050659675,0.0201896749928985,0.249948527409727
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.00678480163336122,0.00590235665809526,-0.0183534206832279,0.00478381741650549,0.2503673312418
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSG1,Tryptase gamma,37598,0.00302156110798815,0.00263231646654512,-0.00213777916644029,0.00818090138241659,0.251042494133062
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,-0.0106664655912094,0.00931484932975934,-0.0289235702775377,0.00759063909511894,0.252187233134218
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,0.0141820592913447,0.0124002219622106,-0.0101223757545881,0.0384864943372775,0.252770924331177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBX2,Chromobox protein homolog 2,37562,0.00453341304088389,0.00396390952253744,-0.0032358496232895,0.0123026757050573,0.252780497657531
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.0131550379368334,0.0115386051951837,-0.0357707041193935,0.00946062824572669,0.254270046784671
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.00688135311026803,0.00604244495598132,-0.00496183900345535,0.0187245452239914,0.254792550895836
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1R,Complement C1r subcomponent,38013,-0.00218083337889702,0.00191792900907472,-0.00593997423668347,0.00157830747888942,0.255526098572379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00349459221789812,0.00307544633617974,-0.00952246703681041,0.00253328260101418,0.255853589910144
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,-0.002775279078737,0.00244448948360208,-0.00756647846659708,0.00201592030912307,0.256258013620136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRTG,Protogenin,40489,-0.00274061837277687,0.00243131191361531,-0.00750598972346287,0.00202475297790913,0.259667218320887
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FXN,"Frataxin, mitochondrial",40489,0.00803451845871319,0.00713763270895874,-0.00595524165084594,0.0220242785682723,0.260328037118215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.00525686790718045,0.00468316705221621,-0.0144358753295242,0.00392213951516333,0.261665833904584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,0.0074128483739727,0.00660590369359165,-0.00553472286546692,0.0203604196134123,0.261816957555365
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.00504357472990686,0.00450776664525915,-0.0138787973546148,0.00379164789480108,0.263218988313028
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00415921910318172,0.00371978123271472,-0.0114499903193026,0.00313155211293913,0.263529139649126
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.00455023381259075,0.00407695641417812,-0.0125410683843799,0.00344060075919836,0.264405694878607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00544233437263769,0.00487871474112147,-0.0041199465199604,0.0150046152652358,0.264641966706838
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00314376640329321,0.00281905789086423,-0.00866911986938711,0.00238158706280068,0.264792429561901
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR4,Proline-rich protein 4,37577,0.00738696147084433,0.00665980716052868,-0.00566626056379188,0.0204401835054805,0.267370493464324
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMI,N-myc-interactor,37857,0.00763704747980625,0.00688950164166426,-0.00586637573785569,0.0211404706974682,0.267663639635779
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00507106750660196,0.00457564006461999,-0.00389718702005322,0.0140393220332571,0.267763399009978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.0033111287127182,0.00299247773979443,-0.00255412765727888,0.00917638508271528,0.268537159400294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM3,Myomesin-3,37671,0.00961271817424995,0.0087116734657056,-0.00746216181853302,0.0266875981670329,0.269860744350264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0130198627042015,0.0118048237035951,-0.0361573171632479,0.010117591754845,0.270075428477733
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00348118846367455,0.00315764289580528,-0.0096701685394529,0.0027077916121038,0.270280021059626
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00427092098450909,0.00388090971934391,-0.00333566206540498,0.0118775040344232,0.271133672320286
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVPL,Envoplakin,37714,0.00366330531759341,0.00333245815182104,-0.00286831265997583,0.0101949232951627,0.271665813794999
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD8,Frizzled-8,37541,-0.00475568940001576,0.00433562187861841,-0.0132535082821078,0.00374212948207633,0.272710757533584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEP1B,Meprin A subunit beta,40359,-0.0124822433833204,0.0114296394854083,-0.0348843367747207,0.00991985000807999,0.274808223293449
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.0092793489829378,0.00849712633405084,-0.00737501863180184,0.0259337165976775,0.274824504702722
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG1,Arginase-1,40227,-0.00556586634346036,0.00509978483760101,-0.0155614446251583,0.00442971193823763,0.275116929874526
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPSD1,Tryptase delta,37959,-0.00401298447614585,0.0036805193065414,-0.011226802316967,0.0032008333646753,0.275586793369474
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP73,Tumor protein p73,37572,0.00368487960482391,0.00338163780721113,-0.0029431304973099,0.0103128897069577,0.275877202341149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00903986104254171,0.00831968726060215,-0.0253464480733219,0.0072667259882385,0.277250169361023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCRN1,Secernin-1,40341,-0.00585400867999381,0.00541872609039517,-0.0164747118171683,0.00476669445718071,0.280011954681619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00649760715468725,0.00602703943408989,-0.00531539013612894,0.0183106044455034,0.281019578667564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.00442316456720865,0.00412108154669526,-0.00365415526431405,0.0125004843987314,0.283151929093598
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMBN,Ameloblastin,40044,0.00307330035514172,0.00286594998809338,-0.0025439616215213,0.00869056233180475,0.28357962830574
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDRG1,Protein NDRG1,39961,-0.00712782495649133,0.00665010054490905,-0.0201620220245131,0.00590637211153041,0.283809852565348
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STC2,Stanniocalcin-2,40309,-0.00280683238368175,0.00262395669210731,-0.00794978750021208,0.00233612273284858,0.284773066465913
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.0051066811131122,0.00477476352404307,-0.00425185539401221,0.0144652176202366,0.2848573735921
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP350,Centrosome-associated protein 350,37482,0.0038723121972927,0.00362199516332569,-0.00322679832282565,0.010971422717411,0.285039793089256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.0091359340071964,0.00855630789655023,-0.00763442947004205,0.0259062974844348,0.285652911191086
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,-0.00497329243439527,0.00468019789521648,-0.0141464803090196,0.00419989544022902,0.287971841332554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00545828825385147,0.00514595172942869,-0.0155443536435317,0.00462777713582876,0.288847585524234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0074028494852451,0.00699198778892738,-0.0211071455515428,0.00630144658105256,0.289727214248294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00590217063684367,0.00558983711979769,-0.0050539101179598,0.0168582513916471,0.291044672311935
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.0090473558817393,0.00858581449844804,-0.0258755522986975,0.00778084053521885,0.292014057567858
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.00574371973106181,0.00545559505189122,-0.0164366860327686,0.00494924657064499,0.29244636825967
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,-0.00423400118625589,0.00403861631934359,-0.0121496891721693,0.00368168679965755,0.29448326283775
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.00662284915709605,0.0064223396132179,-0.0192106347990031,0.00596493648481104,0.302453359697893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TLR1,Toll-like receptor 1,37598,-0.00259573801359356,0.00252378877447307,-0.00754236401156078,0.00235088798437366,0.30372965355739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00568332399056483,0.00553698644656656,-0.0165358174258353,0.00516916944470563,0.304705292512984
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00261212049404751,0.0025490846088599,-0.00238408533931789,0.0076083263274129,0.305510178063934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NXPE4,NXPE family member 4,37562,0.00358306764206317,0.00350560824127297,-0.00328792451083185,0.0104540597949582,0.306754396009332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEX101,Testis-expressed protein 101,37572,0.00388230260978219,0.00379897035229944,-0.00356367928072472,0.0113282845002891,0.306830278612243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00375887070215649,0.00368104340055509,-0.00345597436293148,0.0109737157672445,0.307205664241314
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00364833678536148,0.00358145679362012,-0.0106679921008569,0.00337131853013396,0.308376575493329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.00607166565954517,0.0059623267633107,-0.0056144947965438,0.0177578261156341,0.308536038238326
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.00330073343474468,0.00325563372518368,-0.00308030866661535,0.0096817755361047,0.310668491100833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B4,Protein ATP1B4,37482,0.00413423307670008,0.00408582136339344,-0.00387397679555106,0.0121424429489512,0.311629184443942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSL,Cathepsin L1,40359,-0.00236499668557446,0.00233973335878156,-0.00695087406878631,0.00222088069763739,0.31212872318527
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.00780247447098797,0.00773820931486098,-0.0229693647281155,0.00736441578613956,0.313323816563179
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.0047673305944349,0.00473976284753878,-0.00452260458674112,0.0140572657756109,0.31452250814851
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,0.0086083501419889,0.00856996693555817,-0.0081887850517051,0.0254054853356829,0.31516312643326
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC9,Histone deacetylase 9,37541,0.00614192278909351,0.00612489111334569,-0.00586286379306403,0.0181467093712511,0.315985205360385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.00280355819569225,0.00279843089052699,-0.00828848274112515,0.00268136634974065,0.316443078914103
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,-0.00545049815456479,0.00547593357596978,-0.0161833279634656,0.00528233165433599,0.319582011041341
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DNM1,Dynamin-1,37901,0.0108530611827748,0.0109102513641554,-0.0105310314909699,0.0322371538565194,0.319871814280221
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0046744966379866,0.00470481435140716,-0.0138959327667446,0.00454693949077143,0.320457400237707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.00916120889321907,0.00922063574938924,-0.00891123717558385,0.027233654962022,0.320458003816057
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00238672971176897,0.00240379283207437,-0.0023247042390968,0.00709816366263475,0.32077565286681
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.00389424413664314,0.00392298021159888,-0.00379479707809068,0.011583285351377,0.320886621536643
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NPHS2,Podocin,37598,0.0100383565022659,0.0101173000736919,-0.00979155164217016,0.0298682646467021,0.321119614592288
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANXA4,Annexin A4,40279,-0.00685866817682698,0.006926142132439,-0.0204339067564074,0.00671657040275345,0.322063131528922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,0.00440360428568211,0.00444974442788738,-0.00431789479297715,0.0131251033643414,0.322369541175972
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOB,Apolipoprotein B-100,37987,0.00212495140676993,0.0021540399886471,-0.00209696697097839,0.00634686978451824,0.323907508183305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.00535065073366943,0.00542487243528584,-0.00528209923949082,0.0159834007068297,0.32399495647615
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.00227854065810448,0.00231127287414657,-0.00680863549143176,0.0022515541752228,0.324227654279208
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A13,Protein S100-A13,37598,0.00329106287428187,0.00335484760799073,-0.00328443843737996,0.00986656418594369,0.326617060605647
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00281110230131269,0.00286780404574796,-0.00280979362835332,0.00843199823097869,0.326991578380662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.00790984136669553,0.00808592255257707,-0.00793856683635553,0.0237582495697466,0.327981716193149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00340814510340796,0.00348661677061365,-0.00342562376699479,0.0102419139738107,0.328342935098315
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.00581216217971721,0.00596233147042964,-0.0174983318617593,0.00587400750232488,0.32966782161291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF3,Fibroblast growth factor 3,37598,0.00286439025438021,0.002938774971464,-0.00289560868968923,0.00862438919844965,0.329732719125423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00509412835373211,0.00525216496336911,-0.0153883716819356,0.00520011497447135,0.332109260007755
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,-0.00398966509114582,0.00411705438405252,-0.0120590916838888,0.00407976150159712,0.332533965882683
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPON2,Spondin-2,40267,-0.00322730721492012,0.00333381585239047,-0.00976158628560545,0.00330697185576521,0.333033187280207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00492464482547715,0.00508778749011459,-0.00504741865514745,0.0148967083061017,0.333094959699653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.00596066101019966,0.00616175243287692,-0.00611637375823911,0.0180376957786384,0.333379454109971
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00441931095667857,0.00456905468089882,-0.00453603621788313,0.0133746581312403,0.333448590104872
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH23,Cadherin-23,37942,0.00246069037991204,0.00254444419258547,-0.00252642023755547,0.00744780099737956,0.333519554689435
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA4,Ephrin type-A receptor 4,37671,0.00263415444897255,0.00272540873835903,-0.00270764667821115,0.00797595557615625,0.333803121377803
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ISM2,Isthmin-2,37998,-0.00414428293837376,0.00429100491937955,-0.0125546525803577,0.00426608670361015,0.334157966113308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00295898392245184,0.00306565819576203,-0.00304970614124173,0.00896767398614542,0.334460713980362
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.00502693994173134,0.0052122525946225,-0.00518907514372876,0.0152429550271915,0.334839795554109
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.00570747259127121,0.00597143429187807,-0.0174114838033522,0.00599653862080981,0.339192997160576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,0.00224315307706179,0.00234848415333831,-0.00235987586348129,0.00684618201760488,0.339516729844304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00480848761484317,0.00503592520645578,-0.00506192578981016,0.0146789010194965,0.339677856782586
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL2,Interferon lambda-2,37541,-0.00594932736015047,0.00625405529410832,-0.0182072757366028,0.00630862101630183,0.341482285509637
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NENF,Neudesin,37900,-0.00990482356870453,0.0104265129825034,-0.0303407890144113,0.0105311418770022,0.342147051818816
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.00724104235039366,0.0076732141012528,-0.00779845728806183,0.0222805419888491,0.345351662105946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.00307327728316392,0.00327448420605194,-0.00949126632702572,0.00334471176069789,0.347976988944521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,0.00623296038489901,0.00665349020548719,-0.00680788041785588,0.0192738011876539,0.348880455447087
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00327712163250477,0.00351844561904668,-0.00361903178082672,0.0101732750458363,0.351657865689115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00438120745723655,0.0047177734557673,-0.0136280434305404,0.00486562851606735,0.353079773841616
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD177,CD177 antigen,40316,-0.0114148139856653,0.012355375499745,-0.0356313499651654,0.0128017219938348,0.355565812979434
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0105988623174883,0.0114923949672498,-0.0331239564532979,0.0119262318183214,0.356412143263026
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.00710937931256178,0.00774673553193794,-0.0222929809551601,0.00807422233003659,0.358776617086921
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,-0.00344047138622948,0.00374908945294775,-0.0107886867140071,0.00390774394154812,0.358799641191558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.00563521056874722,0.00615979724932784,-0.0177084131774298,0.00643799203993535,0.360294008910364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.00585691958883848,0.00642956497561137,-0.0184588669410368,0.0067450277633598,0.362343100508632
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH17,Protocadherin-17,40359,0.00306238014966854,0.00336603051626814,-0.00353503966221701,0.0096597999615541,0.362947172209082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.00387492004356985,0.00426111925932651,-0.0044768737047101,0.0122267137918498,0.363170360681376
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MSMB,Beta-microseminoprotein,40236,-0.00606509558741687,0.00668403545979241,-0.01916580508861,0.00703561391377625,0.364209019005413
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FZD10,Frizzled-10,37572,-0.00534421462327735,0.00589097354085076,-0.0168905227633448,0.00620209351679014,0.36432457759369
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,0.00330517858438481,0.00365915495777497,-0.00386676513285413,0.0104771223016238,0.366399997288382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.00496453376650065,0.00552157267684719,-0.00585774868011984,0.0157868162131211,0.368607030185498
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.00192069539611447,0.00214031251472106,-0.00611570792496776,0.00227431713273881,0.369526721481135
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA7A,Semaphorin-7A,40490,-0.00230764464686402,0.00259666509660723,-0.0073971082362142,0.00278181894248616,0.374180066057737
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.0046859225619485,0.00528127624160065,-0.0150372239954858,0.00566537887158877,0.374946770838112
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL5,Interleukin-5,40044,0.0123636983741617,0.0140855336768216,-0.0152439476324088,0.0399713443807321,0.380088258526667
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00286335796640041,0.00326380165913255,-0.00353369328549937,0.0092604092183002,0.380335263121682
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00242802939744788,0.00276768627751609,-0.00785269450137941,0.00299663570648365,0.380349809650393
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLAMF8,SLAM family member 8,39980,0.00450936373549257,0.00516500769314343,-0.00561405134306855,0.0146327788140537,0.382643651740675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.00748977734845342,0.00859029339875785,-0.0243267524100188,0.00934719771311197,0.383285086114392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHC1,SHC-transforming protein 1,37482,0.00981107791831928,0.0112867859747934,-0.0123110225922758,0.0319331784289143,0.384724516047909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.00272771743422551,0.00314220629099899,-0.0034310068961325,0.00888644176458352,0.385361054478245
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,0.00260025723276913,0.00300958490834922,-0.00329852918759533,0.0084990436531336,0.387605178851801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TBR1,T-box brain protein 1,37572,-0.0040587636449667,0.00471796537421928,-0.0133059757784365,0.00518844848850308,0.389651323031674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIM,Vimentin,40042,-0.00983215435821581,0.0114463732228701,-0.0322670458750413,0.0126027371586097,0.390367230434867
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIP1,Huntingtin-interacting protein 1,37562,-0.00281739967418078,0.00328083733109282,-0.00924784084312272,0.00361304149476115,0.390497419163907
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP7,Matrilysin,40015,-0.003997933999199,0.00466167582152249,-0.0131348186093831,0.00513895061098508,0.391117005679207
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.00675649322387347,0.00793278368257557,-0.0223047492417216,0.00879176279397465,0.394385892984519
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.00618818778542255,0.0072754784059921,-0.00807174989032197,0.0204481254611671,0.395032670027044
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,0.00741920162082098,0.00873427923542125,-0.00969998568060467,0.0245383889222466,0.395654394459425
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYMP,Thymidine phosphorylase,40257,0.00546517903143376,0.00643921797806027,-0.00715568820556436,0.0180860462684319,0.396042539868479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00451034461454158,0.00531784946017217,-0.00591264032739587,0.014933329556479,0.396368839011421
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00247018144214196,0.00291721214252395,-0.00324755435720498,0.00818791724148891,0.39714390713423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFP,Properdin,38013,0.00178157279819433,0.00210426604434094,-0.0023427886487139,0.00590593424510256,0.397206248469336
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.0046626116708023,0.00551669176767837,-0.0154753275354519,0.00615010419384731,0.398024330431361
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00167021282119286,0.0019793491196625,-0.00220931145334565,0.00554973709573136,0.398783075225769
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRG3,Proteoglycan 3,37998,0.00406101388883265,0.00481977557940426,-0.0053857462467997,0.013507774024465,0.399482042875214
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPB2,Carboxypeptidase B2,37981,0.00181098578226512,0.00215078036611404,-0.00240454373531839,0.00602651529984863,0.399795364298339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN2,Ataxin-2,37541,-0.00935157894922883,0.0111064480412883,-0.031120217110154,0.0124170592116963,0.399805872206423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00336161471316486,0.00399593185373541,-0.00447041172015653,0.0111936411464863,0.400218035306773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN7,Septin-7,37714,-0.00425533991262014,0.00506832451522157,-0.0141892559624544,0.00567857613721414,0.401150639036431
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00262504508892002,0.00313103565499838,-0.00351178479487682,0.00876187497271685,0.401824101156249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.00215455994054639,0.00257130647698651,-0.00288520075434717,0.00719432063543995,0.402088471643241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CBLN1,Cerebellin-1,37541,0.00793406383055256,0.00947918507217453,-0.0106451389109095,0.0265132665720147,0.402608683894344
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C2,Complement C2,40372,0.00193220257716,0.00231917337132276,-0.00261337723063261,0.00647778238495261,0.40477670113213
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCIN,Adseverin,37541,-0.00590196114542814,0.00709148087966334,-0.0198012636695683,0.00799734137871201,0.405276968105571
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KHDC3L,KH domain-containing protein 3,37482,-0.00545577823707348,0.00659262223373695,-0.0183773178151979,0.00746576134105093,0.407935934904662
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00324434219832376,0.00392247068456408,-0.00444370034342184,0.0109323847400694,0.408185923331267
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.00374943743389046,0.00454919836872539,-0.0126658662365922,0.0051669913688113,0.409842402480786
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL2,Interleukin-2,40044,0.00249142535745575,0.00302524395788514,-0.00343805279999912,0.00842090351491062,0.410210579658742
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,0.00192402875079462,0.00234015885124907,-0.00266268259765356,0.0065107400992428,0.410987485604933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GH2,Growth hormone variant,39980,-0.0133724005625022,0.0162998588972909,-0.0453201240011924,0.018575322876188,0.412000837414861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.00249466695587882,0.00304396912074523,-0.00846084643253947,0.00347151252078183,0.41248834895538
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RYR1,Ryanodine receptor 1,37562,0.00272480291601355,0.00333085004426262,-0.00380366317074118,0.00925326900276828,0.413343327385754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.00361191646923477,0.00442162677487066,-0.0122783049479813,0.00505447200951173,0.414012053170625
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00528947099198994,0.00647679703645021,-0.00740505119945248,0.0179839931834324,0.414126128940806
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANK2,Ankyrin-2,37562,-0.00582894522879398,0.00715671115039193,-0.0198560990835622,0.00819820862597419,0.415389049531125
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD55,Complement decay-accelerating factor,39802,-0.00206942365280033,0.00254238682259265,-0.00705250182508191,0.00291365451948126,0.415675428278199
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,WNT9A,Protein Wnt-9a,40044,-0.00224426357247996,0.00276795839587466,-0.0076694620283943,0.00318093488343437,0.417492307131441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.0041916906888163,0.00517695197643788,-0.0143385165626346,0.00595513518500195,0.418136537632651
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.00505281887636159,0.00624349491653179,-0.0172900689127639,0.00718443116004071,0.418361047837732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,-0.00385641070796429,0.00476653241376009,-0.0131988142389341,0.0054859928230055,0.418495408320239
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00264368421231368,0.00327107110796965,-0.00376761515930683,0.0090549835839342,0.41898934665881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MILR1,Allergin-1,40044,0.00389047324035815,0.00481849912385239,-0.00555378504239254,0.0133347315231088,0.41944634578805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00705122803664462,0.00875532769924448,-0.0101092142538746,0.0242116703271638,0.420624203984805
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTO1,Protein LTO1 homolog,40044,-0.00316499035430374,0.0039743321920738,-0.0109546814507684,0.00462470074216091,0.425836236326945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00487932669004913,0.00613625366327523,-0.00714773048997032,0.0169063838700686,0.426532718603772
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00605959298565554,0.00762463446764803,-0.0210038765422457,0.0088846905709346,0.426779921835603
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00591428313014569,0.00750398255038364,-0.0206220889288976,0.00879352266860623,0.430621555669574
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00331638076961372,0.0042132330303316,-0.00494155596983622,0.0115743175090637,0.431217494272234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RRP15,RRP15-like protein,37541,0.00692504519587603,0.00880428173846278,-0.010331347011511,0.0241814374032631,0.431557091427818
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.00911965275222949,0.0115971612674674,-0.0136107833320066,0.0318500888364656,0.431663055750548
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,-0.00266660337067442,0.00341935644927983,-0.00936854201126288,0.00403533526991405,0.435490098705994
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00292037162841617,0.00375190231140778,-0.00443335690194309,0.0102741001587754,0.436364418061193
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA13,Carbonic anhydrase 13,40173,-0.00775574979987658,0.0099946265774224,-0.0273452178916245,0.0118337182918713,0.437765410512725
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.00372635807595084,0.00481086399442473,-0.0131556515050233,0.00570293535312163,0.43860471951562
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP8,Caspase-8,40434,-0.00462456262384926,0.00597400318267008,-0.0163336088618826,0.0070844836141841,0.438874520803083
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00250970949045446,0.00324922593243146,-0.00887819231802012,0.0038587733371112,0.439890122279168
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.00244059253912284,0.00316825319748741,-0.00865036880619817,0.00376918372795248,0.44111918342351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COPE,Coatomer subunit epsilon,39961,-0.003598819821539,0.00467457862198177,-0.0127609939206233,0.00556335427754527,0.441388485881902
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00390413959702519,0.00508059091244201,-0.0138620977854115,0.00605381859136116,0.442238449189627
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ROBO1,Roundabout homolog 1,40379,0.00178400599249425,0.00232728651454562,-0.00277747557601516,0.00634548756100366,0.443354209544308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.00531618880773435,0.00694253652906002,-0.018923560404692,0.0082911827892233,0.443841679454326
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00330276566844678,0.0043139540867567,-0.00515258434159636,0.0117581156784899,0.443927878017965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MPO,Myeloperoxidase,40332,0.00345825833648006,0.00451881687566298,-0.00539862273981938,0.0123151394127795,0.444103272361641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00238079184007394,0.00311346343268435,-0.00372159648798739,0.00848318016813527,0.444475867663414
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX1B,Syntaxin-1B,37572,-0.00317634728650443,0.00415405914938146,-0.0113183032192921,0.00496560864628323,0.444501488233558
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HEBP1,Heme-binding protein 1,40042,0.00402546421116259,0.0052688729257897,-0.00630152672338523,0.0143524551457104,0.444873681999388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00306870671626726,0.00401894633500022,-0.00480842810033317,0.0109458415328677,0.445143310895437
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.00322613347257158,0.00422646794756715,-0.0115100106498032,0.00505774370466004,0.445285810431216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESR1,Estrogen receptor,37598,0.00427703857436788,0.00561457274563986,-0.00672752400708624,0.015281601155822,0.446208243709197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00318916963742313,0.00418687876799968,-0.0113954520227025,0.00501711274785626,0.446248998542804
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX3,Syntaxin-3,37942,-0.00282813149960121,0.00372450716815898,-0.0101281655491928,0.0044719025499904,0.447668207564441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRND,Prion-like protein doppel,37942,0.00391195216987556,0.0051682311632589,-0.00621778091011188,0.014041685249863,0.449109314929604
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,0.00410029870865642,0.00542588470291052,-0.0065344353090482,0.014735032726361,0.449847426470998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00243096396251015,0.00321848219562373,-0.00387726114091236,0.00873918906593267,0.450074289493082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.0027961899084332,0.00370756065144554,-0.00447062896840006,0.0100630087852665,0.450751179872188
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.00213924105736708,0.00284064647884036,-0.00342842604116002,0.00770690815589418,0.451411427628609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD99,CD99 antigen,40332,-0.00141334646943011,0.00187742813684875,-0.00509310561765365,0.00226641267879343,0.451575322106388
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.00532498993909496,0.00708262299632448,-0.0192069310118909,0.00855695113370101,0.452159238274055
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.0035208749676483,0.00470675545991676,-0.00570436573378854,0.0127461156690851,0.45444524678807
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,0.00260605239471828,0.00348669501217597,-0.00422786982914661,0.00943997461858317,0.454816708249817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.0023143174140756,0.00310565168125931,-0.00377275988119264,0.00840139470934384,0.456166939054539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.00448834456351808,0.00603548892444752,-0.00734121372839907,0.0163179028554352,0.457096236393797
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.00403457498952951,0.00543549883851728,-0.0146881527130234,0.00661900273396436,0.457940674053382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL33,Interleukin-33,40044,-0.00276813117587354,0.00373464260187384,-0.0100880306755463,0.00455176832379919,0.458581060711922
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.00387267179371371,0.00522706052455677,-0.00637236683441755,0.014117710421845,0.458771931655887
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00554972034875779,0.00749262720664754,-0.020235269673787,0.00913582897627138,0.45889384586771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,XG,Glycoprotein Xg,40458,0.00212355799790218,0.00289149066254564,-0.00354376370068727,0.00779087969649163,0.46270578788525
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,0.00221014224047885,0.0030149163125199,-0.00369909373206016,0.00811937821301786,0.463529045258681
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.00353088058014753,0.00483413357712667,-0.0130057823913158,0.00594402123102075,0.46515566578346
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.0048092903524991,0.00661823312060332,-0.0177810272688816,0.0081624465638834,0.467438995248753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.00246089995892328,0.00338865568645011,-0.00910266510436549,0.00418086518651894,0.467718228540521
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,0.00518753794229691,0.007174554448618,-0.00887458877699436,0.0192496646615882,0.469661839797056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,-0.00276500865150539,0.00384018159126558,-0.0102917645703859,0.00476174726737515,0.471524979461094
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDH4,Cadherin-4,37541,-0.00342262029852359,0.0047832568828312,-0.0127978037888727,0.00595256319182555,0.474287077672883
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL25,Interleukin-25,37429,-0.0024040092173151,0.0033732275390874,-0.00901553519392639,0.0042075167592962,0.47606075294255
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00417485761980243,0.00586054099207189,-0.00731180272465847,0.0156615179642633,0.476250051599827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CGN,Cingulin,37572,-0.0028808072935469,0.00405922334379359,-0.0108368850473823,0.00507527046028852,0.477906397316309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00393124288631819,0.00553991270102355,-0.0147894717803243,0.00692698600768797,0.477950993328956
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00370405756604347,0.00524007003386888,-0.00656647970033953,0.0139745948324265,0.47965875378289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00173585361323885,0.0024681662624021,-0.00310175226106927,0.00657345948754697,0.481883325221309
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,0.00367776467963263,0.00525317809429764,-0.00661846438519074,0.013973993744456,0.483875389555927
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.00170676955883669,0.00244117218712933,-0.00649146704561018,0.0030779279279368,0.484464645201983
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00440818767063914,0.0063209479969003,-0.00798087040328546,0.0167972457445637,0.485567059443817
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.00325173256813557,0.004664426619329,-0.0123940087420204,0.00589054360574927,0.48573100703653
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00318385277838247,0.00457418783458215,-0.0121492609341635,0.00578155537739853,0.486411316576311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00253532715574111,0.00364277555535002,-0.00967516724422715,0.00460451293274494,0.486448477720536
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.00223390426715855,0.00321708215746327,-0.00407157676146946,0.00853938529578655,0.487448831140488
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00259969555344124,0.00375077992550162,-0.00995122420742441,0.00475183310054194,0.488254049566382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITGAX,Integrin alpha-X,37714,-0.00368523262663186,0.00533471265827452,-0.0141412694368499,0.0067708041835862,0.489701779830347
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL20,Interleukin-20,40044,-0.00339870906802203,0.00492614021588905,-0.0130539438911646,0.00625652575512051,0.490246287998294
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,0.00180329032531739,0.00263042423286599,-0.00335234117109995,0.00695892182173472,0.493006165782826
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDHR1,Cadherin-related family member 1,39961,0.00290775737882802,0.00425070040288537,-0.00542361541082732,0.0112391301684833,0.493944044326141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00447494264129015,0.00654719569826656,-0.0173074462098926,0.0083575609273123,0.494307491883076
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00571628301510399,0.00840149257394407,-0.0221832084600344,0.0107506424298264,0.496270198888871
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,0.00482440060080406,0.0071015704042848,-0.00909467739159415,0.0187434785932023,0.496932335472554
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.00396955119778663,0.00586419731802708,-0.0154633779411197,0.00752427554554646,0.498471102223469
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.00223890947224945,0.00334203953803766,-0.00431148802230436,0.00878930696680326,0.502918268462234
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00145710187196959,0.00217783693116947,-0.00281145851312257,0.00572566225706174,0.503467446927289
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.004428764242394,0.0067072750232414,-0.00871749480315914,0.0175750232879471,0.509077528673862
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.0036958673150666,0.00559757717973689,-0.00727538395721771,0.0146671185873509,0.509097404193463
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF16,Fibroblast growth factor 16,37598,-0.00312420881228028,0.00473559178996207,-0.0124059687206059,0.00615755109604537,0.509439096825174
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STX5,Syntaxin-5,37598,-0.00265000160848494,0.00403644400504242,-0.0105614318583681,0.0052614286413982,0.511501829576716
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.00576166256348589,0.00879414338031374,-0.011474858461929,0.0229981835889008,0.512369554215533
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OMP,Olfactory marker protein,37541,0.00319970110256453,0.00489189160099659,-0.00638840643538878,0.0127878086405178,0.513070092258549
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BRK1,Protein BRICK1,39961,-0.00277691683244225,0.00426862313697877,-0.0111434181809206,0.00558958451603614,0.515352090459677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,0.00299423525954445,0.00461777164589724,-0.00605659716641414,0.012045067685503,0.516727241382433
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00247547518145815,0.00383956807924778,-0.0100010286167838,0.0050500782538675,0.519114746314586
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MUCL3,Mucin-like protein 3,37482,-0.00279407994590822,0.00435589332205528,-0.0113316308571366,0.00574347096532013,0.521242805983026
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00322103082647301,0.0050588665712981,-0.00669434765327126,0.0131364093062173,0.524324889416262
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.00389343559045436,0.00611629518000743,-0.0158813741432689,0.00809450296236021,0.524417592423523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,-0.00230690555467702,0.00362558434482691,-0.00941305087053776,0.00479923976118372,0.524599946944374
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTPN,Myotrophin,40042,-0.0020315533344525,0.00320227255147619,-0.00830800753534584,0.00424490086644083,0.525822674483235
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00447259909562825,0.0070530854802409,-0.00935144844564392,0.0182966466369004,0.526004662148272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHPK,Sedoheptulokinase,37714,0.00261411753518139,0.0041391713531021,-0.00549865831689872,0.0107268933872615,0.527688083771274
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0157956423876804,0.0250391845319608,-0.0648724440703236,0.0332811592949627,0.528157871162047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.004747431884749,0.00753283937183084,-0.0195117970535374,0.0100169332840394,0.528552473724334
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.00300339075203594,0.00478558077563029,-0.00637634756819943,0.0123831290722713,0.53028244809788
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.00252117559677469,0.00401969204415554,-0.00535742080977017,0.0103997720033195,0.530533289904692
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHIT1,Chitotriosidase-1,40398,-0.00901802705091747,0.0144112306229611,-0.0372640390719213,0.0192279849700863,0.531478807103897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,0.00172258108357106,0.00275897699864588,-0.00368501383377486,0.00713017600091699,0.532403463837764
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00371759934457902,0.00595974938165717,-0.0153987081326271,0.00796350944346904,0.532779937342428
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,0.00228725830738438,0.00367513741251041,-0.00491601102113602,0.00949052763590479,0.533715948987534
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCN,Decorin,40042,0.00135749055204404,0.0022035135164666,-0.00296139594023051,0.00567637704431859,0.537865707514909
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00267687095845791,0.00435236008389446,-0.00585375480597523,0.011207496722891,0.538539553339978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IKZF2,Zinc finger protein Helios,39980,-0.00553583635717572,0.00904714024695092,-0.0232682312411995,0.0121965585268481,0.540620834501316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00552656049844746,0.00904549667349536,-0.0232557339784984,0.0122026129816034,0.54122756048861
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.00244901040200131,0.00401315174544347,-0.00541676701906789,0.0103147878230705,0.541709405482237
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00233255152773755,0.00382996476222494,-0.00983928246169844,0.00517417940622334,0.542515536116974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.0013070360642267,0.00215216905596197,-0.00552528741391216,0.00291121528545876,0.543654681509023
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASP4,Caspase-4,37714,0.00999483087302625,0.016497887378168,-0.0223410283881831,0.0423306901342356,0.544641405036971
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LCP1,Plastin-2,37998,0.00273243023836822,0.00452869520199347,-0.00614381235753898,0.0116086728342754,0.54627981271936
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.00503013143014458,0.0084082180152545,-0.0215102387400434,0.0114499758797542,0.549690228916328
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.00308005932283884,0.00515951228733244,-0.0131927034060104,0.00703258476033275,0.550539506786802
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0102661109848016,0.0173650437256107,-0.0237693747173954,0.0443015966869985,0.554398830462625
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPLX2,Complexin-2,37482,-0.00176847910022026,0.00299485074737531,-0.00763838656507587,0.00410142836463535,0.554861310644801
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.00460247650671418,0.0078142006572036,-0.0107133567814049,0.0199183097948332,0.555878965111957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,INSL3,Insulin-like 3,37942,0.00338310040590664,0.00574544543201911,-0.00787797264085082,0.0146441734526641,0.555984037139497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00187806505897463,0.00319551613573835,-0.00438514656707253,0.00814127668502179,0.556729569297002
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD5L,CD5 antigen-like,37934,-0.00263785135620871,0.00449214408105683,-0.0114424537550801,0.00616675104266266,0.557069605867181
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SHD,SH2 domain-containing adapter protein D,37531,-0.00495896088903077,0.00846401897418734,-0.021548438078438,0.0116305163003764,0.557961388568957
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,-0.00110193509263299,0.00188636878746822,-0.0047992179160707,0.00259534773080473,0.559124561895451
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.00609944641564338,0.0104860120346398,-0.0266520300035374,0.0144531371722506,0.56079419134373
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00369830938983346,0.00639589429467586,-0.00883764342773123,0.0162342622073981,0.563117565021505
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00350801457772728,0.00609355522307277,-0.00843535365949535,0.0154513828149499,0.56483275399465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0033918995898085,0.0058935021604338,-0.0149431638242588,0.00815936464464175,0.564939566902687
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSC1,Hamartin,37598,-0.00421481073418631,0.00735197160460383,-0.0186246750792098,0.0101950536108372,0.566458259603093
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NINJ1,Ninjurin-1,39980,0.00310967460217033,0.00543843168322941,-0.00754965149695932,0.0137690007013,0.567468324795032
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.00159981907567663,0.00282536453318403,-0.00393789540936408,0.00713753356071733,0.571242263635018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,-0.00276328592181004,0.00488851333037493,-0.0123447720493449,0.00681820020572483,0.571905985237443
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.00373324750433653,0.00661818206057962,-0.0167048843430726,0.00923838933439952,0.572702711580674
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MLLT1,Protein ENL,37482,0.003903486480105,0.00692380102670394,-0.00966716353223473,0.0174741364924447,0.572914949555593
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SEMA6C,Semaphorin-6C,37598,-0.00144366912841311,0.00256648099390188,-0.0064739718764608,0.00358663361963457,0.573778740113438
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTSH,Pro-cathepsin H,40013,-0.00391766225959052,0.00699522464448164,-0.0176283025627745,0.0097929780435935,0.575454692527557
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,0.0012717494899305,0.00227645238759436,-0.00319009718975445,0.00573359616961545,0.576407062390111
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.00481732788543809,0.00862903521061211,-0.0120955811273616,0.0217302368982378,0.576668361433899
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.00310101910058594,0.00556406326255397,-0.00780454489401984,0.0140065830951917,0.577311546615479
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDSN,Corneodesmosin,40456,-0.00231369502358075,0.00416962347708198,-0.0104861570386614,0.00585876699149993,0.578975581424249
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00333102583474869,0.00601921743066974,-0.0151286919988614,0.008466640329364,0.58000006790701
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00109995923261994,0.00199362194171767,-0.0028075397731467,0.00500745823838657,0.581134874623853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00206587373435735,0.00375327608746886,-0.00529054739708162,0.00942229486579631,0.582041532278097
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM1,Myomesin-1,37541,-0.0024871958599744,0.00451932190063984,-0.0113450667852285,0.00637067506527968,0.582090692316396
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRNN,Cornulin,39857,0.00353409473772343,0.00642465803671958,-0.00905823501424694,0.0161264244896938,0.582270467233992
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.0025571750288093,0.00465971508166493,-0.0116902165888726,0.00657586653125395,0.583163339741893
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRING1,SREBP regulating gene protein,37482,0.00304464340144621,0.00556609434737392,-0.00786490151940667,0.0139541883222991,0.584389359383628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCL24,C-C motif chemokine 24,40396,0.00437895567534442,0.00800817337158665,-0.0113170641329654,0.0200749754836543,0.584516375991623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00227601167009975,0.00416844623150442,-0.0104461662838484,0.00589414294364892,0.58506719015753
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.00399169946445301,0.00732829525265522,-0.0103717592307512,0.0183551581596572,0.585971178649047
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PMCH,Pro-MCH,37562,-0.00445351221763577,0.00819019820410948,-0.0205063006976904,0.0115992762624188,0.586615040345219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.00362651691675551,0.0066867666573327,-0.0167325795651276,0.00947954573161659,0.587590191520215
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VIT,Vitrin,37990,0.0019193761434527,0.0035475304924493,-0.00503378362174793,0.00887253590865334,0.588484981116326
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.00214607933418433,0.00396736499553443,-0.00562995605706316,0.00992211472543182,0.588562835765979
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.0056560156119319,0.0104608453548553,-0.0261592725074484,0.0148472412835846,0.588734579435436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,-0.00185713169631951,0.00344253735097435,-0.00860450490422925,0.00489024151159022,0.589573117907416
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00172821873125901,0.00321325230878483,-0.00456975579395926,0.00802619325647728,0.59069568703291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.00407427335576196,0.00758430986898093,-0.0107909739874407,0.0189395206989646,0.591140211976728
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00502891925569639,0.00938812998995451,-0.0234296540360072,0.0133718155246145,0.592197239629934
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.00232331404359664,0.00435689011961476,-0.0108628186780416,0.00621619059084829,0.593869149053218
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00141476837101079,0.00265688776351031,-0.00379273164546941,0.006622268387491,0.594394830346153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,-0.00248804252506342,0.00470946390610238,-0.0117185917810241,0.00674250673089724,0.597295514718335
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF830,Zinc finger protein 830,37900,-0.00409141582446265,0.00778149748750298,-0.0193431508999685,0.0111603192510432,0.599044377071493
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZNF174,Zinc finger protein 174,37598,-0.00196835861666177,0.0037441853094034,-0.00930696182309244,0.00537024458976891,0.599098033101643
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BMP4,Bone morphogenetic protein 4,40203,-0.0023004139411157,0.00439119215137186,-0.0109071505578045,0.00630632267557314,0.60037631560686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ESPL1,Separin,37482,-0.00287227586041983,0.00553976910079671,-0.0137302232979814,0.00798567157714171,0.604130152858962
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00188908064413079,0.00364711379280007,-0.00525926238975736,0.00903742367801894,0.604490789219812
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ALCAM,CD166 antigen,40536,-0.000966925944129297,0.00187265209401772,-0.00463732404840403,0.00270347216014543,0.605623778014793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00153101489056854,0.00297098969233568,-0.00735415468754648,0.00429212490640939,0.606335716201884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ANG,Angiogenin,40309,-0.00171525626740627,0.00333275859329153,-0.00824746311025767,0.00481695057544513,0.606793875032005
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGM2,Phosphoglucomutase-2,37572,-0.0029699316808474,0.00580147258652824,-0.0143408179504427,0.00840095458874796,0.608710569605506
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,-0.00159875618226028,0.00313182730351543,-0.00773713769715053,0.00453962533262997,0.609717787248069
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYH7B,Myosin-7B,37482,0.00225221038216393,0.00441545996732022,-0.00640209115378371,0.0109065119181116,0.610008409230079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,-0.00286566307278912,0.0056488329438973,-0.0139373756428278,0.00820604949724959,0.611951591554819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUOX2,Dual oxidase 2,40042,-0.00351549364310257,0.00701125211480882,-0.0172575477881279,0.0102265605019227,0.616091517864131
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAP1A,Ras-related protein Rap-1A,37598,-0.00336931007080095,0.00672325803831543,-0.0165468958258992,0.00980827568429729,0.616279257435135
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00229398160092215,0.00458577356528931,-0.0112820977888892,0.00669413458704489,0.616914070804251
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00316014858091484,0.00634526313254156,-0.0155968643206963,0.00927656715886662,0.618468050486852
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,-0.001345599375762,0.00271716264545955,-0.00667123816086273,0.00398003940933872,0.620451529524311
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SPRR1B,Cornifin-B,37714,0.0040661035153527,0.00823088112159133,-0.0120664234829663,0.0201986305136717,0.621310221883354
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00171379716031707,0.00348346571652082,-0.00511379564406374,0.00854138996469787,0.622741369075029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00139326293905293,0.00283751682114529,-0.00695479590849769,0.00416827003039183,0.623424130352339
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00303556568401994,0.0061956133180212,-0.0151789677873415,0.00910783641930162,0.624174681042411
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAPPA,Pappalysin-1,40044,-0.0022134386329985,0.00453995671846379,-0.0111117538011875,0.00668487653519053,0.625878167754546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDAN1,Codanin-1,37942,0.00108744136449057,0.00223545506081829,-0.00329405055471327,0.00546893328369441,0.626654702235987
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,-0.00192208106088021,0.00397755641870475,-0.00971809164154153,0.00587392951978111,0.62893925843041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,0.000377466831361724,0.000783529561671496,-0.00115825110951441,0.00191318477223786,0.629990134502292
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HRAS,GTPase Hras,37697,0.00456333312975724,0.00950553107133572,-0.0140675077700608,0.0231941740295752,0.631184587538672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00259937169319967,0.00543500081684045,-0.0132519732942069,0.00805322990780761,0.632469219948507
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,0.00630159048648905,0.0132555070898979,-0.0196792034097108,0.0322823843826889,0.634513730843755
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00234549067580687,0.00496494770432664,-0.00738580682467333,0.0120767881762871,0.63664085382177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.00119606318213946,0.0025417382960689,-0.00617787024243452,0.00378574387815559,0.637956199332056
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,-0.00252969347519851,0.00541047458492768,-0.0131342236616568,0.00807483671125975,0.640109549174036
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEB,Nebulin,37562,-0.00162837350742098,0.00351011992089933,-0.00850820855238366,0.0052514615375417,0.642721200980553
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACTN2,Alpha-actinin-2,37562,-0.00243150267716189,0.00526561411416887,-0.0127521063409329,0.00788910098660909,0.644253922058271
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OTOA,Otoancorin,37541,0.0024432814941657,0.00529317465253441,-0.00793134082480175,0.0128179038131331,0.644382359588465
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0042958236862639,0.00936811265131079,-0.0140656771103053,0.0226573244828331,0.646559151913253
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,UBQLN3,Ubiquilin-3,37562,0.00199343917092647,0.00434984094419085,-0.00653224907968759,0.0105191274215405,0.64675986755042
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.00193027884478367,0.00424037123623396,-0.0063808487782349,0.0102414064678022,0.648962215526424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIPF,Gastric triacylglycerol lipase,37628,0.00257779561197291,0.00575517575440409,-0.00870234886665911,0.0138579400906049,0.654226162349264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,-0.00166062018462875,0.00371582228091569,-0.00894363185522349,0.005622391485966,0.654950853199422
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,-0.00182507930006054,0.00408928668766317,-0.00984008120788035,0.00618992260775928,0.655382513874163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ERC2,ERC protein 2,37572,-0.00330803317979637,0.00743532262527429,-0.017881265525334,0.0112651991657412,0.656393710639099
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD33,Myeloid cell surface antigen CD33,40411,0.00341080517806455,0.00766935985198619,-0.0116211401318284,0.0184427504879575,0.656519902569003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00141042950372029,0.00318207002287604,-0.00482642774111675,0.00764728674855733,0.657596302663104
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HDAC8,Histone deacetylase 8,37598,-0.00266216851993605,0.0060328093777413,-0.014486474900309,0.0091621378604369,0.65901631310985
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,-0.0039126708840524,0.00893299753987896,-0.0214213460622152,0.0135960042941104,0.6613920223216
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HSP90B1,Endoplasmin,39878,-0.00295281142078777,0.00678105321390399,-0.0162436757200396,0.010338052878464,0.663241724252291
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,0.00138680219250859,0.00318548222589432,-0.00485674297024428,0.00763034735526146,0.663314791438866
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.00365046898634607,0.00839404311576783,-0.020102793493251,0.0128018555205589,0.663650671678441
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OBP2B,Odorant-binding protein 2b,40184,-0.00278482678684647,0.0064065256922063,-0.0153416171435708,0.00977196356987788,0.663796351084259
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MN1,Transcriptional activator MN1,37572,0.00250364637382571,0.00577019252482128,-0.00880593097482399,0.0138132237224754,0.664373248782046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,0.00192175933101802,0.00443351203229378,-0.00676792425227779,0.0106114429143138,0.664686254606089
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00144497517348395,0.00333640812361359,-0.00509438474879868,0.00798433509576659,0.664954339664802
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RBP1,Retinol-binding protein 1,37572,0.00286235753897986,0.00666324763612164,-0.0101976078278185,0.0159223229057783,0.667512651675003
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL13,Interleukin-13,40044,0.00198843096610589,0.00463210854251064,-0.00709050177721497,0.0110673637094268,0.667731777120011
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00219729308647797,0.00512199773492021,-0.0122364086469216,0.00784182247396563,0.667936436140741
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL24,Interleukin-24,40044,0.00203612357913034,0.00476330632927719,-0.00729995682625294,0.0113722039845136,0.669050116467506
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00084223540597335,0.00197228980132049,-0.00470792341656151,0.00302345260461481,0.669361334372389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCN3,CCN family member 3,40522,-0.00139078867302772,0.00325921395937701,-0.00777884803340667,0.00499727068735122,0.669585222353497
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GAGE2A,G antigen 2A,37482,-0.00256426060985794,0.00601890899645265,-0.0143613222429051,0.00923280102318925,0.670090019530546
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00145069542582046,0.00342420068475778,-0.0081621287679457,0.00526073791630479,0.671821047179696
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00193748456854157,0.00457491573666038,-0.0109043194123959,0.00702935027531277,0.671936005466149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGR,Progesterone receptor,37598,-0.00422465734859913,0.00998674226598014,-0.0237986721899202,0.015349357492722,0.672282793691018
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00301678474809684,0.00722202391794945,-0.0111383821310841,0.0171719516272778,0.67615860686743
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00256147964317275,0.00615514710552245,-0.00950260868365126,0.0146255679699968,0.677305294475739
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.0021861379508484,0.00526532974496999,-0.0125061842509896,0.00813390834929279,0.678006036119544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,-0.00126865178858839,0.00306359523034837,-0.00727329844007118,0.00473599486289441,0.678802391619305
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00152502778887363,0.00379171446171076,-0.00590673255607947,0.00895678813382673,0.687543349149566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00131600676756608,0.00327210823879145,-0.00509732538046517,0.00772933891559733,0.687551318366395
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP3,Stromelysin-1,40332,0.00186410445086743,0.00467083054395659,-0.00729072341528749,0.0110189323170224,0.689828677858165
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TP53BP1,TP53-binding protein 1,37598,-0.00336156840290725,0.00857325357325919,-0.0201651454064953,0.0134420086006808,0.694991056356351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL34,Interleukin-34,39934,-0.00135129241542217,0.00346961255743674,-0.00815173302799818,0.00544914819715384,0.696937604699266
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,POMC,Pro-opiomelanocortin,37628,0.00254877581900564,0.00656869258260255,-0.0103258616428954,0.0154234132809066,0.698008433959201
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00130443790089271,0.00336619416565037,-0.00790217846556743,0.00529330266378201,0.698382937751129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,0.00341291331479166,0.00884862840014906,-0.0139303983495005,0.0207562249790838,0.699725271892881
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.000978611064686381,0.00254900722076412,-0.0040174430880113,0.00597466521738406,0.701044872979785
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00350319734317753,0.00913753693141711,-0.0214127697287551,0.0144063750424,0.701440160983539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.00210712147178869,0.00551543704712704,-0.0087031351405803,0.0129173780841577,0.702436291298304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,-0.00641573400370264,0.0169182414833257,-0.0395754873110211,0.0267440193036158,0.704529704567618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00119473365448314,0.00315071217790159,-0.00737012952317025,0.00498066221420397,0.704548408694853
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF4,Neurotrophin-4,39980,-0.00148852764794531,0.00394120773064451,-0.00921329480000856,0.00623623950411793,0.705671168042926
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL3,Interleukin-3,37482,0.00219312929015764,0.00581839221324001,-0.00921091944779277,0.0135971780281081,0.706231417752382
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0014749917912169,0.00392020606013584,-0.00620861208664936,0.00915859566908315,0.706733462141732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK4,Kallikrein-4,40489,0.00220520130945865,0.00587578206049323,-0.00931133152910808,0.0137217341480254,0.707439760157859
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.00179862492927379,0.00479967412364305,-0.00760873635306658,0.0112059862116142,0.707860664912673
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DLL1,Delta-like protein 1,40411,0.00105197600885406,0.0028288253134257,-0.00449252160546031,0.00659647362316842,0.709989120877719
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DAND5,DAN domain family member 5,37598,0.00194507251081075,0.00525112066098444,-0.00834712398471876,0.0122372690063403,0.711082295574523
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COMMD9,COMM domain-containing protein 9,37900,0.00139944442770148,0.00377949613159389,-0.00600836799022254,0.0088072568456255,0.71118510659424
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00160827258117586,0.00440276708135009,-0.010237696060622,0.00702115089827032,0.714903243457436
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EVI2B,Protein EVI2B,37482,0.00148736704844445,0.00407224761175781,-0.00649423827060086,0.00946897236748975,0.714934647205351
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SDK2,Protein sidekick-2,37671,-0.001329520101698,0.00368979501561701,-0.00856151833230734,0.00590247812891134,0.71861093429024
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK15,Kallikrein-15,37880,0.00177687462582944,0.0049339530383767,-0.00789367332938889,0.0114474225810478,0.718754049602075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,VEGFB,Vascular endothelial growth factor B,37598,0.000988660243950069,0.00274706054966006,-0.00439557843338366,0.00637289892128379,0.718929562637597
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00241195465705013,0.00670250494616298,-0.0155488643515296,0.0107249550374293,0.718957709969403
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,-0.0014221860613997,0.00395868129114907,-0.00918120139205188,0.00633682926925248,0.719408264219829
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00109861627859808,0.0031448662932223,-0.00506532165611763,0.00726255421331379,0.726842417467385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.00180971299175624,0.00518060658703907,-0.00834427591884034,0.0119637019023528,0.726850431281115
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOP56,Nucleolar protein 56,37562,0.00369108356285026,0.0106643847031357,-0.0172111104552958,0.0245932775809963,0.729263250828673
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTNL10,Butyrophilin-like protein 10,37482,-0.00139928238862856,0.00404501997836603,-0.00932752154622598,0.00652895676896885,0.729403020099634
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.00189346668688324,0.00548792915182574,-0.0126498078244617,0.00886287445069521,0.7300819147974
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LMOD2,Leiomodin-2,37541,0.00215635043550469,0.00627913853066615,-0.010150761084601,0.0144634619556103,0.731291782968308
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CAPS,Calcyphosin,37942,-0.00310749490768582,0.00913444947203016,-0.0210110158728649,0.0147960260574933,0.733714908509147
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.000914927570654491,0.00270816531797143,-0.00439307645256951,0.00622293159387849,0.735488880926264
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00162005083724819,0.00480992425619167,-0.00780740070488748,0.0110475023793839,0.736261512341243
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.00142510187930086,0.00424140606966654,-0.00973825777584728,0.00688805401724555,0.736877183152153
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TEF,Thyrotroph embryonic factor,37562,0.0013890659123179,0.00415033932042852,-0.00674559915572199,0.00952373098035779,0.737866327599471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.000720386218254728,0.00215741914314498,-0.00494892773881889,0.00350815530230944,0.738451962935583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.00155378230320027,0.00471889895553764,-0.010802824256054,0.0076952596496535,0.741958393546764
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.00106982295380203,0.0032622612285069,-0.00532420905407148,0.00746385496167555,0.742962126646628
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,0.000752880386987753,0.00229754910037757,-0.00375031584975229,0.0052560766237278,0.743151567979415
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.000920141875588382,0.00282188080168691,-0.00461074449571796,0.00645102824689473,0.744372766747066
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPC5,Glypican-5,40228,-0.00175448650858758,0.00540905004031418,-0.0123562245876034,0.00884725157042822,0.745668814908182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,0.00170819349868491,0.00529743226331627,-0.00867477373741498,0.0120911607347848,0.747111746792986
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL21R,Interleukin-21 receptor,37598,0.00172912939930078,0.0054019377584034,-0.00885866860716989,0.0123169274057714,0.74890194570189
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,APOL1,Apolipoprotein L1,37987,-0.00199406231225124,0.00627251506873938,-0.0142881918469804,0.0103000672224779,0.75056209647401
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSAP,Prosaposin,37901,-0.000861047841993007,0.00273417733149158,-0.00622003541171651,0.00449793972773049,0.752827082415618
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.00166554526887404,0.00532135797278865,-0.0120954068955398,0.00876431635779172,0.754291194432241
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,-0.00136735749476147,0.0043976930600201,-0.00998683589240086,0.00725212090287793,0.755861698831256
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.00156211855808079,0.00504767834890657,-0.00833133100577609,0.0114555681219377,0.756966903876746
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PALM3,Paralemmin-3,37562,0.00216250143051853,0.00698782945301593,-0.0115336442973927,0.0158586471584297,0.756971358540898
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.00218762317517319,0.00707183113072164,-0.0160484121913876,0.0116731658410412,0.757064451995467
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00104003700380582,0.00339753003786561,-0.00561912187041077,0.00769919587802242,0.75952146521754
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00123978750952308,0.00405359437444983,-0.00918483248344475,0.00670525746439859,0.75972441046097
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.00334391812279936,0.0109708224499028,-0.0181588938790102,0.0248467301246089,0.760522383422248
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,-0.0011572897967645,0.00384389165086134,-0.00869131743245273,0.00637673783892374,0.763363200149379
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.00502624102969536,0.0167026798341736,-0.0277110114452848,0.0377634935046756,0.763476926938547
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,-0.00181712717926337,0.00606657259733864,-0.0137076094700471,0.0100733551115204,0.764539592652064
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL36A,Interleukin-36 alpha,37598,0.00170107146774682,0.00570211846358277,-0.0094750807208754,0.012877223656369,0.765461583091364
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00138644774376042,0.00464938082344055,-0.00772633867018305,0.0104992341577039,0.765554843548965
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.00236313798203913,0.00793594584661146,-0.0179175918413976,0.0131913158773193,0.765877663768529
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HK2,Hexokinase-2,40042,-0.000792746757647792,0.00267541804032166,-0.00603656611667824,0.00445107260138265,0.766999112490494
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,-0.00107151985503779,0.00362331817950657,-0.00817322348687066,0.00603018377679508,0.767441072322043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,-0.00149590618612831,0.00507019160214532,-0.0114334817263331,0.00844166935407652,0.767968424649977
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,-0.00114984582385956,0.00390149321844183,-0.00879677253200554,0.00649708088428642,0.768212898641075
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DEFB118,Beta-defensin 118,37541,0.00164584447923323,0.00562785910805841,-0.00938475937256125,0.0126764483310277,0.769950332146177
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00397319514489771,0.0136769622889216,-0.0228336509413886,0.0307800412311841,0.771436271103073
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,-0.00112103967219898,0.00388076653118273,-0.00872734207331712,0.00648526272891917,0.772684915222511
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.000951149279355263,0.00343161446760234,-0.00577481507714532,0.00767711363585585,0.781651874989191
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MATN2,Matrilin-2,40379,0.000794341257521332,0.00286799471569232,-0.00482692838523561,0.00641561090027828,0.781808674241672
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ATXN10,Ataxin-10,39961,-0.00193631476529764,0.00699923855567282,-0.0156548223344164,0.0117821928038211,0.782055251563502
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINB5,Serpin B5,40042,0.00129745488152396,0.00471933960510389,-0.00795245074447966,0.0105473605075276,0.783379059092933
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00229587597097914,0.00837935707143587,-0.0141276638890352,0.0187194158309934,0.784095159211676
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.00160003333420897,0.00587023998749662,-0.0131057037097023,0.0099056370412844,0.78519037370032
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,S100A3,Protein S100-A3,37900,-0.00118918368198542,0.00442380476455399,-0.00985984102051124,0.00748147365654039,0.788076416206211
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.000648412510316659,0.00241614354953237,-0.00538405386740011,0.00408722884676679,0.788421138744686
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00101513655642431,0.00378676985838181,-0.00843720547885266,0.00640693236600403,0.788646166907442
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TOP1,DNA topoisomerase 1,37901,-0.00271932672094345,0.0102821861674694,-0.0228724116091835,0.0174337581672966,0.791422060118695
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMOD4,Tropomodulin-4,37482,-0.00105648253723155,0.00404592792552304,-0.0089865012712567,0.00687353619679361,0.794002220665332
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SKIV2L,Helicase SKI2W,37562,-0.00102073469136543,0.00391211679866468,-0.00868848361674821,0.00664701423401734,0.794161221527182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FAM171B,Protein FAM171B,37900,0.000690498223126168,0.00266666928405026,-0.00453617357361234,0.00591717001986467,0.795688137149825
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CYTH3,Cytohesin-3,37482,0.00183785929842495,0.00712947800297583,-0.0121359175874077,0.0158116361842576,0.796578340310923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.00115177370309552,0.00447056292017418,-0.00761052962044588,0.00991407702663691,0.796692620011709
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00141530773576214,0.00550585764784152,-0.0122067887255315,0.00937617325400724,0.797139707239923
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NLGN1,Neuroligin-1,37572,0.00170558417221275,0.00674104788858062,-0.0115068696894053,0.0149180380338308,0.800260822003527
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.00152412852003481,0.00606084930758839,-0.0103551361228384,0.013403393162908,0.801453815112325
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00125406298577437,0.00501663628676854,-0.00857854413629196,0.0110866701078407,0.802606077564515
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.00129269422207003,0.00521194367869179,-0.0115081038323059,0.00892271538816588,0.80411869145483
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,-0.000546931147377072,0.00222167718592767,-0.0049014184317953,0.00380755613704116,0.805546518751462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.00104683632429995,0.00425408965113494,-0.00729117939192454,0.00938485204052444,0.805625987203462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK12,Kallikrein-12,39980,0.00339846795609888,0.0138274274724626,-0.0237032898899279,0.0305002258021256,0.805857869152227
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,-0.000961758078938064,0.00395281611154554,-0.00870927765756733,0.0067857614996912,0.807769284667163
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,STXBP1,Syntaxin-binding protein 1,37959,0.00180546059478957,0.00743747967422993,-0.0127719995667011,0.0163829207562802,0.808201465189658
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00102258311445447,0.00421320266037518,-0.00928046032878983,0.00723529409988089,0.808234454055333
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.00170609866179986,0.0070509229938191,-0.0155259077296853,0.0121137104060856,0.808808647724942
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,-0.000657223880663797,0.00272710566854444,-0.0060023509910109,0.0046879032296833,0.809560671366692
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,0.000728481959739545,0.00304071768823835,-0.00523132470920762,0.00668828862868671,0.810662324600897
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TSHB,Thyrotropin subunit beta,40359,0.00193783424070823,0.00809832420707362,-0.0139348812051561,0.0178105496865725,0.810885119257136
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EBI3_IL27,Interleukin-27,40453,-0.00071887929444648,0.0030130424556653,-0.00662444250755047,0.00518668391865751,0.811427220180298
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLSPN,Claspin,39925,-0.000765783550053535,0.00330176166393284,-0.0072372364113619,0.00570566931125483,0.816594046516555
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.000740489186654824,0.00319456283520121,-0.00552085397033956,0.0070018323436492,0.816698947119783
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00174514134203033,0.00755601450352733,-0.0165549297689439,0.0130646470848832,0.81734894031836
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CHGB,Secretogranin-1,40406,-0.000896265063983846,0.00388980309420803,-0.00852027912863158,0.00672774900066389,0.817773042888223
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,0.00218305631733151,0.00972563412609866,-0.0168791865698219,0.0212452992044849,0.822399612174545
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00108953046483294,0.00486884947334449,-0.00845341450292226,0.0106324754325881,0.822935273917462
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.00187718757511258,0.00841336734111948,-0.0183673875637068,0.0146130124134816,0.823445779293889
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.000773752457607944,0.0035217742826443,-0.00612892513637488,0.00767643005159077,0.826103472240119
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,-0.00267543257555428,0.01222083599914,-0.0266282711338686,0.0212774059827601,0.826712237815157
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,-0.00147939884214708,0.00677933664040012,-0.0147668986573313,0.0118081009730372,0.827259717607564
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.00100076270743036,0.00461750544992501,-0.0100510733892834,0.00804954797442265,0.828419799578623
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HLA_A,,37959,-0.000681285731850686,0.00314972565641343,-0.00685474801842101,0.00549217655471964,0.828757157575823
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.00084534603841586,0.00392199743629368,-0.00853246101355148,0.00684176893671976,0.829349357364219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYO6,Unconventional myosin-VI,37959,0.00077436504092768,0.00360785262258934,-0.00629702609934742,0.00784575618120278,0.830056528555513
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.00100326125319843,0.00467535309262373,-0.0101669533147409,0.00816043080834408,0.830094027512246
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.000762566692732812,0.00363918662853593,-0.00637023909919761,0.00789537248466323,0.834027459193945
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,0.000958679849290972,0.00471223568012953,-0.00827730208376291,0.0101946617823449,0.838790040825929
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.000919260977892237,0.0047183676487647,-0.00832873961368657,0.010167261569471,0.845532063251819
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,-0.000634485109150114,0.00332979345698633,-0.00716088028484331,0.00589191006654308,0.848882786110533
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.00198638869371477,0.0104473023192895,-0.0224631012395222,0.0184903238520926,0.849206977779583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KLK6,Kallikrein-6,40387,0.00055603227318966,0.0029417059581711,-0.00520971140482569,0.00632177595120501,0.850081943222703
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.000763136325328827,0.00410610230010372,-0.00728482418287447,0.00881109683353213,0.852561896560092
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CORO6,Coronin-6,37541,0.000647294752400449,0.00351891614967507,-0.00624978090096268,0.00754437040576358,0.854057730311316
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAG,Myelin-associated glycoprotein,37572,-0.00081874251422776,0.00450811640730826,-0.00965465067255195,0.00801716564409643,0.855887516028583
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00177940859984865,0.0098190180693931,-0.0210246840158591,0.0174658668161618,0.856197204858129
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.000556048574565626,0.00306982363091557,-0.0054608057420289,0.00657290289116015,0.85626491651946
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.000929031450414666,0.00513881173280777,-0.0110011024467179,0.00914303954588856,0.856536962684746
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.000466007182344404,0.00262616419188769,-0.00561328899844427,0.00468127463375546,0.859158864065172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYOM2,Myomesin-2,37562,0.000800241145921415,0.00452557441887039,-0.00806988471506455,0.00967036700690737,0.859647463409329
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL11,Interleukin-11,40044,0.00107658856806573,0.00616591546507608,-0.0110086057434834,0.0131617828796149,0.861393701355596
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL31,Interleukin-31,37598,0.000952627317752802,0.00561365063102216,-0.0100501279190506,0.0119553825545562,0.865249973384873
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00138424940597642,0.00816528737406104,-0.017388212659136,0.0146197138471832,0.865383495953639
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NEO1,Neogenin,37959,0.000343151011099703,0.00205426736953799,-0.00368321303319475,0.00436951505539416,0.867338705380046
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRTAP,Cartilage-associated protein,37572,0.00076899431154252,0.00468012000707223,-0.00840404090231906,0.0099420295254041,0.869489002952943
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL1A,Interleukin-1 alpha,40044,0.00085421393445969,0.00520160975138106,-0.00934094117824719,0.0110493690471666,0.869559241145385
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF7,Fibroblast growth factor 7,37482,0.0012581513337201,0.00783182310514065,-0.0140922219523556,0.0166085246197958,0.872374684916771
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000556390233391518,0.00349971597977229,-0.00630305308696216,0.0074158335537452,0.873685860583707
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.000560195326343011,0.00355347352472382,-0.00640461278211568,0.0075250034348017,0.874737126083197
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,-0.000751596763708196,0.00481179077506063,-0.010182706682827,0.00867951315541064,0.87587859736055
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.000806640402542507,0.00529595922312812,-0.0095734396747886,0.0111867204798736,0.87894286138978
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,0.00109644232993036,0.00721348030063384,-0.013041979059312,0.0152348637191727,0.879189977699574
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTR,Methionine synthase,37562,-0.000950748582533002,0.00630796659518382,-0.0133143631090933,0.0114128659440273,0.880197431719736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,-0.000385764554195422,0.00258891562952526,-0.00546003918806494,0.0046885100796741,0.88155094262619
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,-0.000960965574112214,0.00656420155377699,-0.0138268006195151,0.0119048694712907,0.883611884968182
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,0.00127842250820255,0.00879484130043328,-0.0159594664406467,0.0185163114570518,0.884428475124955
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.000616308560852388,0.00432139556843316,-0.00785362675327661,0.00908624387498138,0.886594082223842
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.000506129348055761,0.0035630392801095,-0.00647742764095886,0.00748968633707038,0.887042777514176
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FN1,Fibronectin,38013,-0.000358417656021781,0.00252328757366643,-0.00530406130040799,0.00458722598836443,0.887047425021882
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NECTIN1,Nectin-1,37598,0.000436277105065266,0.00307710819350675,-0.00559485495420797,0.0064674091643385,0.887254746866139
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.000524292646498036,0.00375130620431522,-0.00787685280695587,0.00682826751395979,0.888849268362584
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,-0.00113905235091383,0.0082645073633042,-0.0173374867829901,0.0150593820811624,0.890381168699059
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRELP,Prolargin,40357,-0.000298596768073191,0.00224577464649328,-0.00470031507520003,0.00410312153905365,0.894227200169149
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.00046957648023575,0.00358359693358282,-0.00749342647005808,0.00655427350958658,0.895749311766849
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00036800256778839,0.00284208839941925,-0.00593849583065012,0.00520249069507334,0.896977278085471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TMEM25,Transmembrane protein 25,37959,-0.000542335876838381,0.00422012155237844,-0.00881377411950011,0.00772910236582335,0.897745787686793
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL9,Interleukin-9,37714,-0.00070042720698492,0.0055524923378514,-0.0115833121891737,0.0101824577752038,0.899617910166034
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.000598037128020708,0.00480372551302367,-0.0100133391335471,0.00881726487750568,0.900925649018544
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.000651714889261425,0.00529213200846746,-0.0097208638473348,0.0110242936258576,0.901991829463498
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PVALB,Parvalbumin alpha,40417,0.00134201988745085,0.0109116284645496,-0.0200447719030664,0.0227288116779681,0.902116658992212
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.000801308606880643,0.00658384826694394,-0.0137056512100908,0.0121030339963295,0.903131944799827
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,0.000916646799771751,0.0075509760247366,-0.013883266208712,0.0157165598082555,0.903380448797591
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CRX,Cone-rod homeobox protein,40042,-0.00124418553521223,0.0103925945365134,-0.0216136708267784,0.019125299756354,0.904707709899894
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.000305218257171012,0.00257594309208798,-0.00535406671766345,0.00474363020332143,0.905682524022031
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,-0.000556414502181984,0.00472395561303434,-0.0098153675037293,0.00870253849936533,0.906239250821648
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PKD1,Polycystin-1,37990,0.000290515490979781,0.00248983008210495,-0.00458955146994593,0.00517058245190549,0.907114696649199
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.000469060376379349,0.00405749544923519,-0.00748363070412163,0.00842175145688033,0.907968612970622
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,-0.000775052705146588,0.0069052068174185,-0.0143092580672869,0.0127591526569937,0.910633421141043
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MB,Myoglobin,40536,0.000532530874780262,0.00474461089021232,-0.00876690647003588,0.0098319682195964,0.910635225239342
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CST6,Cystatin-M,39992,-0.000517087734953071,0.00461388032677366,-0.00956029317542944,0.0085261177055233,0.910767604431039
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.000597752250033139,0.00538825209962201,-0.009963221865226,0.0111587263652923,0.911668334975029
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,FGF6,Fibroblast growth factor 6,37598,0.000460162396362281,0.00414892520883832,-0.00767173101296084,0.0085920558056854,0.911688433780079
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CA8,Carbonic anhydrase-related protein,37598,-0.00028558868657511,0.00268273443264386,-0.00554374817455708,0.00497257080140686,0.915223516128219
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NRXN3,Neurexin-3,37572,0.000350744199677083,0.00336946039758187,-0.00625339817958339,0.00695488657893756,0.917095498116107
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,0.000436452631518717,0.00419570760928585,-0.00778713428268154,0.00866003954571897,0.917152209789713
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.00056058588054988,0.00541091042293613,-0.0100447985484049,0.0111659703095047,0.917486090097902
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,0.000204532743766845,0.00206742656100698,-0.00384762331580684,0.00425668880334052,0.92119446561675
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,-0.000247770262471789,0.00250994735312344,-0.00516726707459374,0.00467172654965016,0.921365769387607
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,EXOSC10,Exosome component 10,37562,0.000595338250871447,0.00605566729348423,-0.0112737696443576,0.0124644461461005,0.921686906587841
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.000737076347314622,0.00759170403198633,-0.0156168162500078,0.0141426635553786,0.922656632094025
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.000246403459233125,0.00277284928606872,-0.00518838114146157,0.00568118805992782,0.929191990939471
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.000309825580119,0.00362497084710611,-0.00741476844044697,0.00679511728020898,0.931889192051301
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.000330139459582908,0.00386955940730715,-0.00791447589790492,0.00725419697873911,0.932010584292884
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.00018313596697423,0.00218184526824975,-0.00409328075879528,0.00445955269274374,0.933108152143939
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRR5,Proline-rich protein 5,37598,0.000389343037525738,0.00465264687338753,-0.00872984483431382,0.0095085309093653,0.933310501689132
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,-0.000429003102286294,0.00552576156666921,-0.0112594957729579,0.0104014895683854,0.938118060703566
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CPA4,Carboxypeptidase A4,37410,-0.000328347839849712,0.00424508755854765,-0.00864871945460312,0.00799202377490369,0.938348124462127
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCC,Netrin receptor DCC,37572,-0.000167615143425677,0.00225813312353487,-0.00459355606555402,0.00425832577870266,0.940830648550539
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.00076535430553725,0.0108958137269543,-0.0221211492103677,0.0205904405992932,0.944001318844736
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PCDH12,Protocadherin-12,37959,0.000169889938843132,0.00246637799873568,-0.0046642109386788,0.00500399081636506,0.945084278965082
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.000417005301227538,0.00605747868855541,-0.0122896635307961,0.0114556529283411,0.945116899444304
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYL6B,Myosin light chain 6B,37572,0.000613928023641087,0.00894802416312068,-0.0169241993360755,0.0181520553833576,0.945300740869423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.000385229691207921,0.00574244794019279,-0.0116404276539858,0.0108699682715699,0.946515232120389
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.000225813733271134,0.00368270457593703,-0.00744391470210771,0.00699228723556544,0.951107397705998
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NTF3,Neurotrophin-3,40341,-0.00020473058024235,0.00336975179622621,-0.00680944410084573,0.00639998294036103,0.951554783423
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,0.000395754395166305,0.00658612288460428,-0.0125130464586581,0.0133045552489907,0.952085540092576
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,-0.000702556021874991,0.0116986484187422,-0.0236319069226097,0.0222267948788597,0.952113032379941
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LTB,Lymphotoxin-beta,37900,-0.000202443100140002,0.00341143006468628,-0.00688884602692512,0.00648395982664511,0.952680119654614
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CASQ2,Calsequestrin-2,37562,0.000284925539226678,0.00483376807758549,-0.00918925989284089,0.00975911097129424,0.952996965537641
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,-0.000275015504673821,0.00491810757782205,-0.00991450635720505,0.0093644753478574,0.955407211615128
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,-0.000268727526896981,0.00491931754014244,-0.00991058990557617,0.0093731348517822,0.956436464977677
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CFD,Complement factor D,38013,-9.50890806637769e-05,0.00183521769259022,-0.0036921157581406,0.00350193759681305,0.958678049222631
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.000298166011360515,0.0057811477060118,-0.0116292155151436,0.0110328834924226,0.9588676683141
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,IFNL1,Interferon lambda-1,39961,-0.000221434617591396,0.00438329944663111,-0.00881270153298837,0.00836983229780558,0.959710420673196
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,-0.000116934152030103,0.00236110253787249,-0.00474469512626019,0.00451082682219998,0.960501351778121
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAP1,Antigen peptide transporter 1,37714,0.000292962791216296,0.00595491820920074,-0.0113786768988171,0.0119646024812497,0.96076321951176
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TAGLN3,Transgelin-3,37482,0.000285254485341007,0.00589556722346305,-0.0112700572726466,0.0118405662433286,0.961410497772666
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TTN,Titin,37562,-0.000297658593247225,0.006326802937489,-0.0126981923507257,0.0121028751642312,0.962476296625468
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.000251701129941868,0.00539417695436306,-0.0103208857006097,0.0108242879604935,0.962783620913971
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,-0.000211932420296235,0.00488455536326153,-0.00978566093228884,0.00936179609169637,0.965392680434041
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,-0.000171265230270906,0.00395752687079321,-0.0079280178970256,0.00758548743648379,0.965482321292638
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000177039513158,0.00415098618594593,-0.00831297243761202,0.00795889341129602,0.965981195659831
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,-0.000143486899406571,0.00408720586127635,-0.00815441038750821,0.00786743658869507,0.971995468147452
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.000149318545441552,0.00428212736203946,-0.0085422881750389,0.0082436510841558,0.972183777791855
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.000148607863633194,0.00468800586419031,-0.00933709935744619,0.00903988363017981,0.974712104439609
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00022031099248408,0.00700812801735821,-0.013515619921538,0.0139562419065062,0.974921913638777
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.000180509259713485,0.00585771074917999,-0.0113006038086793,0.0116616223281063,0.975417016291718
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00021136492679502,0.00819830910622159,-0.0162800507749893,0.0158573209213993,0.979431928046392
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,7.53171883376572e-05,0.00303198058233699,-0.00586736475304284,0.00601799912971816,0.980182226304516
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SERPINI1,Neuroserpin,37642,7.63251322831359e-05,0.00308380949052114,-0.0059679414691383,0.00612059173370457,0.980254528271272
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,-0.000191463135123716,0.00837411068475225,-0.0166047200772381,0.0162217938069907,0.981759294646732
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LPO,Lactoperoxidase,39831,0.00012972497125837,0.00572977935437002,-0.0111006425633069,0.0113600925058236,0.981937345171105
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DRAXIN,Draxin,40228,9.28488597433702e-05,0.00418755752890879,-0.00811476389691786,0.0083004616164046,0.982310588632773
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,NME1,Nucleoside diphosphate kinase A,37598,4.32219461536403e-05,0.00211701370449792,-0.00410612491466229,0.00419256880696957,0.983711455518958
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.000140572170597516,0.0078171892262083,-0.0151811187127708,0.0154622630539658,0.985653133817833
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,-9.06552561942476e-05,0.00729845978109088,-0.0143956364271324,0.0142143259147439,0.990089801153293
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,MANSC4,MANSC domain-containing protein 4,37562,-6.02503732329458e-05,0.00633248468927342,-0.0124719203642088,0.0123514196177429,0.992408793246766
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-2.89752683548535e-05,0.00449416651475469,-0.00883754163727404,0.00877959110056434,0.994855925067512
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,1.79732515948682e-05,0.00558998167265875,-0.0109383908268163,0.010974337330006,0.997434645766172
NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-1.253039176985e-05,0.005662964766437,-0.0111119413339864,0.0110868805504467,0.998234557793515
